<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:media="http://search.yahoo.com/mrss/"><channel><title>MedRise: medical news and analysis</title><link>https://med-rise.com/medical-news</link><description>Medical news, analysis and guides for medical students, residents and GME programs.</description><language>en-us</language><copyright>&#169; 2026 ViaAI LLC</copyright><lastBuildDate>Sun, 15 Nov 2026 14:55:25 -0600</lastBuildDate><atom:link href="https://med-rise.com/feed.xml" rel="self" type="application/rss+xml"/><image><url>https://med-rise.com/images/icons/icon-512.png</url><title>MedRise: medical news and analysis</title><link>https://med-rise.com/medical-news</link></image><item><title>SOAP 2027 Match Week Runs March 15-18, With All Four Offer Rounds on One Thursday</title><link>https://med-rise.com/articles/soap-2027-match-week</link><guid isPermaLink="true">https://med-rise.com/articles/soap-2027-match-week</guid><pubDate>Sun, 15 Nov 2026 14:55:25 -0600</pubDate><dc:creator>MedRise News Desk (with AI assistance)</dc:creator><category>Guide</category><category>Articles</category><description>SOAP 2027 Match Week runs March 15-18, with all four offer rounds on Thursday. See the hour-by-hour schedule, eligibility rules and 2026 SOAP results.</description><content:encoded><![CDATA[<p>SOAP for the 2027 Match opens Monday, March 15, and all four offer rounds fall on Thursday, March 18, between 9 a.m. and 8 p.m. ET, the <a href="https://www.nrmp.org/wp-content/uploads/2026/03/2027-MRM-Week-and-SOAP-Calendar-FINAL.pdf">NRMP's 2027 calendar</a> shows. In 2026, programs sent 4,333 SOAP offers; 1,586 were turned down.</p>
<p>The squeeze matters most to international medical graduates. IMGs made up 68.4% of the 13,820 applicants who were SOAP-eligible in 2026, according to the NRMP's <a href="https://www.nrmp.org/wp-content/uploads/2026/05/Main_Match_Results_and_Data-2026.pdf">Results and Data report</a>, and four days in March can decide whether training starts this July or a year later.</p>
<p>The market is crowded. The same report counted 2,851 positions placed in SOAP, almost five eligible applicants per position, although not every eligible applicant takes part. When SOAP closed, 2,632 of those positions had been filled and 219 were still open.</p>
<h2>The 2027 SOAP clock, from Monday's email to Thursday's last round</h2>
<p>All times are Eastern. SOAP fills the first four days of Match Week.</p>
<div class="post-table"><table>
<caption>SOAP 2027 schedule (ET). Source: NRMP 2027 Match Week and SOAP calendar.</caption>
<thead><tr><th>Day</th><th>Time</th><th>What happens</th></tr></thead>
<tbody>
<tr><td>Mon, March 15</td><td>10 a.m.</td><td>You learn by email and in the NRMP's R3 system whether you matched, but not where. SOAP opens, and eligible applicants see the List of Unfilled Programs under the SOAP tab.</td></tr>
<tr><td>Mon, March 15</td><td>11 a.m.</td><td>You can start preparing applications in the service each program requires.</td></tr>
<tr><td>Tue, March 16</td><td>8 a.m.</td><td>Programs start reviewing applications and may contact and interview applicants.</td></tr>
<tr><td>Tue, March 16</td><td>11:30 a.m.</td><td>Programs can begin building SOAP preference lists. Applicants do not rank programs.</td></tr>
<tr><td>Wed, March 17</td><td>All day</td><td>Reviews, interviews and preference lists continue.</td></tr>
<tr><td>Thu, March 18</td><td>9 a.m. to 11 a.m.</td><td>Round 1: offers released, then the deadline to accept or reject.</td></tr>
<tr><td>Thu, March 18</td><td>12 p.m. to 2 p.m.</td><td>Round 2</td></tr>
<tr><td>Thu, March 18</td><td>3 p.m. to 5 p.m.</td><td>Round 3</td></tr>
<tr><td>Thu, March 18</td><td>6 p.m. to 8 p.m.</td><td>Round 4</td></tr>
<tr><td>Thu, March 18</td><td>9 p.m.</td><td>SOAP ends. An updated List of Unfilled Programs, including programs that did not take part in SOAP, opens to remaining unmatched and partially matched applicants.</td></tr>
<tr><td>Fri, March 19</td><td>12 p.m.</td><td>Match Day: results by email and in R3.</td></tr>
<tr><td>Fri, April 30</td><td>11:59 p.m.</td><td>The post-SOAP list is no longer available in R3.</td></tr>
</tbody>
</table></div>
<p>Each offer window lasts two hours. Before rounds 2, 3 and 4, programs can change and re-certify their preference lists until five minutes before the hour, so a quiet morning does not mean the day is over.</p>
<h2>What 2026 showed: 4,333 offers, 2,632 acceptances</h2>
<p>Of the 4,333 offers sent to applicants in 2026, 2,632 were accepted, 1,586 were rejected and 115 were left to expire, the NRMP reported.</p>
<p>The rejection count needs context. When you accept one offer, the R3 system automatically rejects any other offer you hold for the same training year, according to the NRMP's <a href="https://www.nrmp.org/wp-content/uploads/2021/08/SOAP_View_Respond_to_Offers_MRM-App.pdf">guide to viewing and responding to SOAP offers</a>. The report does not say how many of the 1,586 rejections happened that way.</p>
<p><strong>Where the positions were.</strong> Family medicine had 898 SOAP positions, internal medicine 532 (512 categorical and 20 primary care) and pediatrics 177. Another 917, about a third of the total, were PGY-1-only: 559 in preliminary surgery, 197 transitional year, 150 preliminary internal medicine and 11 preliminary OB/GYN.</p>
<p>Together those categories held nearly nine in ten SOAP positions. For the full picture of which specialties had open seats before SOAP, see <a href="https://med-rise.com/articles/unfilled-residency-positions-by-specialty-2026-match">unfilled residency positions by specialty: 2026 Match data</a>.</p>
<div class="post-table"><table>
<caption>How SOAP changed placement rates in 2026 (active applicants). Source: NRMP Results and Data 2026, Table 4A.</caption>
<thead><tr><th>Applicant type</th><th>Matched by the algorithm</th><th>Placed after SOAP</th><th>Gain</th></tr></thead>
<tbody>
<tr><td>U.S. MD seniors</td><td>93.5%</td><td>97.8%</td><td>+4.3 points</td></tr>
<tr><td>U.S. DO seniors</td><td>93.2%</td><td>98.5%</td><td>+5.3 points</td></tr>
<tr><td>U.S. citizen IMGs</td><td>70.0%</td><td>77.8%</td><td>+7.8 points</td></tr>
<tr><td>Non-U.S. citizen IMGs</td><td>56.4%</td><td>59.9%</td><td>+3.5 points</td></tr>
<tr><td>All applicants</td><td>79.8%</td><td>84.7%</td><td>+4.9 points</td></tr>
</tbody>
</table></div>
<p>SOAP lifted U.S. citizen IMGs more than any other group and non-U.S. citizen IMGs the least. Across the Match and SOAP combined, programs filled 99.3% of positions, according to the NRMP's <a href="https://www.nrmp.org/about/news/2026/05/new-reports-2026-main-residency-match-outcome-and-demographic-reports/">May 26, 2026 report announcement</a>. For the wider results, read <a href="https://med-rise.com/articles/2026-nrmp-match-results-what-they-mean-for-imgs">2026 NRMP Match results: what they mean for IMGs</a>.</p>
<h2>Who can use SOAP in 2027, and the March 3 deadline that decides it</h2>
<p>There is no separate SOAP registration. To take part, you must be registered for the Main Residency Match, be fully or partially unmatched, and be verified as eligible to start graduate medical education on July 1, according to the NRMP's <a href="https://www.nrmp.org/wp-content/uploads/2026/02/Navigating-MW-SOAP-for-Applicants.pdf">2026 Match Week and SOAP guide for applicants</a>.</p>
<ul>
<li><strong>Register early.</strong> Standard registration closes Friday, January 29, 2027, at 11:59 p.m. ET; after that, a $50 late fee applies. The last chance to register and be eligible for SOAP is Wednesday, March 3, 2027, at 9 p.m. ET, per the <a href="https://www.nrmp.org/wp-content/uploads/2026/03/2027-Main-Residency-Match-Calendar-FINAL.pdf">2027 Main Residency Match calendar</a>.</li>
<li><strong>IMGs: finish verification by March 3.</strong> ECFMG says passing results for the exams required for certification must be available by the rank order list deadline, though you do not need to be fully certified to enter the Match (<a href="https://www.ecfmg.org/eras/applicants-nrmp.html">ECFMG</a>).</li>
<li><strong>Partial matches have limits.</strong> An applicant matched to an advanced PGY-2 position, for example, may apply only to preliminary positions.</li>
<li><strong>The NRMP decides eligibility.</strong> The List of Unfilled Programs shows each applicant only the programs they are eligible for, according to the <a href="https://www.nrmp.org/residency-applicants/soap/">NRMP's SOAP page</a>.</li>
</ul>
<p>If you are not SOAP-eligible, you cannot use SOAP. Under the 2027 calendar, you may apply to and contact non-SOAP and non-Match programs from Tuesday, March 16, and accept their offers from Thursday, March 18.</p>
<h2>Five SOAP rules that can cost you the week</h2>
<ol>
<li><strong>Wait for the program to call.</strong> Apart from submitting an application, you and your representatives may not contact a program until it contacts you. Our explainer on <a href="https://med-rise.com/articles/nrmp-questions-answered">NRMP Match rules and common violations</a> covers what counts as a breach.</li>
<li><strong>Budget your 45 applications.</strong> In 2026, applicants could apply to up to 45 programs for all of SOAP within each application service, and submitted applications could not be withdrawn. The NRMP lists its 2027 applicant guide as coming in early 2027, so confirm the limit then. Programs you applied to see your application in every round, and the rounds "indicate when offers are made, not when applications are reviewed" (<a href="https://www.nrmp.org/help/item/do-i-need-to-reapply-to-programs-after-the-first-soap-round/">NRMP</a>).</li>
<li><strong>Use the program's application service.</strong> Most specialties used ERAS in 2026, while emergency medicine and OB/GYN used ResidencyCAS. The List of Unfilled Programs shows which service each program requires. You may also apply to a specialty different from the one you chose in the main season.</li>
<li><strong>Commit only through R3.</strong> A program cannot ask you to commit before its offer reaches you in R3, and an accepted offer is "a binding commitment under the Match Participation Agreement," the NRMP's 2026 guide says.</li>
<li><strong>Answer before each deadline.</strong> Offers you neither accept nor reject expire automatically, and a rejected or expired offer will not be extended to you again in a later round.</li>
</ol>
<h2>Your Thursday decision table: settle these before March 15</h2>
<p>Most programs contact SOAP applicants by phone or email and hold brief phone or video interviews, according to the <a href="https://www.nrmp.org/help/item/do-programs-usually-conduct-interviews-during-soap/">NRMP</a>. Make the hard decisions in advance.</p>
<div class="post-table"><table>
<caption>SOAP offer scenarios and what to weigh</caption>
<thead><tr><th>Situation on March 18</th><th>What to weigh</th></tr></thead>
<tbody>
<tr><td>An offer from a categorical program you would attend</td><td>Accepting is binding and settles that training year. List in advance which programs you would accept on sight.</td></tr>
<tr><td>An offer from a preliminary or transitional-year program</td><td>It is a one-year position, so you will reapply. Ask where its past preliminary residents went next.</td></tr>
<tr><td>Two offers in the same round</td><td>Accepting one makes R3 reject the other offers for that year automatically. Compare them before you click.</td></tr>
<tr><td>No offer in round 1</td><td>Programs re-certify their lists before rounds 2, 3 and 4. Keep your phone and email open until 8 p.m.</td></tr>
<tr><td>Still unplaced at 9 p.m.</td><td>Use the post-SOAP list, contact programs directly, and start planning the next cycle.</td></tr>
</tbody>
</table></div>
<p>The evidence on preliminary years is thin but useful. A two-center study of 287 OB/GYN reapplicants from 2017 to 2024, published in 2026 in the <a href="https://doi.org/10.1016/j.jsurg.2026.104125">Journal of Surgical Education</a>, found that 82% entered SOAP and 71% of those with known outcomes eventually matched into OB/GYN.</p>
<p>Surgical preliminary years, especially in OB/GYN and general surgery, were linked with better re-match results than nonsurgical ones. The study covers one specialty at two institutions, so treat it as a signal, not a rule.</p>
<h2>What to do before Match Week: a 2027 SOAP checklist</h2>
<ol>
<li>Confirm your NRMP registration and certify your rank order list by Wednesday, March 3, 2027, at 9 p.m. ET.</li>
<li>If you are an IMG, check with ECFMG that your exam results and verification will be complete by March 3.</li>
<li>Choose your SOAP specialties now, using the 2026 mix above, and draft a personal statement for each.</li>
<li>Ask your letter writers whether you may assign their letters to a different specialty if you need to.</li>
<li>If you need a visa, check each program's own website for the visa types it sponsors. For immigration questions, speak with an immigration attorney or the official agency.</li>
<li>Block March 15 to 18 on your calendar and tell your school's advising office how to reach you.</li>
<li>If you are planning a stronger reapplication, build U.S. clinical experience. MedRise lists <a href="https://med-rise.com/medicine/observerships/">U.S. clinical observerships for IMGs in South Texas</a>.</li>
</ol>
<p><strong>What to watch next:</strong> the NRMP's 2027 SOAP applicant guide, due in early 2027, and the 2027 Advance Data Tables, which the NRMP plans to post publicly on Match Day. For the 2026 cycle's version of this guide, see <a href="https://med-rise.com/articles/soap-list-2025-find-unfilled-residency-positions-apply-now">The SOAP List of Unfilled Programs: Who Can See It, When, and How to Apply</a>.</p>
<p>SOAP rewards the applicant who made the hard choices in February. By the time round 1 opens at 9 a.m. on March 18, the only decision left should be yes or no.</p>
<h2>FAQ</h2>
<h3>When is SOAP 2027?</h3>
<p>From 10 a.m. ET Monday, March 15, to 9 p.m. ET Thursday, March 18, 2027. Match Day is Friday, March 19.</p>
<h3>Is there a public SOAP list?</h3>
<p>No. The List of Unfilled Programs appears inside the NRMP's R3 system at 10 a.m. on Monday of Match Week, only for SOAP-eligible applicants, and it shows each applicant only the programs they are eligible for. Treat any "full SOAP list" posted online with caution.</p>
<h3>How many programs can I apply to in SOAP?</h3>
<p>In 2026 the limit was 45 programs for all of SOAP within each application service. Check the NRMP's 2027 applicant guide when it is released in early 2027.</p>
<h3>Can I email a SOAP program to show interest?</h3>
<p>No. Apart from submitting your application, you and anyone acting for you must wait until the program contacts you.</p>
<h3>What happens if I don't get a position in SOAP?</h3>
<p>From 9 p.m. on March 18, you can use the updated List of Unfilled Programs and contact programs directly until the list closes at 11:59 p.m. ET on April 30, 2027. No new positions are added to that list after it is released. For a plan for the year ahead, read <a href="https://med-rise.com/medrise-motivation/didnt-match-or-soap-build-your-comeback-year">how to build your comeback year</a>.</p>
<h2>Sources</h2>
<ul>
<li><a href="https://www.nrmp.org/wp-content/uploads/2026/03/2027-MRM-Week-and-SOAP-Calendar-FINAL.pdf">NRMP, 2027 Main Residency Match Week and SOAP Calendar</a></li>
<li><a href="https://www.nrmp.org/wp-content/uploads/2026/03/2027-Main-Residency-Match-Calendar-FINAL.pdf">NRMP, 2027 Main Residency Match Calendar</a></li>
<li><a href="https://www.nrmp.org/wp-content/uploads/2026/05/Main_Match_Results_and_Data-2026.pdf">NRMP, Results and Data: 2026 Main Residency Match</a> (May 2026)</li>
<li><a href="https://www.nrmp.org/about/news/2026/05/new-reports-2026-main-residency-match-outcome-and-demographic-reports/">NRMP, 2026 Main Residency Match Outcome and Demographic Reports</a> (May 26, 2026)</li>
<li><a href="https://www.nrmp.org/wp-content/uploads/2026/02/Navigating-MW-SOAP-for-Applicants.pdf">NRMP, Navigating Match Week and SOAP for Applicants</a> (2026 Match)</li>
<li><a href="https://www.nrmp.org/residency-applicants/soap/">NRMP, Supplemental Offer and Acceptance Program</a></li>
<li><a href="https://www.nrmp.org/wp-content/uploads/2021/08/SOAP_View_Respond_to_Offers_MRM-App.pdf">NRMP, SOAP: View and Respond to Offers</a></li>
<li>NRMP help center: <a href="https://www.nrmp.org/help/item/do-i-need-to-reapply-to-programs-after-the-first-soap-round/">reapplying after the first SOAP round</a> and <a href="https://www.nrmp.org/help/item/do-programs-usually-conduct-interviews-during-soap/">interviews during SOAP</a></li>
<li><a href="https://www.ecfmg.org/eras/applicants-nrmp.html">ECFMG, ERAS and NRMP information for applicants</a></li>
<li>Schroeder BE, et al. <a href="https://pubmed.ncbi.nlm.nih.gov/42679672/">Outcomes of Residency Reapplication in Obstetrics and Gynecology</a>. Journal of Surgical Education, 2026 (PubMed; <a href="https://doi.org/10.1016/j.jsurg.2026.104125">doi:10.1016/j.jsurg.2026.104125</a>)</li>
</ul>
<p><em>MedRise Articles share educational information only. They are not medical, legal or immigration advice. Confirm requirements with the official organization or program.</em></p>]]></content:encoded><media:content url="https://med-rise.com/images/articles/og/soap-2027-match-week.jpg" medium="image" type="image/jpeg"/></item><item><title>Tacrolimus Toxicity During Diarrheal Illness: A Hidden Risk in Kidney Transplant Recipients</title><link>https://med-rise.com/articles/tacrolimus-toxicity-diarrhea-kidney-transplant</link><guid isPermaLink="true">https://med-rise.com/articles/tacrolimus-toxicity-diarrhea-kidney-transplant</guid><pubDate>Sun, 15 Nov 2026 14:54:31 -0600</pubDate><dc:creator>Gabriel Lipsyc</dc:creator><category>Commentary</category><category>Articles</category><description>Diarrhea can raise tacrolimus levels in kidney transplant recipients. A renal fellow explains why, how toxicity presents and what to monitor.</description><content:encoded><![CDATA[<p>Diarrhea is a common presentation in renal transplant recipients. Causes range from self-limiting gastrointestinal infections to medication-related side effects and opportunistic infections.</p>
<p>Although clinicians understandably focus on dehydration, electrolyte disturbances and infectious causes, a crucial consequence may be overlooked: diarrhea can significantly increase tacrolimus exposure and cause potentially severe drug toxicity.</p>
<p>Understanding this interaction is particularly important because tacrolimus has a narrow therapeutic index, and changes in its concentration can have serious consequences for allograft function.</p>
<h2>Why tacrolimus levels may rise during diarrhea</h2>
<p>Tacrolimus is a calcineurin inhibitor commonly used to prevent rejection after kidney transplantation. Its pharmacokinetics are complex, with significant variability between patients. They are influenced by gastrointestinal absorption, hepatic metabolism, drug interactions and genetic factors.</p>
<p>Tacrolimus is metabolized predominantly by cytochrome P450 3A enzymes (particularly CYP3A4 and CYP3A5). It is also a substrate of P-glycoprotein, a transport protein in the intestinal wall that limits drug absorption by carrying tacrolimus back into the intestinal lumen.</p>
<p>During diarrhea, intestinal inflammation and epithelial injury may reduce intestinal CYP3A activity and P-glycoprotein function. As a result, more tacrolimus can reach the systemic circulation, raising blood concentrations even though the dose has not changed.</p>
<p>This can seem counterintuitive. Clinicians may initially assume that rapid gastrointestinal transit reduces drug absorption. In transplant recipients, however, diarrhea can produce the opposite effect.</p>
<p>The increase in tacrolimus exposure may persist even after diarrhea resolves, reflecting the time required for intestinal enzyme and transporter activity to recover.</p>
<h2>Recognizing tacrolimus toxicity</h2>
<p>Tacrolimus toxicity can present with renal, neurological, metabolic and cardiovascular manifestations.</p>
<p>Acute kidney injury is particularly important in kidney transplant recipients. Tacrolimus can cause renal vasoconstriction, reducing renal blood flow and glomerular filtration. A patient presenting with diarrhea and a rising creatinine may therefore have more than one contributing mechanism at the same time: volume depletion, infection and calcineurin inhibitor toxicity.</p>
<p>Neurological symptoms include tremor, headache and paresthesia. More severe, although less common, toxicity can produce confusion, seizures or posterior reversible encephalopathy syndrome (PRES).</p>
<p>Other recognized effects include hyperkalemia, hypomagnesemia, hypertension and disturbances of glucose metabolism.</p>
<p>These findings are not specific to tacrolimus toxicity. Their presence should trigger a broader clinical assessment rather than an assumption that an elevated tacrolimus concentration fully explains each abnormality.</p>
<h2>A structured clinical assessment</h2>
<p>When a renal transplant recipient presents with diarrhea, the initial assessment should establish the severity of illness, hydration status, allograft function and potential infectious causes.</p>
<p>The history should cover symptom duration, stool frequency, fever, abdominal pain, vomiting, recent travel, exposure to antimicrobials and other medications, and sick contacts.</p>
<p>Mycophenolate mofetil, commonly part of the immunosuppressive regimen in renal transplant recipients, is a frequent contributor to gastrointestinal symptoms.</p>
<p>Infectious differentials include common bacterial and viral gastroenteritis and cytomegalovirus gastrointestinal disease. Norovirus is particularly relevant because infection may persist in immunosuppressed patients.</p>
<p>Initial investigations generally include renal function, electrolytes including magnesium, a complete blood count and a tacrolimus trough concentration. Microbiological investigations should be guided by symptom severity, duration and the patient's immunological risk.</p>
<p>The tacrolimus result must be interpreted cautiously. For twice-daily immediate-release formulations, the usual trough sample is taken approximately 12 hours after the preceding dose, immediately before the next dose. An incorrectly timed sample can lead to inappropriate dose changes.</p>
<h2>Management: more than simply reducing the dose</h2>
<p>Management begins with identifying and treating the underlying cause of diarrhea and correcting fluid and electrolyte imbalances.</p>
<p>The transplant team should be involved early when there is acute kidney injury, significant gastrointestinal illness, a marked rise in tacrolimus levels or uncertainty about immunosuppression management.</p>
<p>An elevated tacrolimus concentration may require dose reduction or temporary withholding. These decisions must be balanced against the risk of under-immunosuppression and rejection.</p>
<p>Importantly, there is no universal tacrolimus target that applies to every transplant recipient. Target concentrations depend on factors including time since transplantation, immunological risk, previous rejection and local immunosuppression protocols. Repeat trough concentrations are often required during the illness and after recovery.</p>
<p>A dose that appears safe during active diarrhea may become inappropriate once intestinal function normalizes.</p>
<p>Clinicians should also review interacting medications. Macrolide antibiotics, azole antifungals and certain calcium-channel blockers can increase tacrolimus concentrations by inhibiting CYP3A metabolism.</p>
<p>Changes to other immunosuppressive agents, particularly mycophenolate, should also be considered carefully. Although dose reduction may sometimes be necessary during severe gastrointestinal illness, uncoordinated changes can increase the risk of rejection.</p>
<h2>Why follow-up matters</h2>
<p>A single satisfactory tacrolimus result does not necessarily exclude subsequent toxicity.</p>
<p>The relationship between diarrhea and tacrolimus exposure is not linear: concentrations may rise as gastrointestinal inflammation evolves and remain elevated even after symptoms improve.</p>
<p>Patients discharged after a diarrheal illness will therefore require early repeat blood tests, particularly if their tacrolimus dose was changed during their admission.</p>
<p>Clear discharge documentation should specify the current tacrolimus formulation and dose, the most recent concentration, the target therapeutic range and the arrangements for repeat monitoring.</p>
<h2>Clinical lessons</h2>
<ul><li>Diarrhea in a transplant recipient should trigger consideration of altered tacrolimus exposure, even when the dose has not changed.</li><li>Acute kidney injury may be multifactorial. Dehydration and tacrolimus nephrotoxicity can occur at the same time, and neither excludes infection, obstruction or other allograft pathology.</li><li>Tacrolimus concentrations must be interpreted using the correct sampling interval and the patient's individual target range.</li><li>Monitoring should continue beyond the immediate illness, as tacrolimus exposure can change again after intestinal function recovers.</li></ul>
<h2>Conclusion</h2>
<p>Diarrhea in kidney transplant recipients is not only a gastrointestinal problem. It can substantially alter tacrolimus pharmacokinetics and create a risk of nephrotoxicity, among other complications.</p>
<p>For clinicians outside specialist transplant services, the most important message is straightforward: when a patient taking tacrolimus develops significant diarrhea, checking the trough concentration and discussing management with the transplant team early are essential.</p>
<h2>Sources</h2>
<ol><li>Lemahieu W, Maes B, Verbeke K, et al. Cytochrome P450 3A4 and P-glycoprotein activity and assimilation of tacrolimus in transplant patients with persistent diarrhea. Am J Transplant. 2005;5(6):1383-1391. <a href="https://pubmed.ncbi.nlm.nih.gov/15888045/">PubMed</a></li><li>Staatz CE, Tett SE. Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation. Clin Pharmacokinet. 2004;43(10):623-653. <a href="https://pubmed.ncbi.nlm.nih.gov/15244495/">PubMed</a></li><li>Anglicheau D, Flamant M, Schlageter MH, et al. Pharmacokinetic interaction between corticosteroids and tacrolimus after renal transplantation. Nephrol Dial Transplant. 2003;18(11):2409-2414. <a href="https://pubmed.ncbi.nlm.nih.gov/14551375/">PubMed</a></li><li>Maes BD, Lemahieu W, Kuypers D, et al. Differential effect of diarrhea on FK506 versus cyclosporine A trough levels and resultant prevention of allograft rejection in renal transplant recipients. Am J Transplant. 2002;2(10):989-992. <a href="https://pubmed.ncbi.nlm.nih.gov/12484345/">PubMed</a></li><li>Sato K, Amada N, Sato T, et al. Severe elevations of FK506 blood concentration due to diarrhea in renal transplant recipients. Clin Transplant. 2004;18(5):585-590. <a href="https://pubmed.ncbi.nlm.nih.gov/15344965/">PubMed</a></li><li>van Boekel GAJ, Aarnoutse RE, van der Heijden JJ, et al. Effect of mild diarrhea on tacrolimus exposure. Transplantation. 2012;94(7):763-767. <a href="https://pubmed.ncbi.nlm.nih.gov/22955188/">PubMed</a></li><li>Asano T, Nishimoto K, Hayakawa M. Increased tacrolimus trough levels in association with severe diarrhea, a case report. Transplant Proc. 2004;36(7):2096-2097. <a href="https://pubmed.ncbi.nlm.nih.gov/15518758/">PubMed</a></li><li>U.S. Food and Drug Administration. Prograf (tacrolimus) prescribing information. 2023. <a href="https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/050708s055,210115s007lbl.pdf">FDA label (PDF)</a></li></ol>
<p>More from MedRise: <a href="https://med-rise.com/medicine/residents/">MedRise for residents and fellows</a> and <a href="https://med-rise.com/articles">more MedRise Articles</a>.</p>
<p><em>This contributor article reflects the author's own views and experience. It is for education only and is not medical, legal or career advice.</em></p>]]></content:encoded><media:content url="https://med-rise.com/images/articles/og/tacrolimus-toxicity-diarrhea-kidney-transplant-photo.jpg" medium="image" type="image/jpeg"/></item><item><title>FDA Approves Asundexian, the First Factor XIa Inhibitor, for Secondary Stroke Prevention</title><link>https://med-rise.com/medical-news/fda-approves-asundexian-first-factor-xia-inhibitor-stroke</link><guid isPermaLink="true">https://med-rise.com/medical-news/fda-approves-asundexian-first-factor-xia-inhibitor-stroke</guid><pubDate>Sun, 15 Nov 2026 07:34:25 -0600</pubDate><dc:creator>MedRise News Desk (with AI assistance)</dc:creator><category>News</category><category>Medical News</category><description>The FDA approved asundexian (Sunharbo) on Nov. 9, 2026, the first factor XIa inhibitor, for secondary stroke prevention. What trainees should know.</description><content:encoded><![CDATA[<p>The U.S. Food and Drug Administration <a href="https://www.fda.gov/news-events/press-announcements/fda-approves-first-factor-xla-inhibitor-help-prevent-stroke-certain-adults-high-risk">approved asundexian (Sunharbo) on November 9, 2026</a>, making it the first factor XIa inhibitor approved in the United States. In the pivotal trial, adding it to antiplatelet therapy after a non-cardioembolic stroke cut ischemic strokes by 26%.</p>
<p>For students and residents, this is a new drug class arriving on stroke wards, in pharmacology teaching and, once it ships, on discharge medication lists. It also comes with a sharp boundary: the same 50 mg dose lost to apixaban in atrial fibrillation, so knowing exactly who the label covers matters as much as the headline number.</p>
<h2>A once-daily pill added to antiplatelets, for a defined group</h2>
<p>According to the FDA, Sunharbo is approved for use with antiplatelet therapy to lower stroke risk in adults after a recent mild-to-moderate non-cardioembolic ischemic stroke or a high-risk transient ischemic attack (TIA). The agency stated plainly that it is not approved for stroke prevention in patients with atrial fibrillation.</p>
<p>The dose is 50 mg by mouth once daily, <a href="https://www.bayer.com/media/en-us/bayers-asundexian-first-fxia-inhibitor-approved-by-us-food-and-drug-administration-for-secondary-stroke-risk-reduction/">Bayer said</a> in its approval announcement. The FDA granted the application Fast Track and Priority Review. Hylton V. Joffe, MD, director of the FDA's Office of Cardiology, Hematology, Endocrinology, and Nephrology, called the approval "a meaningful advance for patients and health care providers."</p>
<p>Bayer says China's regulator approved asundexian recently and that applications are under review elsewhere; <a href="https://www.tctmd.com/news/asundexian-first-factor-xia-inhibitor-gain-fda-approval">TCTMD reported</a> that Europe and Japan are among them.</p>
<h2>The trial: 12,327 patients and 2.2 points fewer ischemic strokes</h2>
<p>The approval rests on OCEANIC-STROKE, a phase 3, double-blind trial published in <a href="https://doi.org/10.1056/NEJMoa2513880">The New England Journal of Medicine</a> in April 2026. Patients were randomized within 72 hours of a non-cardioembolic ischemic stroke or high-risk TIA to asundexian 50 mg or placebo, on top of planned single or dual antiplatelet therapy.</p>
<p>The trial did not enroll every stroke patient. Each participant had at least one of the following: a nonlacunar infarct on imaging, a history of atherosclerosis, or atherosclerotic plaque on cerebrovascular imaging.</p>
<ul>
<li><strong>Ischemic stroke:</strong> 6.2% with asundexian vs. 8.4% with placebo (hazard ratio 0.74; 95% CI, 0.65 to 0.84).</li>
<li><strong>Major bleeding:</strong> 1.9% vs. 1.7% (hazard ratio 1.10; 95% CI, 0.85 to 1.44), which the authors described as similar.</li>
<li><strong>Serious adverse events:</strong> 19.2% vs. 19.5%.</li>
</ul>
<p>The FDA puts the median treatment time at 14.2 months. The absolute gap of 2.2 percentage points works out to roughly one ischemic stroke avoided for every 45 patients treated during the trial, by MedRise's arithmetic from the published rates. Bayer funded the study.</p>
<h2>The catch: older patients, the first 90 days and atrial fibrillation</h2>
<p>Overall major bleeding matched placebo, but the FDA said it was higher with asundexian in patients over 75 and during the first 90 days of treatment. <a href="https://www.healio.com/news/neurology/20261110/fda-approves-sunharbo-first-factor-xia-inhibitor-for-reducing-risk-for-secondary-stroke">Healio reported</a> those rates as 2.6 vs. 1.7 and 4.5 vs. 3.1 events per 100 patient-years, respectively. Gastrointestinal bleeding was also more common, and diarrhea was the most frequent side effect.</p>
<p>The bigger warning sign came earlier. In <a href="https://doi.org/10.1056/NEJMoa2407105">OCEANIC-AF</a>, which tested the same 50 mg dose against apixaban in 14,810 patients with atrial fibrillation, the trial was stopped early. Stroke or systemic embolism occurred in 1.3% of asundexian patients vs. 0.4% on apixaban (hazard ratio 3.79), even though major bleeding was lower (0.2% vs. 0.7%).</p>
<p>Cost is another open question. TCTMD reported a list price of $748.50 for a 30-day supply, which Bayer says does not reflect what most patients pay.</p>
<h2>What to know before you see it on rounds</h2>
<ul>
<li><strong>The class:</strong> asundexian inhibits activated factor XI. The NEJM authors note that people with low factor XI levels have a lower risk of ischemic stroke, the idea behind the drug.</li>
<li><strong>The indication:</strong> non-cardioembolic stroke or high-risk TIA, alongside antiplatelets. It is not an atrial fibrillation drug.</li>
<li><strong>Label details worth memorizing:</strong> the FDA says it is not recommended with combined P-gp and strong CYP3A4 inducers such as carbamazepine, or in moderate or severe hepatic impairment. It should be held at least 24 hours before elective surgery or invasive procedures and for at least 24 hours after thrombolysis.</li>
<li><strong>Review the basics:</strong> our <a href="https://med-rise.com/shelf-prep/anticoagulants-vs-antiplatelets-vs-thrombolytics">anticoagulants vs. antiplatelets vs. thrombolytics guide</a> covers the drugs asundexian will be compared with. More resources for trainees are on our <a href="https://med-rise.com/medicine/students/">students</a> and <a href="https://med-rise.com/medicine/residents/">residents</a> pages.</li>
</ul>
<p>What to watch next: decisions in Europe and Japan, and whether stroke guidelines adopt the drug. Ashkan Shoamanesh, MD, a co-principal investigator of the trial, named guideline incorporation, physician education and equitable access as the next steps, according to TCTMD.</p>
<p>Factor XI drugs were pitched as clot protection with less bleeding. Asundexian now has a U.S. label backing part of that pitch, and a stopped atrial fibrillation trial marking its limits.</p>
<p><strong>Sources:</strong> <a href="https://www.fda.gov/news-events/press-announcements/fda-approves-first-factor-xla-inhibitor-help-prevent-stroke-certain-adults-high-risk">FDA press announcement, Nov. 9, 2026</a>; <a href="https://www.bayer.com/media/en-us/bayers-asundexian-first-fxia-inhibitor-approved-by-us-food-and-drug-administration-for-secondary-stroke-risk-reduction/">Bayer approval announcement</a>; <a href="https://doi.org/10.1056/NEJMoa2513880">Sharma M, et al. Asundexian for Secondary Stroke Prevention. N Engl J Med 2026;394:1467-1479</a> (<a href="https://pubmed.ncbi.nlm.nih.gov/41985132/">PubMed abstract</a>); <a href="https://doi.org/10.1056/NEJMoa2407105">Piccini JP, et al. Asundexian versus Apixaban in Patients with Atrial Fibrillation. N Engl J Med 2024</a>; <a href="https://www.tctmd.com/news/asundexian-first-factor-xia-inhibitor-gain-fda-approval">TCTMD, Nov. 10, 2026</a>; <a href="https://www.healio.com/news/neurology/20261110/fda-approves-sunharbo-first-factor-xia-inhibitor-for-reducing-risk-for-secondary-stroke">Healio, Nov. 10, 2026</a>.</p>
<p><em>MedRise Medical News summarizes public announcements and research for education only. It is not medical, legal or immigration advice.</em></p>]]></content:encoded><media:content url="https://med-rise.com/images/medical-news/og/fda-approves-asundexian-first-factor-xia-inhibitor-stroke.jpg" medium="image" type="image/jpeg"/></item><item><title>IMG Psychiatry Match 2026: Non-U.S. IMGs Filled 222 Spots, Up 67% Since 2022</title><link>https://med-rise.com/articles/img-psychiatry-match-2026</link><guid isPermaLink="true">https://med-rise.com/articles/img-psychiatry-match-2026</guid><pubDate>Sat, 14 Nov 2026 14:57:10 -0600</pubDate><dc:creator>MedRise News Desk (with AI assistance)</dc:creator><category>Analysis</category><category>Articles</category><description>IMG psychiatry match 2026: non-U.S. IMGs filled 222 spots, three states placed 44% of them, and 65 went unfilled. State data and a 2027 Match plan.</description><content:encoded><![CDATA[<p>Non-U.S. citizen IMGs filled 222 psychiatry residency positions in the 2026 Main Residency Match, up from 190 in 2025 and 133 in 2022, according to the <a href="https://www.nrmp.org/wp-content/uploads/2026/03/Advance-Data-Tables-2026_Public.pdf">NRMP's Advance Data Tables</a>. That is a 67% rise in four years.</p>
<p>Psychiatry itself grew more slowly. It offered 2,516 first-year positions in 2026, 23% more than in 2022, and 65 of them were still empty when the matching algorithm finished, up from 8 a year earlier, the <a href="https://www.nrmp.org/about/news/2026/03/nrmp-releases-results-of-the-2026-main-residency-match-for-more-than-38000-future-residents/">NRMP said on March 20, 2026</a>.</p>
<p>Why it matters: psychiatry is opening doors for IMGs at the same moment the overall non-U.S. IMG match rate fell to 56.4%, a five-year low. The new seats are not spread evenly. Three states placed 44% of the non-U.S. IMGs who matched into psychiatry, and the rank order list deadline for the 2027 Match is March 3, 2027.</p>
<h2>Non-U.S. IMGs now outnumber U.S. IMGs in psychiatry</h2>
<p>Five years of NRMP data show a quiet reversal. In 2022, U.S. citizen IMGs filled 188 psychiatry positions and non-U.S. citizen IMGs filled 133. Since 2024, non-U.S. IMGs have filled more.</p>
<div class="post-table"><table>
<caption>Psychiatry PGY-1 positions in the NRMP Main Residency Match, 2022-2026. Source: NRMP Advance Data Tables, 2026 Main Residency Match (Tables 3, 7A, 7E, 7F).</caption>
<thead><tr><th>Match year</th><th>Positions offered</th><th>Filled by U.S. citizen IMGs</th><th>Filled by non-U.S. citizen IMGs</th><th>Unfilled after the algorithm</th></tr></thead>
<tbody>
<tr><td>2022</td><td>2,047</td><td>188</td><td>133</td><td>17</td></tr>
<tr><td>2023</td><td>2,164</td><td>202</td><td>149</td><td>21</td></tr>
<tr><td>2024</td><td>2,261</td><td>178</td><td>185</td><td>12</td></tr>
<tr><td>2025</td><td>2,388</td><td>153</td><td>190</td><td>8</td></tr>
<tr><td>2026</td><td>2,516</td><td>177</td><td>222</td><td>65</td></tr>
</tbody>
</table></div>
<p>Taken together, IMGs filled 399 psychiatry positions in 2026, about 15.9% of the positions offered. That is almost the same share as in 2022 (15.7%). What changed is the mix: the non-U.S. IMG share rose from 6.5% to 8.8%, while the U.S. IMG share slipped from 9.2% to 7.0%.</p>
<p>U.S. graduates still take most seats. U.S. MD seniors filled 1,414 psychiatry positions (56.2%) and U.S. DO seniors filled 566 (22.5%), up from 387 DO seniors in 2022.</p>
<p>Keep the scale in view. Psychiatry accounted for only 3.3% of all non-U.S. IMG first-year matches in 2026 and 6.0% of U.S. IMG matches, so most IMGs who matched did so in other specialties. Our <a href="https://med-rise.com/articles/2026-nrmp-match-results-what-they-mean-for-imgs">analysis of the 2026 NRMP Match results for IMGs</a> covers the other specialties.</p>
<h2>Three states placed almost half of non-U.S. IMGs</h2>
<p>The NRMP's <a href="https://www.nrmp.org/wp-content/uploads/2026/03/Main_Match_Results_by_State_Specialty_and_AppType_2026.pdf">2026 results by state, specialty and applicant type</a> show where those psychiatry matches happened. New York, Texas and Florida together placed 98 of the 222 non-U.S. IMGs. Add Ohio and Virginia and the five states account for 116, or 52%.</p>
<div class="post-table"><table>
<caption>Psychiatry PGY-1 matches by state, 2026 Main Residency Match. "IMG share" is U.S. plus non-U.S. citizen IMGs as a share of filled positions. Source: NRMP, Main Match Results by State, Specialty and Applicant Type 2026.</caption>
<thead><tr><th>State</th><th>Positions offered</th><th>Filled</th><th>U.S. citizen IMGs</th><th>Non-U.S. citizen IMGs</th><th>IMG share</th></tr></thead>
<tbody>
<tr><td>New York</td><td>322</td><td>317</td><td>38</td><td>51</td><td>28%</td></tr>
<tr><td>Texas</td><td>176</td><td>176</td><td>14</td><td>26</td><td>23%</td></tr>
<tr><td>Florida</td><td>192</td><td>171</td><td>36</td><td>21</td><td>33%</td></tr>
<tr><td>Ohio</td><td>84</td><td>84</td><td>0</td><td>9</td><td>11%</td></tr>
<tr><td>Virginia</td><td>49</td><td>46</td><td>1</td><td>9</td><td>22%</td></tr>
<tr><td>Connecticut</td><td>44</td><td>44</td><td>4</td><td>8</td><td>27%</td></tr>
<tr><td>Missouri</td><td>51</td><td>51</td><td>6</td><td>7</td><td>25%</td></tr>
<tr><td>California</td><td>275</td><td>275</td><td>10</td><td>6</td><td>6%</td></tr>
<tr><td>Pennsylvania</td><td>124</td><td>124</td><td>2</td><td>5</td><td>6%</td></tr>
<tr><td>Washington</td><td>25</td><td>25</td><td>0</td><td>0</td><td>0%</td></tr>
</tbody>
</table></div>
<p>The contrast is sharp. California offered the second-most psychiatry positions in the country, 275, and filled six with non-U.S. IMGs. Pennsylvania filled 124 positions with seven IMGs in all. Smaller states can matter more than their size suggests: Kansas placed 5 non-U.S. IMGs in 14 positions, and New Mexico placed 5 in 16.</p>
<p>U.S. citizen IMGs were even more concentrated. New York (38) and Florida (36) placed 74 of the 177, or 42%.</p>
<p>The strongest caveat: a state total tells you where IMGs matched last cycle, not which program will interview you or sponsor your visa. These are counts, not a list of IMG-friendly programs. Confirm every program's requirements on its own website.</p>
<h2>A third of psychiatry's empty seats were in Florida</h2>
<p>Florida had 21 of psychiatry's 65 unfilled positions after the 2026 algorithm ran. Alabama and Oklahoma had 6 each, New York 5, and Arizona, West Virginia and Wisconsin 4 each, according to the same NRMP state report.</p>
<p>The NRMP's release does not say why unfilled positions jumped. The rise came in the same year psychiatry added 30 programs and 128 positions. Across all specialties, 2,862 positions were unfilled after the algorithm, and 2,581 of them were offered through the Supplemental Offer and Acceptance Program (SOAP). SOAP outcomes by specialty are in the NRMP's <a href="https://www.nrmp.org/match-data/results-and-data-2026-main-residency-match/">Results and Data report</a>, published May 26, 2026. For every specialty's unfilled count, see <a href="https://med-rise.com/articles/unfilled-residency-positions-by-specialty-2026-match">unfilled residency positions by specialty in the 2026 Match</a>.</p>
<h2>Psychiatry still leans on IMGs, but programs screen hard</h2>
<p>The workforce case for IMGs is long-standing. In 2020 AMA data, IMGs made up 29% of active U.S. psychiatrists, compared with 23% in other specialties, and more than 40% in Florida and New Jersey, according to a <a href="https://pubmed.ncbi.nlm.nih.gov/35486365/">2022 study in Academic Psychiatry</a> (<a href="https://doi.org/10.1007/s40596-022-01635-y">doi:10.1007/s40596-022-01635-y</a>).</p>
<p>Getting an interview is the hard part. In the NRMP's <a href="https://www.nrmp.org/wp-content/uploads/2026/08/2026-PD-Survey-Report-Narrative-FINAL.pdf">2026 Program Director Survey</a>, psychiatry was among the five specialties receiving the highest mean number of applications. Across specialties, program directors most often cited the Step 2 CK score (89%), a Step 1 pass (87%) and specialty-specific letters of recommendation (86%) when choosing whom to interview.</p>
<p>For IMG applicants, 92% of responding programs required Step 1 and 84% required Step 2 CK before considering an interview. Among programs requiring Step 2 CK, 32% set a target score for IMGs. Read these figures with care: only 12.7% of programs responded overall, and 50 of the 433 psychiatry program directors surveyed did.</p>
<p>The best specialty-specific benchmarks are in the NRMP's July 28, 2026 Charting Outcomes reports. For the first time there are separate reports for <a href="https://www.nrmp.org/match-data/2026/07/charting-outcomes-characteristics-of-non-u-s-citizen-international-medical-students-graduates-who-matched-to-their-preferred-specialty-2026-main-residency-match/">non-U.S. citizen IMGs</a> and U.S. citizen IMGs, and the NRMP says they will now be published every year. Check the psychiatry pages for measures such as the Step 2 CK score and the number of contiguous psychiatry ranks.</p>
<h2>The 2027 Match calendar, hour by hour</h2>
<p>If you are applying in the current cycle, these are the NRMP's <a href="https://www.nrmp.org/match-calendars/main-residency-applicants/">2027 applicant dates</a>. Times are Eastern.</p>
<div class="post-table"><table>
<caption>2027 Main Residency Match applicant calendar. Source: NRMP.</caption>
<thead><tr><th>Date</th><th>What happens</th></tr></thead>
<tbody>
<tr><td>Jan 29, 2027, 11:59 p.m.</td><td>Standard registration deadline; a $50 late fee applies after</td></tr>
<tr><td>Feb 1, 2027, noon</td><td>Ranking opens</td></tr>
<tr><td>Mar 3, 2027, 9 p.m.</td><td>Rank order list certification deadline, and the deadline for IMGs to meet ECFMG verification requirements</td></tr>
<tr><td>Mar 15, 2027, 10 a.m.</td><td>Applicants learn whether they matched; SOAP begins at 11 a.m.</td></tr>
<tr><td>Mar 18, 2027</td><td>Four SOAP offer rounds at 9 a.m., noon, 3 p.m. and 6 p.m., each with a two-hour window; SOAP ends at 9 p.m.</td></tr>
<tr><td>Mar 19, 2027, noon</td><td>Match Day</td></tr>
</tbody>
</table></div>
<h2>What to do now: a psychiatry checklist for IMGs</h2>
<ol>
<li><strong>Check your ECFMG verification status.</strong> IMGs must complete the medical science examination, clinical skills and communication skills requirements by March 3, 2027. The NRMP says IMGs who miss that deadline <a href="https://www.nrmp.org/residency-applicants/get-ready-for-the-match/are-you-eligible/">cannot participate in the Match</a>, and the same verification applies to SOAP.</li>
<li><strong>Re-register if you were in a past Match.</strong> Past participants must register again for the 2027 Match, the NRMP's <a href="https://www.nrmp.org/about/news/2026/09/img-welcome-newsletter-2/">September 2026 IMG newsletter</a> says.</li>
<li><strong>Filter by visa first.</strong> The NRMP says non-U.S. citizen applicants who need a visa are responsible for confirming that an institution will sponsor their visa type before certifying a rank order list. Check each program's website. For immigration questions, talk to an immigration attorney or the official agency.</li>
<li><strong>Look at geography honestly.</strong> If every psychiatry program on your list is in a state that placed few IMGs in 2026, research programs in other states too, then confirm their policies one by one.</li>
<li><strong>Rank only programs you would attend.</strong> The NRMP tells applicants to rank only programs they would be willing to attend, and to be ready to enter training wherever a match occurs. Our guide to <a href="https://med-rise.com/articles/nrmp-questions-answered">NRMP Match rules and the binding commitment</a> explains what that means.</li>
<li><strong>Prepare for SOAP before Match Week.</strong> Only eligible unmatched and partially matched applicants can use SOAP, and the <a href="https://www.nrmp.org/residency-applicants/soap/">List of Unfilled Programs</a> appears at the start of SOAP showing only programs you are eligible for. Applicants who are not SOAP-eligible may not contact SOAP programs. See <a href="https://med-rise.com/articles/soap-list-2025-find-unfilled-residency-positions-apply-now">how the SOAP List of Unfilled Programs works</a>.</li>
<li><strong>If you are not in this cycle, build for the next one.</strong> Use the Charting Outcomes psychiatry data to set your targets, gather new psychiatry letters, and get hands-on U.S. clinical experience where you can. MedRise arranges <a href="https://med-rise.com/medicine/observerships/">U.S. clinical observerships for IMGs in South Texas</a> in internal medicine, pediatrics and family medicine.</li>
</ol>
<p>For the 2025 cycle's version of this guide, see <a href="https://med-rise.com/articles/img-psychiatry-match-2025-what-to-do-if-you-didnt-match-how-to-reapply-successfully">what to do if you didn't match into psychiatry as an IMG</a>.</p>
<p>Psychiatry is growing, and non-U.S. IMGs are getting a bigger slice of it. That slice is not spread evenly, so check where IMGs actually matched before you certify your list on March 3.</p>
<h2>FAQ</h2>
<h3>How many IMGs matched into psychiatry in 2026?</h3>
<p>399 in all: 177 U.S. citizen IMGs and 222 non-U.S. citizen IMGs, out of 2,451 filled psychiatry positions, according to the NRMP's Advance Data Tables.</p>
<h3>Is psychiatry a good specialty for IMGs?</h3>
<p>IMGs filled about 16% of psychiatry positions in 2026, but the share was 33% in Florida and 6% in California. There is no specialty-wide answer; check each program's own requirements and recent residents.</p>
<h3>Which states matched the most IMGs into psychiatry in 2026?</h3>
<p>For non-U.S. citizen IMGs: New York (51), Texas (26) and Florida (21). For U.S. citizen IMGs: New York (38) and Florida (36).</p>
<h3>When is the 2027 rank order list deadline?</h3>
<p>March 3, 2027, at 9 p.m. Eastern. IMGs must also meet ECFMG verification requirements by then to take part in the Match.</p>
<h3>Can IMGs take part in SOAP?</h3>
<p>Yes, if they are SOAP-eligible: unmatched or partially matched applicants who meet the eligibility requirements, including ECFMG verification by the rank order list deadline.</p>
<h2>Sources</h2>
<ul>
<li><a href="https://www.nrmp.org/wp-content/uploads/2026/03/Advance-Data-Tables-2026_Public.pdf">NRMP, Advance Data Tables: 2026 Main Residency Match</a> (March 2026)</li>
<li><a href="https://www.nrmp.org/about/news/2026/03/nrmp-releases-results-of-the-2026-main-residency-match-for-more-than-38000-future-residents/">NRMP news release on the 2026 Main Residency Match results</a> (March 20, 2026)</li>
<li><a href="https://www.nrmp.org/wp-content/uploads/2026/03/Main_Match_Results_by_State_Specialty_and_AppType_2026.pdf">NRMP, Main Match Results by State, Specialty and Applicant Type 2026</a></li>
<li><a href="https://www.nrmp.org/match-data/results-and-data-2026-main-residency-match/">NRMP, Results and Data: 2026 Main Residency Match</a> (May 26, 2026)</li>
<li><a href="https://www.nrmp.org/wp-content/uploads/2026/08/2026-PD-Survey-Report-Narrative-FINAL.pdf">NRMP, 2026 Program Director Survey report</a> (August 2026)</li>
<li><a href="https://www.nrmp.org/match-data/2026/07/charting-outcomes-characteristics-of-non-u-s-citizen-international-medical-students-graduates-who-matched-to-their-preferred-specialty-2026-main-residency-match/">NRMP, Charting Outcomes for non-U.S. citizen IMGs, 2026 Main Residency Match</a> (July 28, 2026)</li>
<li><a href="https://www.nrmp.org/match-calendars/main-residency-applicants/">NRMP, 2027 Main Residency Match applicant calendar</a></li>
<li><a href="https://www.nrmp.org/about/news/2026/09/img-welcome-newsletter-2/">NRMP, IMG Welcome Newsletter</a> (September 8, 2026) and <a href="https://www.nrmp.org/residency-applicants/get-ready-for-the-match/are-you-eligible/">eligibility requirements</a></li>
<li><a href="https://www.nrmp.org/residency-applicants/soap/">NRMP, Supplemental Offer and Acceptance Program</a></li>
<li>Duvivier RJ, et al. <a href="https://pubmed.ncbi.nlm.nih.gov/35486365/">International Medical Graduates in the United States Psychiatry Workforce</a>. Academic Psychiatry, 2022 (PubMed; <a href="https://doi.org/10.1007/s40596-022-01635-y">doi:10.1007/s40596-022-01635-y</a>)</li>
</ul>
<p><em>MedRise Articles share educational information only. They are not medical, legal or immigration advice. Confirm requirements with the official organization or program.</em></p>]]></content:encoded><media:content url="https://med-rise.com/images/articles/og/img-psychiatry-match-2026.jpg" medium="image" type="image/jpeg"/></item><item><title>2026 NRMP Match Results: What They Mean for IMGs and 2027 Applicants</title><link>https://med-rise.com/articles/2026-nrmp-match-results-what-they-mean-for-imgs</link><guid isPermaLink="true">https://med-rise.com/articles/2026-nrmp-match-results-what-they-mean-for-imgs</guid><pubDate>Sat, 14 Nov 2026 13:27:31 -0600</pubDate><dc:creator>MedRise News Desk (with AI assistance)</dc:creator><category>Analysis</category><category>Articles</category><description>Non-U.S. IMGs matched at 56.4% in 2026, a five-year low, while U.S. IMGs hit a record 70%. What the 2026 NRMP results mean for your 2027 application.</description><content:encoded><![CDATA[<p><strong>In short:</strong> The 2026 Main Residency Match, released March 20, 2026, was the largest on record, and it split IMGs in two. U.S. citizen IMGs matched at 70.0%, their highest rate on record. Non-U.S. citizen IMGs matched at 56.4%, their lowest in five years, and those who need visa sponsorship matched at 54.4%.</p>

<h2>2026 match rates by applicant type</h2>
<div class="post-table"><table>
<caption>Sources: NRMP Match by the Numbers (March 2026) and the NRMP's May 26, 2026 outcome report. "Active" applicants certified a rank order list.</caption>
<thead><tr><th>Applicant type</th><th>Active applicants</th><th>Matched to PGY-1</th><th>Change from 2025</th><th>Placed after SOAP</th></tr></thead>
<tbody>
<tr><td>U.S. MD seniors</td><td>20,934</td><td>93.5%</td><td>No change</td><td>97.8%</td></tr>
<tr><td>U.S. DO seniors</td><td>8,503</td><td>93.2%</td><td>+0.6 points</td><td>98.5%</td></tr>
<tr><td>U.S. citizen IMGs</td><td>4,210</td><td>70.0%</td><td>+2.2 points</td><td>77.8%</td></tr>
<tr><td>Non-U.S. citizen IMGs</td><td>11,944</td><td>56.4%</td><td>&minus;1.6 points</td><td>59.9%</td></tr>
<tr><td>All active applicants</td><td>48,050</td><td>79.8%</td><td>No change</td><td>84.7%</td></tr>
</tbody>
</table></div>

<h2>What the numbers mean for non-U.S. IMGs</h2>
<ul>
<li><strong>More applicants, barely more matches.</strong> 11,944 non-U.S. IMGs certified rank order lists, 479 more than in 2025, but only 80 more matched (6,733 in all).</li>
<li><strong>Visa status made a big difference.</strong> Non-U.S. IMGs who needed visa sponsorship matched at 54.4%, a five-year low; the high for this group was 59.1% in 2023. Foreign-born IMGs who are U.S. permanent residents matched at 67.9%, a five-year high.</li>
<li><strong>Your share of the seats.</strong> Non-U.S. IMGs filled 16.4% of PGY-1 positions, and U.S. IMGs 7.2%.</li>
</ul>

<h2>What the numbers mean for U.S. citizen IMGs</h2>
<p>Fewer U.S. citizen IMGs applied (4,210, down 377) and 2,949 matched, but the match rate rose to 70.0%, a record. After SOAP, 77.8% had a position.</p>

<h2>Where the positions are</h2>
<ul>
<li><strong>Internal medicine:</strong> 11,632 positions, 95.2% filled, down 1.6 points.</li>
<li><strong>Family medicine:</strong> 5,491 positions, 83.6% filled, leaving 899 unfilled before SOAP.</li>
<li><strong>Pediatrics:</strong> 3,185 positions, 94.4% filled.</li>
<li><strong>Emergency medicine:</strong> 3,198 positions, 95.6% filled, down 2.3 points.</li>
<li><strong>Psychiatry:</strong> 2,516 positions, 97.4% filled; unfilled positions rose from 8 to 65.</li>
</ul>
<p>See every specialty with open positions in <a href="https://med-rise.com/articles/unfilled-residency-positions-by-specialty-2026-match">unfilled residency positions by specialty: 2026 Match data</a>.</p>

<h2>What to do now for the 2027 Match</h2>
<ol>
<li><strong>Know the 2027 dates.</strong> Standard NRMP registration runs until January 29, 2027. Rank order lists open February 1 and must be certified by March 3, 2027, at 9 p.m. ET. Match Week runs March 15 to 19, and Match Day is Friday, March 19, 2027.</li>
<li><strong>Finish ECFMG requirements by March 3, 2027.</strong> IMGs must meet ECFMG's verification requirements by the rank order list deadline to take part in the Match.</li>
<li><strong>Use real score data.</strong> Check the NRMP's Charting Outcomes reports for <a href="https://www.nrmp.org/wp-content/uploads/2026/07/Non-US-IMG_Charting-Outcomes_FINAL.pdf">non-U.S. IMGs</a> and <a href="https://www.nrmp.org/wp-content/uploads/2026/07/US-IMG_Charting-Outcomes_FINAL.pdf">U.S. IMGs</a> (July 2026) for your specialty instead of averages quoted on social media.</li>
<li><strong>If you need a visa, filter your list first.</strong> Confirm on each program's own website that it sponsors the visa you need before you spend an application on it.</li>
<li><strong>Rank in true order of preference.</strong> The NRMP advises ranking programs in the order you actually prefer them, not where you think you will match.</li>
<li><strong>Prepare for SOAP before Match Week.</strong> Read the <a href="https://www.nrmp.org/residency-applicants/soap/">NRMP's SOAP rules</a> and have your documents ready, so a Monday surprise does not cost you the week.</li>
</ol>

<p>For last year’s results, see <a href="https://med-rise.com/articles/2025-nrmp-match-results-what-they-mean-for-imgs-and-residency-applicants">2025 NRMP Match results: what they mean for IMGs</a>.</p>

<h2>How MedRise can help</h2>
<p>MedRise offers <a href="https://med-rise.com/packages/">CV advisory, interview coaching and the Residency Rescue Package</a> for IMGs and reapplicants, and <a href="https://med-rise.com/medicine/observerships/">U.S. clinical observerships in South Texas</a>. You can start with a free 10-minute call.</p>

<h2>Frequently asked questions</h2>
<h3>Did IMGs match at a higher rate in 2026?</h3>
<p>It depends on citizenship. U.S. citizen IMGs rose to 70.0%, a record. Non-U.S. citizen IMGs fell to 56.4%, a five-year low.</p>
<h3>Which specialty had the most unfilled positions in 2026?</h3>
<p>Family medicine, with 899 positions unfilled after the matching algorithm ran, before SOAP.</p>
<h3>When is Match Day 2027?</h3>
<p>Friday, March 19, 2027. The rank order list certification deadline is March 3, 2027, at 9 p.m. ET.</p>

<h2>Sources</h2>
<ul>
<li><a href="https://www.nrmp.org/wp-content/uploads/2026/03/2026_Match_by_the_Number.pdf">NRMP, Match by the Numbers: 2026 Main Residency Match</a> (March 2026)</li>
<li><a href="https://www.nrmp.org/about/news/2026/03/nrmp-releases-results-of-the-2026-main-residency-match-for-more-than-38000-future-residents/">NRMP news release on the 2026 Main Residency Match results</a> (March 20, 2026)</li>
<li><a href="https://www.nrmp.org/about/news/2026/05/new-reports-2026-main-residency-match-outcome-and-demographic-reports/">NRMP, 2026 Main Residency Match outcome reports</a> (May 26, 2026)</li>
<li><a href="https://www.nrmp.org/wp-content/uploads/2026/03/Advance-Data-Tables-2026_Public.pdf">NRMP, Advance Data Tables: 2026 Main Residency Match</a> (March 2026)</li>
<li><a href="https://www.nrmp.org/wp-content/uploads/2026/04/2027-MRM-Applicant-Checklist-FINAL.pdf">NRMP, 2027 Main Residency Match applicant checklist</a></li>
</ul>
<p><em>MedRise is not affiliated with the NRMP, ECFMG, Intealth, the AAMC or ERAS. Figures come from the NRMP's public reports and are for education only; check the NRMP for official data. This is not legal or immigration advice, and no outcome is promised.</em></p>]]></content:encoded><media:content url="https://med-rise.com/images/articles/og/2026-nrmp-match-results-what-they-mean-for-imgs.jpg" medium="image" type="image/jpeg"/></item><item><title>Unfilled Residency Positions by Specialty: 2026 Match Data</title><link>https://med-rise.com/articles/unfilled-residency-positions-by-specialty-2026-match</link><guid isPermaLink="true">https://med-rise.com/articles/unfilled-residency-positions-by-specialty-2026-match</guid><pubDate>Sat, 14 Nov 2026 13:27:22 -0600</pubDate><dc:creator>MedRise News Desk (with AI assistance)</dc:creator><category>Analysis</category><category>Articles</category><description>2,862 residency positions were unfilled after the 2026 Match. See which specialties had open spots, how SOAP filled most, and what it means for 2027.</description><content:encoded><![CDATA[<p><strong>In short:</strong> When the matching algorithm ran for the 2026 Main Residency Match (results released March 20, 2026), 2,862 of 44,344 positions were left unfilled, 389 more than in 2025. Family medicine, preliminary surgery and categorical internal medicine made up more than two-thirds of them. SOAP then filled most of the rest: the NRMP puts the combined Match and SOAP fill rate at 99.3%.</p>

<h2>The 2026 Match at a glance</h2>
<div class="post-table"><table>
<caption>Source: NRMP, Match by the Numbers, 2026 Main Residency Match</caption>
<thead><tr><th>Measure</th><th>2026</th><th>2025</th></tr></thead>
<tbody>
<tr><td>Positions offered</td><td>44,344</td><td>43,237</td></tr>
<tr><td>PGY-1 positions offered</td><td>41,126</td><td>40,041</td></tr>
<tr><td>Positions filled in the Match</td><td>41,482</td><td>40,764</td></tr>
<tr><td>Unfilled after the Match</td><td>2,862</td><td>2,473</td></tr>
<tr><td>Share of positions filled</td><td>93.5%</td><td>94.3%</td></tr>
</tbody>
</table></div>
<p>Positions grew faster than matches. Total positions rose 2.6% from 2025, while the number of filled positions rose 1.8%. That gap is why a record-size Match still left more seats open than the year before.</p>

<h2>Which specialties had the most unfilled positions</h2>
<p>These are PGY-1 positions left open after the algorithm ran and before SOAP began.</p>
<div class="post-table"><table>
<caption>Source: NRMP, Advance Data Tables 2026, Table 2. Fill rates calculated by MedRise from the NRMP's offered and filled counts.</caption>
<thead><tr><th>Specialty (PGY-1)</th><th>Positions offered</th><th>Unfilled</th><th>Filled</th></tr></thead>
<tbody>
<tr><td>Family medicine</td><td>5,491</td><td>899</td><td>83.6%</td></tr>
<tr><td>Surgery, preliminary (PGY-1 only)</td><td>1,207</td><td>543</td><td>55.0%</td></tr>
<tr><td>Internal medicine, categorical</td><td>11,194</td><td>537</td><td>95.2%</td></tr>
<tr><td>Transitional year</td><td>1,937</td><td>191</td><td>90.1%</td></tr>
<tr><td>Pediatrics, categorical</td><td>3,126</td><td>175</td><td>94.4%</td></tr>
<tr><td>Emergency medicine</td><td>3,198</td><td>140</td><td>95.6%</td></tr>
<tr><td>Medicine, preliminary (PGY-1 only)</td><td>1,565</td><td>135</td><td>91.4%</td></tr>
<tr><td>Psychiatry</td><td>2,516</td><td>65</td><td>97.4%</td></tr>
<tr><td>Internal medicine, primary care track</td><td>438</td><td>17</td><td>96.1%</td></tr>
<tr><td>Osteopathic neuromusculoskeletal medicine</td><td>27</td><td>15</td><td>44.4%</td></tr>
<tr><td>OB/GYN, preliminary (PGY-1 only)</td><td>21</td><td>11</td><td>47.6%</td></tr>
</tbody>
</table></div>
<p>Advanced and reserved positions were nearly full. Of 2,864 PGY-2 positions, 35 went unfilled, 17 of them in diagnostic radiology. Of 354 physician-only (R) positions, 55 went unfilled.</p>

<h2>Specialties that filled every PGY-1 position</h2>
<p>Anesthesiology (1,865 positions), orthopedic surgery (963), medicine-pediatrics (404), neurological surgery (280), physical medicine and rehabilitation (253), vascular surgery (110), thoracic surgery (56) and dermatology (31 PGY-1 positions) filled every PGY-1 seat. Categorical general surgery left 3 of 1,807 open and OB/GYN 2 of 1,638. Dermatology left 1 of its 546 PGY-2 positions open.</p>

<h2>What changed from 2025</h2>
<ul>
<li><strong>Family medicine</strong> added 134 positions, to 5,491, but its fill rate fell from 85.0% to 83.6%. The NRMP says more applicants matched into family medicine than the year before, and it plans a Blue Ribbon Panel on the specialty in 2026.</li>
<li><strong>Internal medicine</strong>, counting all the tracks the NRMP groups together (11,632 positions), filled 95.2%, down 1.6 points.</li>
<li><strong>Emergency medicine</strong> filled 95.6%, down 2.3 points from 97.9% in 2025.</li>
<li><strong>Psychiatry</strong> added 30 programs and 128 positions. Its unfilled positions rose from 8 to 65.</li>
</ul>

<h2>Where the unfilled positions went: SOAP</h2>
<p>Unfilled positions in participating programs move into the Supplemental Offer and Acceptance Program (SOAP) during Match Week. The NRMP's full results report, released May 26, 2026, says 2,851 positions were offered in SOAP and 2,632 were filled, bringing the combined Match and SOAP fill rate to 99.3%. (The NRMP's Match Day news release gave a lower SOAP figure, 2,581; this article uses the later full report.)</p>
<p>So a position that is unfilled on the Monday of Match Week is usually filled by the end of that week. If you go unmatched, SOAP is your main window, and it moves fast. Our <a href="https://med-rise.com/articles/soap-2027-match-week">SOAP 2027 Match Week guide</a> walks through the week hour by hour.</p>

<h2>Why some positions go unfilled</h2>
<p>This part is MedRise's analysis, not an NRMP finding.</p>
<ul>
<li><strong>A preliminary year is a different product.</strong> Preliminary surgery and medicine are one-year positions. Many applicants rank them only as a backup, and a preliminary year does not come with a categorical spot afterward.</li>
<li><strong>Growth can outpace interest.</strong> Family medicine and psychiatry have been adding positions quickly. When positions grow faster than applicant interest, more stay open.</li>
<li><strong>Eligibility narrows the field.</strong> Visa sponsorship, graduation-year limits and score cutoffs mean that many applicants cannot apply to a given open program, even when it has seats.</li>
</ul>

<h2>What this means for the 2027 Match</h2>
<ul>
<li><strong>Know the 2027 dates.</strong> Standard NRMP registration runs until January 29, 2027. Rank order lists open February 1 and must be certified by March 3, 2027, at 9 p.m. ET. Match Week runs March 15 to 19, and Match Day is Friday, March 19, 2027.</li>
<li><strong>IMGs: finish ECFMG requirements on time.</strong> To take part, international medical graduates must meet ECFMG's verification requirements by the March 3, 2027 rank order list deadline.</li>
<li><strong>Rank a backup you would really attend.</strong> Family medicine, internal medicine and pediatrics had the most open categorical positions. If a preliminary or transitional year is part of your plan, know how you would reach a PGY-2 or categorical spot afterward.</li>
<li><strong>Get ready for SOAP before Match Week.</strong> Have your application documents and letters final, and read the <a href="https://www.nrmp.org/residency-applicants/soap/">NRMP's SOAP rules and eligibility</a> now rather than on Monday of Match Week.</li>
</ul>
<p>For the applicant side of the same data, including match rates for U.S. and non-U.S. IMGs, see <a href="https://med-rise.com/articles/2026-nrmp-match-results-what-they-mean-for-imgs">2026 NRMP Match results: what they mean for IMGs</a>.</p>
<p>For the same breakdown from the year before, see <a href="https://med-rise.com/articles/what-specialties-had-unfilled-positions-in-the-2025-residency-match">what specialties had unfilled positions in the 2025 Match</a>.</p>

<h2>Sources</h2>
<ul>
<li><a href="https://www.nrmp.org/wp-content/uploads/2026/03/Advance-Data-Tables-2026_Public.pdf">NRMP, Advance Data Tables: 2026 Main Residency Match</a> (March 2026)</li>
<li><a href="https://www.nrmp.org/wp-content/uploads/2026/03/2026_Match_by_the_Number.pdf">NRMP, Match by the Numbers: 2026 Main Residency Match</a> (March 2026)</li>
<li><a href="https://www.nrmp.org/about/news/2026/03/nrmp-releases-results-of-the-2026-main-residency-match-for-more-than-38000-future-residents/">NRMP news release on the 2026 Main Residency Match results</a> (March 20, 2026)</li>
<li><a href="https://www.nrmp.org/about/news/2026/05/new-reports-2026-main-residency-match-outcome-and-demographic-reports/">NRMP, 2026 Main Residency Match outcome reports, including SOAP results</a> (May 26, 2026)</li>
<li><a href="https://www.nrmp.org/wp-content/uploads/2026/04/2027-MRM-Applicant-Checklist-FINAL.pdf">NRMP, 2027 Main Residency Match applicant checklist</a></li>
</ul>
<p><em>MedRise is not affiliated with the NRMP, ECFMG, Intealth, the AAMC or ERAS. Figures come from the NRMP's public reports and are for education only; check the NRMP for official data. This is not legal or immigration advice, and no outcome is promised.</em></p>]]></content:encoded><media:content url="https://med-rise.com/images/articles/og/unfilled-residency-positions-by-specialty-2026-match.jpg" medium="image" type="image/jpeg"/></item><item><title>AI Trained on 700 Hours of Surgery: Inside NVIDIA&#x27;s Big Push Into Medicine</title><link>https://med-rise.com/articles/nvidia-healthcare-ai-2026-medical-students-residents</link><guid isPermaLink="true">https://med-rise.com/articles/nvidia-healthcare-ai-2026-medical-students-residents</guid><pubDate>Sat, 14 Nov 2026 13:08:57 -0600</pubDate><dc:creator>MedRise News Desk (with AI assistance)</dc:creator><category>Analysis</category><category>Articles</category><description>NVIDIA released 700+ hours of surgical video to train robots, a $1B drug lab and AI agents for radiotherapy. What it means for med students and residents.</description><content:encoded><![CDATA[<p>The company that built its name on video-game graphics now wants to teach robots to operate. In March, NVIDIA released more than 700 hours of surgical video as an open dataset, plus an AI model that turns a typed instruction into robot motion.</p><p>For medical students and residents, this is not just a tech story. It is a training story. The AI arriving on the wards in the next few years will draft notes, help plan radiation and guide surgical robots, and someone will have to check its work. That someone is you.</p><h2>From gaming chips to the operating room</h2><p>At its GTC conference in San Jose, NVIDIA launched what it called the first domain-specific physical AI platform for healthcare robotics, according to <a href="https://gamesbeat.com/nvidia-releases-open-physical-ai-models-for-healthcare-robotics/">NVIDIA's announcement as reported by GamesBeat</a>. Three pieces matter:</p><ul><li><strong>Open-H:</strong> more than 700 hours of surgical video gathered with about three dozen collaborators. NVIDIA calls it the largest healthcare robotics dataset.</li><li><strong>Cosmos-H:</strong> models that generate realistic surgical video from text prompts, images or robot motion data, so a robot can rehearse on synthetic cases before it ever meets a patient.</li><li><strong>GR00T-H:</strong> a vision-language-action model, trained on Open-H, that converts a text command describing a clinical task into robot movement.</li></ul><p>This is already more than a demo. CMR Surgical, which <a href="https://medtechspectrum.com/news/16/25365/cmr-surgical-advances-physical-ai-to-support-the-future-of-robotic-surgery-with-nvidia.html">contributed most of the surgical data in Open-H</a>, is using Cosmos-H simulation to train and validate robotic intelligence for its Versius system before clinical deployment. Johnson &amp; Johnson MedTech is using Isaac Sim and Cosmos-based workflows to train and validate its Monarch Platform for Urology, according to <a href="https://investor.nvidia.com/news/press-release-details/2026/NVIDIA-and-Global-Robotics-Leaders-Take-Physical-AI-to-the-Real-World">NVIDIA's robotics press release</a>.</p><h2>The $1 billion bet on drug discovery</h2><p>The surgery news followed a January splash. At the J.P. Morgan Healthcare Conference, NVIDIA announced a joint research lab with Eli Lilly, with $1 billion committed over five years for compute, talent and infrastructure, plus a collaboration with Thermo Fisher Scientific on autonomous laboratories, <a href="https://www.techrepublic.com/article/news-nvidia-expands-healthcare-push-lilly-thermo-fisher/">TechRepublic reported</a>. NVIDIA also told the room that U.S. healthcare is adopting AI at nearly three times the pace of the broader economy. That is the company's own claim, not an independent measurement.</p><h2>Berlin: AI that designs proteins and plans radiation</h2><p>Then, on October 21, NVIDIA went further at GTC Berlin. In <a href="https://investor.nvidia.com/news/press-release-details/2026/Healthcare-and-Life-Sciences-Leaders-Build-on-NVIDIA-to-Advance-Drug-Discovery-and-Expand-Patient-Care/default.aspx">its announcement</a>, the company unveiled:</p><ul><li><strong>RFD4-Proteina</strong>, an open BioNeMo model built with the UW Medicine Institute for Protein Design that lets scientists and AI agents design and refine new proteins against chosen goals.</li><li><strong>A radiotherapy partnership with Siemens Healthineers</strong>, which is exploring NVIDIA's Nemotron models to help oncologists evaluate and refine treatment plans and plans to use NVIDIA Holoscan to adapt treatment in real time.</li><li><strong>AI scribes and clinical assistants in Europe</strong>, as companies including Corti, Dedalus and Sword build on Nemotron.</li></ul><p>Kimberly Powell, NVIDIA's vice president of healthcare, framed it plainly: &ldquo;Agentic and physical AI are opening new possibilities across medicine.&rdquo;</p><h2>Who is actually using this?</h2><p>NVIDIA's own <a href="https://blogs.nvidia.com/blog/ai-in-healthcare-survey-2026">State of AI in Healthcare and Life Sciences survey</a>, published in February, found that 70% of respondents were actively using AI, up from 63% in the previous survey. Generative AI use jumped to 69% from 54%, and 47% said they were using or assessing AI agents. The company says the report draws on <a href="https://www.nvidia.com/en-eu/lp/industries/healthcare-life-sciences/ai-survey-report/">more than 600 industry respondents</a>.</p><p>Read the fine print, though. The survey comes from the company that sells the hardware, the answers are self-reported, and the respondents are industry professionals, not a random sample of hospitals. It shows direction, not proof that patients are better off.</p><h2>Washington wants AI agents too</h2><p>The agent idea has reached Medicare. At the HIMSS conference in Las Vegas in March, CMS Administrator Dr. Mehmet Oz said the agency had discussed giving an agentic AI tool to every Medicare beneficiary, <a href="https://www.nextgov.com/artificial-intelligence/2026/03/ai-nihilism-barrier-better-health-care-cms-lead-says/412088/">Nextgov reported</a>. Not everyone is sold. <a href="https://www.npr.org/2026/02/14/nx-s1-5704189/dr-oz-ai-avatars-replace-rural-health-workers">NPR reported</a> that critics, including a University of Minnesota rural health researcher, warned that AI avatars for rural care could erode trust and turn rural patients into test subjects for unproven technology.</p><h2>The catch: AI can be confidently wrong</h2><p>Medicine has seen this movie. A widely used proprietary sepsis model, tested independently at Michigan Medicine, reached an area under the curve of just 0.63 and missed 67% of patients who developed sepsis (<a href="https://doi.org/10.1001/jamainternmed.2021.2626">Wong et al., JAMA Internal Medicine, 2021</a>). It was already in wide use. Faster chips do not fix a model that was never tested on patients like yours.</p><h2>What it means if you are in training</h2><ol><li><strong>AI will draft; you will verify.</strong> Catching the anchoring error, the missed red flag or the bad drug interaction in an AI draft is clinical reasoning, and it is the skill that makes the tool safe.</li><li><strong>Ask who built it.</strong> NVIDIA supplies models and infrastructure. The device maker or software vendor is responsible for the clinical product, and you should know whether it is FDA-cleared for the use in front of you.</li><li><strong>Learn the robot's limits.</strong> Systems trained partly on synthetic video will reach operating rooms. Know what a system was trained on and how to take over when it misbehaves.</li><li><strong>New careers are opening.</strong> Clinical informatics and imaging AI need clinicians who speak both languages. Our guide to <a href="https://med-rise.com/medicine/ai-medicine/">AI in medicine</a> covers the informatics pathway.</li></ol><h2>Cheat sheet: NVIDIA's healthcare names</h2><div class="post-table"><table><thead><tr><th>Name</th><th>What it does</th><th>Where you may meet it</th></tr></thead><tbody><tr><td>NVIDIA Clara</td><td>The umbrella brand for NVIDIA's healthcare and life sciences software</td><td>Behind imaging, genomics and device software</td></tr><tr><td>MONAI</td><td>Open-source framework for medical imaging AI</td><td>Radiology and pathology research</td></tr><tr><td>BioNeMo</td><td>Models for biology and drug discovery, including protein design</td><td>Translational labs and pharma</td></tr><tr><td>Holoscan</td><td>Real-time AI for devices that stream sensor data</td><td>Endoscopy, surgical video, radiotherapy</td></tr><tr><td>Parabricks</td><td>Accelerated genomics analysis</td><td>Clinical sequencing</td></tr><tr><td>Nemotron</td><td>Open language models used to build AI agents</td><td>AI scribes and documentation assistants</td></tr><tr><td>Cosmos-H, GR00T-H</td><td>Synthetic surgical data and robot models</td><td>Robotic surgery and simulation centers</td></tr></tbody></table></div><p>Definitions are based on <a href="https://blogs.nvidia.com/blog/nvidia-clara-ai-healthcare-enterprises">NVIDIA's description of its Clara platform</a> and the 2026 announcements above.</p><h2>What to watch next</h2><ul><li>Whether robots trained partly in simulation win regulatory clearance for new tasks.</li><li>Whether CMS turns the beneficiary AI-agent idea into a formal pilot, and what safeguards come with it.</li><li>NVIDIA's next GTC in San Jose, which the company usually holds in March. Find AI and informatics meetings on the <a href="https://med-rise.com/medicine/conferences/">MedRise conference list</a>.</li></ul><p>NVIDIA is building the machines. Medicine still needs people who can tell when the machine is wrong. You can practice that skill now with <a href="https://med-rise.com/viva/">MedRise Viva</a>.</p><p><em>MedRise is not affiliated with NVIDIA, CMS or any company named here, and this article is not sponsored. It is education only and is not medical or legal advice.</em></p>]]></content:encoded><media:content url="https://med-rise.com/images/articles/og/nvidia-healthcare-ai-2026-medical-students-residents.jpg" medium="image" type="image/jpeg"/></item><item><title>CMS Awards Final 200 Section 126 Residency Slots to 99 Teaching Hospitals</title><link>https://med-rise.com/medical-news/cms-final-section-126-residency-slots-99-hospitals</link><guid isPermaLink="true">https://med-rise.com/medical-news/cms-final-section-126-residency-slots-99-hospitals</guid><pubDate>Sat, 14 Nov 2026 07:27:36 -0600</pubDate><dc:creator>MedRise News Desk (with AI assistance)</dc:creator><category>News</category><category>Medical News</category><description>CMS posted the fifth and final round of Section 126 Medicare-funded residency slots on Nov. 9, 2026. What 200 new GME positions mean for students and IMGs.</description><content:encoded><![CDATA[<p>On November 9, 2026, the Centers for Medicare &amp; Medicaid Services (CMS) posted the results of <a href="https://www.cms.gov/medicare/payment/prospective-payment-systems/acute-inpatient-pps/direct-graduate-medical-education-dgme">Round 5 of the Section 126 awards</a> on its Direct Graduate Medical Education page. This is the last round of the 1,000 Medicare-funded residency slots created by Section 126 of the Consolidated Appropriations Act, 2021. According to the <a href="https://www.aamc.org/news/press-releases/cms-announces-distribution-last-medicare-supported-graduate-medical-education-residency-positions">Association of American Medical Colleges (AAMC)</a> and <a href="https://www.aha.org/node/712409">AHA News</a>, this final round sends 200 positions to 99 teaching hospitals.</p>
<h2>What changed</h2>
<p>Medicare pays teaching hospitals for a capped number of full-time equivalent (FTE) residents. The AAMC notes that this cap dates back to the Balanced Budget Act of 1997. Section 126 added 1,000 new FTE cap slots, phased in at no more than 200 per year beginning in fiscal year 2023. With Round 5 posted, all five rounds are now out.</p>
<ul>
<li><strong>Size of this round:</strong> 200 FTE slots for 99 hospitals in 31 states, according to the AAMC.</li>
<li><strong>Specialty mix:</strong> the AAMC reports that CMS estimates about 42% of the new positions will go to primary care and psychiatry programs. This is an estimate, not a final count by specialty.</li>
<li><strong>Start date:</strong> the CMS <a href="https://www.cms.gov/files/document/frequently-asked-questions-section-126.pdf">Section 126 FAQ</a> says slots awarded in this round take effect July 1, 2027.</li>
<li><strong>Permanent funding:</strong> CMS states that all cap slots awarded through Section 126 are permanent.</li>
<li><strong>Limits:</strong> no single hospital can receive more than 25 Section 126 slots in total.</li>
</ul>
<p>To qualify, a hospital had to fit at least one of four groups: rural (or treated as rural), already training more residents than its Medicare cap, located in a state with a new medical school or branch campus, or serving a geographic Health Professional Shortage Area (HPSA). CMS ranked applications by HPSA score, so hospitals serving areas with the greatest shortages were funded first. CMS also says the law's requirement that each of the four groups receive at least 10% of the slots has now been met.</p>
<p>Section 126 is separate from Section 4122 of the Consolidated Appropriations Act, 2023, which added another 200 slots beginning in fiscal year 2026, at least half of them for psychiatry. CMS posted those results on December 18, 2025.</p>
<h2>Why it matters for students and residents</h2>
<p>Every residency position needs funding, and Medicare is a major source of GME support. Permanent new slots at hospitals in rural and shortage areas can, over time, mean more training positions in places that have struggled to grow programs. For international medical graduates and U.S. students applying broadly, these are often the community and rural programs already on their lists.</p>
<p>Two points keep expectations realistic. First, 200 slots is small next to a Main Residency Match that offers tens of thousands of positions each year. Second, a cap slot is funding, not automatically a new seat. One of the four eligible groups is hospitals already training residents above their cap, so some awards may pay for residents a hospital already trains rather than add new positions. Programs that do want to grow usually also need accreditor approval for a larger resident complement before they can add seats.</p>
<p>The AAMC projects a shortfall of up to 86,000 physicians by 2036. Its president and CEO, David J. Skorton, MD, said "our country remains in desperate need of additional, permanent residency positions." The AAMC is urging Congress to pass the Resident Physician Shortage Reduction Act of 2025 (H.R. 4731 / S. 2439).</p>
<h2>What to do now</h2>
<ul>
<li><strong>Applicants in the 2027 Match:</strong> the July 1, 2027 effective date lines up with the start of the next residency year, but do not assume a program has more positions. Check each program's website and its listing in the NRMP system for its current number of positions. Our <a href="https://med-rise.com/articles/residency-process-guide">residency process guide</a> walks through building a balanced list.</li>
<li><strong>Students planning ahead:</strong> awards were ranked by HPSA score, so programs in rural and shortage areas are worth a closer look. CMS estimates about 42% of these positions will go to primary care and psychiatry.</li>
<li><strong>Residents:</strong> if your hospital received slots, ask your program leadership how they plan to use them. New funding can affect program size over the next few years.</li>
<li><strong>GME leaders:</strong> CMS posted the full award list as a ZIP file on its DGME page. Confirm your hospital's award and plan with your finance and cost report teams before July 1, 2027. MedRise supports <a href="https://med-rise.com/medicine/hospitals/">hospitals and GME offices</a> with recruitment and IMG onboarding.</li>
</ul>
<h2>What we don't know yet</h2>
<p>CMS has not published a specialty-by-specialty count in the sources we reviewed, so the 42% figure for primary care and psychiatry is an estimate. It is also not yet clear how many of the 200 slots will create new training positions versus fund residents already in place, or whether lawmakers will create more slots now that Section 126 is fully distributed.</p>
<p>Want help planning your next application cycle? See our support for <a href="https://med-rise.com/medicine/students/">medical students</a> and <a href="https://med-rise.com/medicine/residents/">residents</a>.</p>
<hr>
<p><strong>Sources:</strong> <a href="https://www.cms.gov/medicare/payment/prospective-payment-systems/acute-inpatient-pps/direct-graduate-medical-education-dgme">CMS, Direct Graduate Medical Education (DGME), Section 126 and Section 4122 (Round 5 posted Nov. 9, 2026)</a>; <a href="https://www.cms.gov/files/document/frequently-asked-questions-section-126.pdf">CMS, Frequently Asked Questions: Section 126</a>; <a href="https://www.aamc.org/news/press-releases/cms-announces-distribution-last-medicare-supported-graduate-medical-education-residency-positions">AAMC, CMS Announces Distribution of Last Medicare-Supported GME Residency Positions (Nov. 10, 2026)</a>; <a href="https://www.aha.org/node/712409">AHA News, CMS allocates 200 Medicare-funded residency slots to 99 teaching hospitals (Nov. 10, 2026)</a>; <a href="https://www.aamc.org/advocacy-policy/washington-highlights/applications-open-final-round-section-126-residency-distributions">AAMC, Applications Open for Final Round of Section 126 Residency Distributions (Jan. 9, 2026)</a>.</p>
<p><em>MedRise Medical News summarizes public announcements and research for education only. It is not medical, legal or immigration advice.</em></p>]]></content:encoded><media:content url="https://med-rise.com/images/medical-news/og/cms-final-section-126-residency-slots-99-hospitals.jpg" medium="image" type="image/jpeg"/></item><item><title>What Specialties Had Unfilled Positions in the 2025 Residency Match?</title><link>https://med-rise.com/articles/what-specialties-had-unfilled-positions-in-the-2025-residency-match</link><guid isPermaLink="true">https://med-rise.com/articles/what-specialties-had-unfilled-positions-in-the-2025-residency-match</guid><pubDate>Fri, 03 Oct 2025 20:46:56 -0500</pubDate><dc:creator>MedRise News Desk (with AI assistance)</dc:creator><category>Analysis</category><category>Articles</category><description>Family medicine and preliminary surgery held over half of the 2,374 unfilled PGY-1 positions in the 2025 Match. Full specialty table and what SOAP did next.</description><content:encoded><![CDATA[<p><strong>Looking for the latest data?</strong> See <a href="https://med-rise.com/articles/unfilled-residency-positions-by-specialty-2026-match">unfilled residency positions by specialty: 2026 Match data</a>. This article covers the 2025 Match.</p>
<p>Two specialties held more than half of the 2,374 PGY-1 positions left empty after the 2025 Match algorithm ran: family medicine with 805 and preliminary surgery with 521, according to the NRMP's <a href="https://www.nrmp.org/wp-content/uploads/2025/03/Advance_Data_Tables_2025.pdf">Advance Data Tables 2025</a>.</p>
<p>That matters because unfilled positions are the menu for SOAP, the four-day scramble for unmatched applicants during Match Week. Know where the empty seats cluster, and you know which backup specialties to prepare for before Match Week instead of during it.</p>
<p>Preliminary surgery is the outlier. It left 43.6% of its 1,194 PGY-1 seats open, the highest share of any large category. At the other end, anesthesiology and categorical OB/GYN each had a single unfilled position.</p>
<h2>The 2025 unfilled-position map, specialty by specialty</h2>
<div class="post-table"><table>
<caption>PGY-1 positions after the matching algorithm, before SOAP, 2025 Main Residency Match. Source: NRMP Advance Data Tables 2025, Table 2. Shares calculated by MedRise.</caption>
<thead><tr><th>Specialty</th><th>Offered</th><th>Filled</th><th>Unfilled</th><th>Share unfilled</th></tr></thead>
<tbody>
<tr><td>Family Medicine</td><td>5,357</td><td>4,552</td><td>805</td><td>15.0%</td></tr>
<tr><td>Surgery, preliminary (PGY-1 only)</td><td>1,194</td><td>673</td><td>521</td><td>43.6%</td></tr>
<tr><td>Internal Medicine, categorical</td><td>10,941</td><td>10,584</td><td>357</td><td>3.3%</td></tr>
<tr><td>Transitional year (PGY-1 only)</td><td>1,860</td><td>1,617</td><td>243</td><td>13.1%</td></tr>
<tr><td>Pediatrics, categorical</td><td>3,135</td><td>2,988</td><td>147</td><td>4.7%</td></tr>
<tr><td>Medicine, preliminary (PGY-1 only)</td><td>1,600</td><td>1,455</td><td>145</td><td>9.1%</td></tr>
<tr><td>Emergency Medicine</td><td>3,068</td><td>3,003</td><td>65</td><td>2.1%</td></tr>
<tr><td>Internal Medicine, primary care</td><td>411</td><td>400</td><td>11</td><td>2.7%</td></tr>
<tr><td>OB/GYN, preliminary (PGY-1 only)</td><td>17</td><td>8</td><td>9</td><td>52.9%</td></tr>
<tr><td>Psychiatry</td><td>2,388</td><td>2,380</td><td>8</td><td>0.3%</td></tr>
<tr><td>Neurology</td><td>932</td><td>925</td><td>7</td><td>0.8%</td></tr>
<tr><td>Surgery, categorical</td><td>1,778</td><td>1,774</td><td>4</td><td>0.2%</td></tr>
<tr><td>Radiology, diagnostic (PGY-1)</td><td>151</td><td>147</td><td>4</td><td>2.6%</td></tr>
<tr><td>Pathology</td><td>622</td><td>619</td><td>3</td><td>0.5%</td></tr>
<tr><td>Anesthesiology</td><td>1,805</td><td>1,804</td><td>1</td><td>0.1%</td></tr>
<tr><td>Obstetrics and Gynecology</td><td>1,587</td><td>1,586</td><td>1</td><td>0.1%</td></tr>
</tbody>
</table></div>
<p>Across all training levels, 43,237 positions were offered and 40,764 were filled, leaving 2,473 open before SOAP. Internal medicine looks large in raw numbers, but its 357 categorical vacancies were only 3.3% of nearly 11,000 seats. Internal medicine overall (categorical and primary care) offered 11,352 positions and filled 10,984.</p>
<h2>Three things the 2025 numbers tell you</h2>
<ol>
<li><strong>Empty seats are concentrated, not scattered.</strong> Family medicine, preliminary surgery, transitional year, categorical internal medicine, pediatrics and preliminary medicine held 2,218 of the 2,374 open PGY-1 positions, about 93%.</li>
<li><strong>Competitive categorical specialties barely appear.</strong> Anesthesiology, OB/GYN, general surgery, neurology and psychiatry had 21 open PGY-1 positions between them. If one of those is your goal, do not count on SOAP for a categorical seat; plan for a preliminary or transitional year as the bridge.</li>
<li><strong>Family medicine leans on IMGs.</strong> Of the 4,552 family medicine positions filled by the algorithm, IMGs took 1,427, or 31%: 626 U.S. citizen IMGs and 801 non-U.S. citizen IMGs.</li>
</ol>
<h2>What SOAP did with them: 2,521 seats for 13,670 eligible applicants</h2>
<p>The NRMP's <a href="https://www.nrmp.org/wp-content/uploads/2025/05/Main_Match_Results_and_Data_20250529_FINAL.pdf">Results and Data report for 2025</a> shows how those vacancies were resolved. It counted 2,521 positions placed in SOAP and 13,670 SOAP-eligible applicants, 68.2% of them IMGs. That is about 5.4 eligible applicants per seat.</p>
<p>Programs sent 3,757 offers: 2,318 were accepted, 1,324 were rejected and 115 were left to expire. When SOAP closed, 203 positions were still empty, and the combined fill rate for the Match and SOAP reached 99.4%.</p>
<p>The SOAP pool mirrored the unfilled map. Family medicine placed 805 positions, internal medicine 370 (359 categorical and 11 primary care) and pediatrics 147. Another 965, or 38%, were PGY-1-only, led by 549 in preliminary surgery and 260 in the transitional year. The NRMP's SOAP count can exceed the algorithm's unfilled count because it also takes in positions at programs that submitted no rank order list.</p>
<h2>How to use the 2025 map if you are applying now</h2>
<ul>
<li><strong>Pick SOAP backups from the map, not by mood.</strong> Family medicine, internal medicine, pediatrics and PGY-1-only positions made up about nine in ten SOAP positions in 2025 (2,287 of 2,521) and again in 2026. Draft a personal statement for each backup you would accept before Match Week.</li>
<li><strong>Check the trend before you lean on 2025.</strong> In 2026, family medicine's unfilled positions rose to 899 and preliminary surgery's to 543, according to the <a href="https://www.nrmp.org/wp-content/uploads/2026/05/Main_Match_Results_and_Data-2026.pdf">NRMP's 2026 report</a>. The full 2026 breakdown is in our <a href="https://med-rise.com/articles/unfilled-residency-positions-by-specialty-2026-match">2026 unfilled-positions analysis</a>.</li>
<li><strong>Treat a preliminary year as a bridge, and choose it with your goal in mind.</strong> In a two-center study of OB/GYN reapplicants published in 2026 in the <a href="https://doi.org/10.1016/j.jsurg.2026.104125">Journal of Surgical Education</a>, general surgery preliminary residents re-matched into OB/GYN 75% of the time, while nonsurgical preliminary years did worse. It covers one specialty at two institutions, so read it as a signal, not a rule.</li>
<li><strong>Do not read "unfilled" as "easy."</strong> With more than five eligible applicants per SOAP seat, programs still choose. Have your documents, references and phone ready before Monday of Match Week.</li>
<li><strong>Know the 2027 calendar.</strong> SOAP for the 2027 Match runs March 15 to 18, with all four offer rounds on Thursday. Our <a href="https://med-rise.com/articles/soap-2027-match-week">SOAP 2027 Match Week guide</a> has the hour-by-hour schedule and rules.</li>
</ul>
<p>For how IMGs did overall that year, see <a href="https://med-rise.com/articles/2025-nrmp-match-results-what-they-mean-for-imgs-and-residency-applicants">2025 NRMP Match results: what they mean for IMGs</a>.</p>
<p>Unfilled numbers are not a consolation list. Read them in February, and Match Week becomes a plan instead of a panic.</p>
<h2>FAQ</h2>
<h3>Which specialty had the most unfilled positions in the 2025 Match?</h3>
<p>Family medicine, with 805 PGY-1 positions open after the matching algorithm, out of 5,357 offered.</p>
<h3>Which specialty had the highest share of unfilled positions?</h3>
<p>Among large categories, preliminary surgery: 521 of 1,194 PGY-1 positions, or 43.6%, were open before SOAP.</p>
<h3>How many positions were still unfilled after SOAP in 2025?</h3>
<p>203 of the 2,521 positions placed in SOAP were still unfilled when it ended. Counting the Match and SOAP together, 99.4% of positions were filled.</p>
<h3>Can I see the list of unfilled programs?</h3>
<p>Only during Match Week, and only if you are SOAP-eligible: the NRMP's List of Unfilled Programs appears inside its R3 system and shows each applicant only the programs they are eligible for.</p>
<h2>Sources</h2>
<ul>
<li><a href="https://www.nrmp.org/wp-content/uploads/2025/03/Advance_Data_Tables_2025.pdf">NRMP, Advance Data Tables: 2025 Main Residency Match</a> (March 2025)</li>
<li><a href="https://www.nrmp.org/wp-content/uploads/2025/05/Main_Match_Results_and_Data_20250529_FINAL.pdf">NRMP, Results and Data: 2025 Main Residency Match</a> (May 2025)</li>
<li><a href="https://www.nrmp.org/wp-content/uploads/2026/05/Main_Match_Results_and_Data-2026.pdf">NRMP, Results and Data: 2026 Main Residency Match</a> (May 2026)</li>
<li>Schroeder BE, et al. <a href="https://pubmed.ncbi.nlm.nih.gov/42679672/">Outcomes of Residency Reapplication in Obstetrics and Gynecology</a>. Journal of Surgical Education, 2026 (PubMed; <a href="https://doi.org/10.1016/j.jsurg.2026.104125">doi:10.1016/j.jsurg.2026.104125</a>)</li>
</ul>
<p><em>MedRise Articles share educational information only. They are not medical, legal or immigration advice. Confirm requirements with the official organization or program.</em></p>]]></content:encoded><media:content url="https://med-rise.com/images/articles/og/what-specialties-had-unfilled-positions-in-the-2025-residenc.jpg" medium="image" type="image/jpeg"/></item><item><title>Neuralink Wins U.K. Approval for GB-PRIME Brain-Implant Study After $650 Million Raise</title><link>https://med-rise.com/medical-news/neuralinks-lightning-link-moment</link><guid isPermaLink="true">https://med-rise.com/medical-news/neuralinks-lightning-link-moment</guid><pubDate>Wed, 13 Aug 2025 21:30:04 -0500</pubDate><dc:creator>MedRise News Desk (with AI assistance)</dc:creator><category>News</category><category>Medical News</category><description>Neuralink received U.K. regulatory and ethics approvals for GB-PRIME, a feasibility study of its N1 brain implant at two NHS hospitals, two months after closing a $650 million funding round.</description><content:encoded><![CDATA[<p>Neuralink, the brain-computer interface company co-founded by Elon Musk, received approval to begin GB-PRIME, its first clinical study in Great Britain, the company announced on July 31, 2025. The approvals came from the Medicines and Healthcare products Regulatory Agency, the Health Research Authority, Health and Care Research Wales and the London–Camberwell St Giles Research Ethics Committee (<a href="https://www.eweek.com/news/neuralink-great-britain-clinical-trials/">eWeek</a>).</p>
<h2>What the study will test</h2>
<p>GB-PRIME is a feasibility study of the safety and early functionality of Neuralink's N1 Implant, run at University College London Hospitals, the lead site, and Newcastle upon Tyne Hospitals (<a href="https://www.uclh.nhs.uk/news/uclh-evaluate-safety-and-functionality-neuralinks-brain-computer-interface-bci-technology">UCLH</a>). It plans to enroll up to seven people with severe neurological conditions, such as spinal cord injury or motor neurone disease, that make it hard to use digital devices (<a href="https://www.biopharmatrend.com/post/1323-neuralink-begins-uk-clinical-trial-of-brain-implant-for-people-with-paralysis">BiopharmaTrend</a>).</p>
<p>Eligible participants have tetraplegia or tetraparesis, meaning paralysis or weakness in the arms and legs. The implant is designed to let them control computers or smartphones with their thoughts. UCLH says the study will not, at this stage, include controlling a robotic arm.</p>
<p>The N1 records brain signals through more than 1,000 electrodes spread across threads finer than a human hair, which Neuralink's R1 surgical robot places within microns of target neurons (<a href="https://www.ucl.ac.uk/brain-sciences/news/2025/jul/uclh-evaluate-safety-and-functionality-neuralinks-brain-computer-interface-bci-technology">UCL</a>).</p>
<h2>The funding and the road here</h2>
<p>Two months earlier, on June 2, 2025, Neuralink closed a $650 million Series E round (<a href="https://techcrunch.com/2025/06/02/elon-musks-neuralink-closes-a-650m-series-e">TechCrunch</a>). Semafor reported that it valued the company at $9 billion before the new money, and the round brought total funding to about $1.2 billion (<a href="https://pharmaphorum.com/news/neuralink-raises-650m-widen-use-brain-implants">pharmaphorum</a>).</p>
<p>The U.S. Food and Drug Administration initially rejected Neuralink's request for human trials in 2022, citing safety concerns; after further testing it allowed the U.S. PRIME study, and the first person received an implant in January 2024 (eWeek). GB-PRIME builds on that U.S. study.</p>
<h2>Why it matters for medicine</h2>
<p>Brain-computer interfaces could restore some independence to people who cannot move their arms, but the big questions remain open: how long implants keep working, how safely they can be removed or replaced, and who owns and protects the neural data they record. Early feasibility studies like GB-PRIME are designed to answer safety questions first, with small numbers of participants, before any larger trial.</p>
<p>For students, BCIs sit at the meeting point of neurology, neurosurgery, rehabilitation medicine and engineering, and they raise ethics questions that are likely to show up in interviews and journal clubs.</p>
<p>Related: <a href="https://med-rise.com/medical-news/googles-medgemma-the-free-to-use-ai-that-can-read-x-rayswhat-patients-should-know">Google's MedGemma chest X-ray models</a> and <a href="https://med-rise.com/articles/nvidia-healthcare-ai-2026-medical-students-residents">NVIDIA's push into medicine</a>.</p>
<p><em>This article is news and education, not medical or legal advice.</em></p>]]></content:encoded><media:content url="https://med-rise.com/images/medical-news/og/neuralinks-lightning-link-moment.jpg" medium="image" type="image/jpeg"/></item><item><title>Spatial AI Takes Center Stage at AI4: The Next Frontier in 3D Intelligence</title><link>https://med-rise.com/medical-news/spatial-ai-takes-center-stage-at-ai4-the-next-frontier-in-3d-intelligence</link><guid isPermaLink="true">https://med-rise.com/medical-news/spatial-ai-takes-center-stage-at-ai4-the-next-frontier-in-3d-intelligence</guid><pubDate>Wed, 13 Aug 2025 21:21:54 -0500</pubDate><dc:creator>MedRise News Desk</dc:creator><category>News</category><category>Medical News</category><description>Published August 13, 2025. This recap covers a session at the Ai4 2025 conference in Las Vegas (August 11–13, 2025) and has not been updated. At the AI4…</description><content:encoded><![CDATA[<p><em>Published August 13, 2025. This recap covers a session at the Ai4 2025 conference in Las Vegas (August 11–13, 2025) and has not been updated.</em></p> <p><em> </em>By MedRise News Staff</p><p>At the AI4 conference, Ryan Wang—co-founder and general partner of Outpost Capital and managing partner at Solaris Venture Partners—unveiled a deep dive into Spatial AI, calling it “the new frontier where AI meets 3D.” His session, “Spatial AI: A New Frontier – The Industry Landscape &amp; Investment Thesis,” mapped out a rapidly emerging sector poised to transform robotics, gaming, and immersive computing.</p><p><strong>What is Spatial AI?</strong></p><p>Spatial AI sits at the intersection of artificial intelligence and 3D spatial computing. Unlike traditional AI systems that process 2D data, Spatial AI is designed to natively understand and interact with three-dimensional environments.</p><p>According to Wang, Spatial AI takes 3D data as its default input, produces 3D output without translation into 2D or text, and applies spatial reasoning to interpret real-world space and relationships—similar to how humans process their surroundings.</p><p><strong>The First Industry Map for Spatial AI</strong></p><p>In a landmark reveal, Wang presented what he called the world’s first industry map for Spatial AI, categorizing companies into sectors such as:</p><ul><li><p>Interactions &amp; Manipulation – Robotic perception, control, and brain-computer interfaces.</p></li><li><p>Media &amp; Entertainment – Animation, virtual beings, co-presence, and immersive games.</p></li><li><p>Developer Tools – AI assistants, game engines, and AR/VR spatial interfaces.</p></li><li><p>Foundational 3D Models – Generative 3D, world simulations, and foundational AI labs.</p></li><li><p>Data &amp; Simulation – Synthetic data and digital twins fueling AI training.</p></li></ul><p>Notable players span from NVIDIA, Apple, Google, and Meta to startups working on brain-computer interfaces, generative 3D asset creation, and real-time spatial sensing.</p><p><strong>Ecosystem Enablers</strong></p><p>Wang outlined three critical enablers driving this sector’s growth:</p><ol><li><p>Infrastructure – High-performance compute for large-scale spatial simulations, with NVIDIA’s Omniverse platform leading the charge.</p></li><li><p>Big Tech – Meta and xAI investing heavily into spatial computing foundations.</p></li><li><p>Enterprise Data – A surge in synthetic spatial data enabling richer AI training environments.</p></li></ol><p>These elements feed into the “Spatial AI Engine,” an interconnected ecosystem that depends on advancements across hardware, software, and simulation.</p><p><strong>Why It Matters</strong></p><p>Spatial AI has implications far beyond gaming or robotics—it could redefine how machines perceive, navigate, and collaborate in the physical world. From autonomous drones to industrial digital twins, the ability for AI to natively understand and operate in 3D space unlocks possibilities in manufacturing, logistics, telepresence, and healthcare simulation.</p><p>The investment landscape is heating up, and those who position themselves early in Spatial AI’s infrastructure and tooling could shape the foundations of a trillion-dollar industry.</p>]]></content:encoded><media:content url="https://med-rise.com/images/medical-news/og/spatial-ai-takes-center-stage-at-ai4-the-next-frontier-in-3d.jpg" medium="image" type="image/jpeg"/></item><item><title>FDA Grants Breakthrough Therapy Designation to Dyne&#x27;s DYNE-251 for Duchenne</title><link>https://med-rise.com/medical-news/fda-hands-dynes-dyne-251-a-fast-track-to-the-cliniccould-this-exon-skipping-nanomachine-outmuscle-gene-therapy-for-duchenne</link><guid isPermaLink="true">https://med-rise.com/medical-news/fda-hands-dynes-dyne-251-a-fast-track-to-the-cliniccould-this-exon-skipping-nanomachine-outmuscle-gene-therapy-for-duchenne</guid><pubDate>Wed, 06 Aug 2025 16:42:25 -0500</pubDate><dc:creator>MedRise News Desk (with AI assistance)</dc:creator><category>News</category><category>Medical News</category><description>FDA gave DYNE-251 (z-rostudirsen) Breakthrough Therapy Designation for Duchenne in August 2025. Its FDA decision date is now January 21, 2027.</description><content:encoded><![CDATA[<p>The FDA granted Breakthrough Therapy Designation on August 4, 2025 to DYNE-251, Dyne Therapeutics' investigational drug for Duchenne muscular dystrophy in boys whose mutations are amenable to exon 51 skipping, <a href="https://www.parentprojectmd.org/?p=25967">Parent Project Muscular Dystrophy reported</a>.</p><p>The designation is meant to speed development and review when early data suggest a drug may substantially improve on available therapy. For families of the roughly 13% of Duchenne patients with exon 51-amenable mutations, it put a new option on a faster track.</p><h2>What the designation was based on</h2><p>The designation rested on the Phase 1/2 DELIVER trial, where patients showed sustained functional improvements such as faster time to rise and improved walking speed over 18 months, according to Parent Project MD. It brings extra FDA guidance and eligibility for rolling and priority review, <a href="https://cureduchenne.org/research/dyne-therapeutics-granted-breakthrough-therapy-designation-for-exon-51skipping-therapeutic-dyne-251/">CureDuchenne noted</a>.</p><p>It was the company's second breakthrough designation of the year. Its myotonic dystrophy type 1 drug, DYNE-101, had received one earlier in 2025, <a href="https://investors.dyne-tx.com/node/11271/pdf">Dyne said</a>.</p><h2>How the drug works</h2><p>DYNE-251 links a phosphorodiamidate morpholino oligomer, the same class of molecule used in existing exon-skipping drugs, to an antibody fragment that binds the transferrin receptor 1 on muscle cells. The goal is to get more of the drug into muscle so cells can make near full-length dystrophin.</p><h2>Update, November 2026: an FDA decision is due in January</h2><ul><li>The drug was renamed zeleciment rostudirsen (z-rostudirsen).</li><li>Japan's health ministry granted it orphan drug designation on September 29, 2025, <a href="https://www.barchart.com/story/news/35099576/dyne-therapeutics-receives-orphan-drug-designation-in-japan-for-dyne-251-in-duchenne-muscular-dystrophy">Dyne announced</a>.</li><li>Dyne <a href="https://investors.dyne-tx.com/news-releases/news-release-details/dyne-therapeutics-announces-submission-biologics-license">submitted a Biologics License Application</a> on May 26, 2026, seeking accelerated approval based on dystrophin as a surrogate endpoint, with a proposed dose of 20 mg/kg given intravenously every 4 weeks.</li><li>The FDA accepted the application with Priority Review and set a target action date of January 21, 2027, <a href="https://www.barchart.com/story/news/3361754/dyne-therapeutics-announces-u-s-fda-acceptance-of-biologics-license-application-bla-for-z-rostudirsen-in-exon-51-duchenne-muscular-dystrophy-dmd">Dyne announced</a> on July 20, 2026.</li><li>A confirmatory Phase 3 trial is under way, as accelerated approval requires.</li></ul><h2>Why it matters for students and residents</h2><p>Duchenne is a staple of pediatrics, neurology and board exams. Accelerated approval on a surrogate endpoint such as dystrophin is a recurring debate: the drug reaches patients sooner, but clinical benefit must still be confirmed. Expect that tension to come up on rounds. More in <a href="https://med-rise.com/medical-news">MedRise Medical News</a> and our <a href="https://med-rise.com/shelf-prep">Shelf Prep guides</a>.</p><p>January 21, 2027 is the date to watch for families, clinicians and the trainees who will care for these patients.</p><p><em>MedRise Medical News summarizes public announcements and research for education only. It is not medical, legal or immigration advice.</em></p>]]></content:encoded><media:content url="https://med-rise.com/images/medical-news/og/fda-hands-dynes-dyne-251-a-fast-track-to-the-cliniccould-thi.jpg" medium="image" type="image/jpeg"/></item><item><title>Joby Buys Blade&#x27;s Passenger Business as Blade&#x27;s Organ-Transport Arm Becomes Strata</title><link>https://med-rise.com/medical-news/how-joby-aviations-evtol-fleet-could-transform-organ-transportand-the-future-of-emergency-medicine</link><guid isPermaLink="true">https://med-rise.com/medical-news/how-joby-aviations-evtol-fleet-could-transform-organ-transportand-the-future-of-emergency-medicine</guid><pubDate>Wed, 06 Aug 2025 16:27:20 -0500</pubDate><dc:creator>MedRise News Desk (with AI assistance)</dc:creator><category>News</category><category>Medical News</category><description>Joby agreed to buy Blade&#x27;s passenger business for up to $125M; Blade&#x27;s organ-transport arm, renamed Strata, named Joby its preferred eVTOL partner.</description><content:encoded><![CDATA[<p>Joby Aviation agreed on August 4, 2025 to buy Blade Air Mobility's passenger business for up to $125 million, and Blade's medical division, which flies human organs for transplant, will stay a separate public company named Strata Critical Medical, <a href="https://www.jobyaviation.com/news/joby-to-acquire-blades-passenger-business-accelerating-air-taxi-commercialization">Joby announced</a>.</p><p>The detail that matters for hospitals: Joby becomes Strata's preferred partner for electric vertical takeoff and landing (eVTOL) aircraft wherever Joby operates, putting organ transport on the list of early uses for electric air taxis.</p><h2>The deal</h2><ul><li>Joby pays up to $125 million in cash or stock for Blade's passenger business, which flew more than 50,000 passengers in 2024 from 12 urban terminals, including JFK and Newark.</li><li>Blade's medical division was excluded and was renamed Strata Critical Medical, <a href="https://www.airmedandrescue.com/latest/news/joby-aviation-acquires-blades-urban-passenger-business-eyes-global-rollout">Air Med &amp; Rescue reported</a>.</li><li>Blade founder Rob Wiesenthal leads Blade as a Joby subsidiary and serves as non-executive chairman of Strata, <a href="https://www.axios.com/2025/08/04/joby-blade-evtols">Axios reported</a>.</li><li>Blade's chief financial officer, William Heyburn, and president, Melissa Tomkiel, became co-CEOs of Strata, according to Axios.</li><li>Joby said Blade's passenger flights would continue as normal, and that it planned to carry its first passengers in Dubai in 2026.</li></ul><p>Electric air taxis like Joby's take off and land vertically like helicopters but run on batteries. Joby's plan is to move Blade's existing customers gradually from conventional helicopters to its own aircraft, using Blade's terminals instead of building its own.</p><h2>Why organ transport is a test case</h2><p>Donor organs are flown under tight time limits, and transplant teams already rely on helicopters and planes to move them. A June 2025 federal executive order also called for eVTOL pilot projects that include medical response, Axios reported. Whether electric aircraft improve transplant logistics in practice has yet to be shown. Range, weather limits, landing sites at hospitals and certification by aviation regulators will all decide how quickly these aircraft can carry anything as critical as a donor heart or kidney.</p><h2>What it means for students and residents</h2><ul><li><strong>Transplant logistics are clinical.</strong> Ischemic time affects outcomes, so how organs move is part of transplant medicine.</li><li><strong>Watch for evidence, not announcements.</strong> The question is whether eVTOL flights shorten transport times and improve graft outcomes in real programs. More in <a href="https://med-rise.com/medical-news">MedRise Medical News</a>; meet transplant and aerospace physicians at events on our <a href="https://med-rise.com/medicine/conferences/">conference list</a>.</li></ul><p>The aircraft are coming. The data on patient benefit will take longer.</p><p><em>MedRise Medical News summarizes public announcements and research for education only. It is not medical, legal or immigration advice.</em></p>]]></content:encoded><media:content url="https://med-rise.com/images/medical-news/og/how-joby-aviations-evtol-fleet-could-transform-organ-transpo.jpg" medium="image" type="image/jpeg"/></item><item><title>From a 250% Threat to a 100% Tariff: Where U.S. Tariffs on Imported Drugs Stand</title><link>https://med-rise.com/medical-news/trumps-250-pharma-tariff-threat-a-hard-ball-business-move-aimed-at-on-shoring-drug-production</link><guid isPermaLink="true">https://med-rise.com/medical-news/trumps-250-pharma-tariff-threat-a-hard-ball-business-move-aimed-at-on-shoring-drug-production</guid><pubDate>Tue, 05 Aug 2025 22:05:01 -0500</pubDate><dc:creator>MedRise News Desk (with AI assistance)</dc:creator><category>Analysis</category><category>Medical News</category><description>In August 2025 the President said tariffs on imported medicines could reach 250%. In April 2026 a Section 232 proclamation set 100% tariffs on patented drugs, with wide exemptions for generics and companies with pricing deals.</description><content:encoded><![CDATA[<p>U.S. tariffs on imported medicines went from a threat to policy over about eight months. In an August 5, 2025, CNBC interview, President Donald Trump said the United States would start with a "small tariff" on pharmaceutical imports, raise it to 150% within 18 months and eventually to 250%, to push drug production into the country (<a href="https://www.bnnbloomberg.ca/tariffs/2025/08/05/us-to-initially-impose-small-tariff-on-pharma-imports-trump-says/">Reuters via BNN Bloomberg</a>). Earlier that summer he had floated 200% (<a href="https://www.thefiscaltimes.com/2025/08/05/Trump-Threatens-250-Tariff-Pharma-Imports">The Fiscal Times</a>).</p>
<h2>The September 2025 announcement</h2>
<p>On September 25, 2025, the President announced on social media a 100% tariff on branded or patented drugs starting October 1, unless the manufacturer was building a U.S. plant (<a href="https://www.foleyhoag.com/news-and-insights/publications/alerts-and-updates/2025/september/100-us-tariff-on-branded-patented-drugs-effective-october-1-2025/">Foley Hoag</a>). That tariff was not put into effect at the time; the administration instead negotiated company-by-company deals on pricing and U.S. manufacturing (<a href="https://www.ropesgray.com/en/insights/alerts/2026/04/100-on-brand-us-imposes-new-tariffs-and-key-exemptions-on-patented-pharmaceuticals">Ropes &amp; Gray</a>).</p>
<h2>The April 2026 Section 232 proclamation</h2>
<p>On April 2, 2026, after a national-security investigation the Commerce Department opened in April 2025, the President signed a proclamation imposing 100% tariffs on patented pharmaceuticals and their key ingredients. They took effect July 31, 2026, for 17 large drugmakers named in the proclamation, most of which were exempt because of agreements with the administration (<a href="https://www.arnoldporter.com/en/perspectives/advisories/2026/04/trade-winds-shift-for-pharma">Arnold &amp; Porter</a>).</p>
<ul><li><strong>Not covered:</strong> generic drugs and biosimilars, and U.S.-made products (<a href="https://www.cov.com/news-and-insights/insights/2026/04/trump-administration-announces-section-232-tariffs-on-patented-pharmaceuticals-and-ingredients">Covington</a>).</li><li><strong>Exempt:</strong> companies with "most favored nation" drug-pricing deals, or negotiating them, through January 20, 2029 (<a href="https://taxnews.ey.com/news/2026-0786-new-tariffs-imposed-on-pharmaceuticals-following-section-232-investigation">EY</a>).</li><li><strong>Since September 29, 2026:</strong> the tariffs apply to branded drugmakers beyond the first 17, though exemptions, trade-deal rates and pricing deals still decide who pays and how much (<a href="https://www.managedhealthcareexecutive.com/view/tariffs-on-patented-drugs-now-apply-to-all-branded-drugmakers">Managed Healthcare Executive</a>).</li></ul>
<h2>What it means for patients and hospitals</h2>
<p>Because generics are excluded, the direct effect falls on imported brand-name drugs whose makers lack an exemption. A benefits consultant quoted by Managed Healthcare Executive did not expect a cost impact for the 2026–27 plan year, but open questions, such as how ingredients and biosimilars are treated, could change costs later.</p>
<h2>What to watch</h2>
<p>The proclamation lets the President revise rates or the list of covered products depending on negotiations with trading partners, and a joint status report on those talks was due by July 1, 2026 (<a href="https://www.thompsonhinesmartrade.com/2026/04/president-trump-announces-section-232-tariffs-on-pharmaceuticals-and-active-pharmaceutical-ingredients/">Thompson Hine</a>). Expect the rules to keep changing.</p>
<p>For residents and students, the practical effects show up in formularies, prior authorizations and the price of brand-name drugs without a generic. It is worth knowing which of your patients' medicines are imported brand-name products.</p>
<p>Related: <a href="https://med-rise.com/medical-news/trump-turns-up-the-heat-on-big-pharmawhile-hhs-unlocks-a-trove-of-health-data">White House presses 17 drugmakers on Medicaid prices</a> and <a href="https://med-rise.com/medical-news/cms-final-section-126-residency-slots-99-hospitals">CMS awards the final Section 126 residency slots</a>.</p>
<p><em>This article is news and education, not medical or legal advice.</em></p>]]></content:encoded><media:content url="https://med-rise.com/images/medical-news/og/trumps-250-pharma-tariff-threat-a-hard-ball-business-move-ai.jpg" medium="image" type="image/jpeg"/></item><item><title>HHS Releases MAHA Children&#x27;s Health Report and Plans Administration for a Healthy America</title><link>https://med-rise.com/medical-news/fresh-vision-for-americas-health-trump-administration-unveils-child-wellness-blueprint-and-historic-agency-makeover</link><guid isPermaLink="true">https://med-rise.com/medical-news/fresh-vision-for-americas-health-trump-administration-unveils-child-wellness-blueprint-and-historic-agency-makeover</guid><pubDate>Sat, 02 Aug 2025 13:04:40 -0500</pubDate><dc:creator>MedRise News Desk (with AI assistance)</dc:creator><category>News</category><category>Medical News</category><description>The MAHA Commission&#x27;s May 2025 assessment and HHS&#x27;s plan for an Administration for a Healthy America, fact-checked against HHS sources.</description><content:encoded><![CDATA[<p>The White House's Make America Healthy Again Commission released its first report on May 22, 2025, blaming rising childhood chronic disease on poor diet, environmental chemicals, too little activity and chronic stress, and overmedicalization, <a href="https://www.hhs.gov/press-room/maha-commission-childhood-chronic-disease-root-causes.html">HHS announced</a>.</p><p>Two months earlier, HHS had announced a restructuring to cut its workforce from about 82,000 to 62,000 and fold five agencies into a new Administration for a Healthy America. Together, the two moves reshape the prevention, nutrition and primary care programs that trainees work alongside.</p><h2>An assessment of causes, not yet a rulebook</h2><p>The May report, formally the Make Our Children Healthy Again Assessment, diagnosed problems rather than setting rules. It gave the commission 82 days to produce a strategy. That strategy arrived on September 9, 2025, with what HHS called <a href="https://www.hhs.gov/press-room/maha-commission-report-childhood-disease-strategy.html">more than 120 initiatives</a>.</p><p>The assessment drew criticism over its sourcing. Days after release, the news site NOTUS found that seven of the more than 500 studies it cited did not appear to have been published, and the White House said the report would be updated, <a href="https://www.npr.org/2025/05/29/nx-s1-5417346/white-house-acknowledges-problems-in-rfk-jr-s-make-america-healthy-again-report">NPR reported</a>.</p><h2>The reorganization: 28 divisions down to 15</h2><p>According to the <a href="https://www.hhs.gov/about/news/hhs-restructuring-doge-fact-sheet.html">HHS fact sheet</a> published March 27, 2025:</p><ul><li>Full-time staff would fall from about 82,000 to 62,000. <a href="https://www.npr.org/sections/shots-health-news/2025/03/27/nx-s1-5342414/hhs-doge-rif-rfk-job-cuts">NPR reported</a> that about 10,000 of the cuts would come through layoffs, with the rest from early retirements and buyouts.</li><li>HHS would shrink from 28 divisions to 15 and from 10 regional offices to 5.</li><li>The Administration for a Healthy America would combine the Office of the Assistant Secretary for Health, HRSA, SAMHSA, ATSDR and NIOSH.</li><li>Its planned divisions cover primary care, maternal and child health, mental health, environmental health, HIV/AIDS and the health workforce.</li></ul><h2>Why it matters if you are in training</h2><ul><li><strong>Workforce programs are inside the merger.</strong> HRSA runs programs many trainees rely on, such as the National Health Service Corps. Check each program's official page for current rules before you apply.</li><li><strong>The four drivers are now federal talking points.</strong> Expect patients and families to ask about ultra-processed food, screen time and medication use, and be ready to explain what the evidence does and does not show.</li><li><strong>Check the primary study.</strong> The citation errors are a reminder that any report, including a government one, is only as strong as its sources.</li></ul><h2>What to watch</h2><p>How the strategy's initiatives become agency rules, and how programs from HRSA and SAMHSA are organized under the new structure. We cover policy that affects trainees in <a href="https://med-rise.com/medical-news">MedRise Medical News</a>; see also our guides for <a href="https://med-rise.com/medicine/students/">students</a> and <a href="https://med-rise.com/medicine/residents/">residents</a>.</p><p>The report set the agenda. The reorganization decides who carries it out.</p><p><strong>Sources:</strong> <a href="https://www.hhs.gov/press-room/maha-commission-childhood-chronic-disease-root-causes.html">HHS, May 22, 2025</a>; <a href="https://www.hhs.gov/press-room/maha-commission-report-childhood-disease-strategy.html">HHS, September 9, 2025</a>; <a href="https://www.hhs.gov/about/news/hhs-restructuring-doge-fact-sheet.html">HHS restructuring fact sheet</a>; <a href="https://www.npr.org/2025/05/29/nx-s1-5417346/white-house-acknowledges-problems-in-rfk-jr-s-make-america-healthy-again-report">NPR, May 29, 2025</a>; <a href="https://www.npr.org/sections/shots-health-news/2025/03/27/nx-s1-5342414/hhs-doge-rif-rfk-job-cuts">NPR, March 27, 2025</a>.</p><p><em>MedRise Medical News summarizes public announcements and research for education only. It is not medical, legal or immigration advice.</em></p>]]></content:encoded><media:content url="https://med-rise.com/images/medical-news/og/fresh-vision-for-americas-health-trump-administration-unveil.jpg" medium="image" type="image/jpeg"/></item><item><title>White House Presses 17 Drugmakers on Medicaid Prices as HHS Relaunches HealthData.gov</title><link>https://med-rise.com/medical-news/trump-turns-up-the-heat-on-big-pharmawhile-hhs-unlocks-a-trove-of-health-data</link><guid isPermaLink="true">https://med-rise.com/medical-news/trump-turns-up-the-heat-on-big-pharmawhile-hhs-unlocks-a-trove-of-health-data</guid><pubDate>Thu, 31 Jul 2025 22:55:30 -0500</pubDate><dc:creator>MedRise News Desk (with AI assistance)</dc:creator><category>News</category><category>Medical News</category><description>July 2025 letters gave 17 drugmakers until Sept. 29 to commit to most-favored-nation prices, as HHS relaunched HealthData.gov. Fact-checked.</description><content:encoded><![CDATA[<p>The White House sent letters to the chief executives of 17 drugmakers on July 31, 2025, giving them until September 29 to commit to most-favored-nation prices, the lowest paid in other developed countries, for every Medicaid patient, <a href="https://www.manatt.com/insights/insight/white-house-announces-new-efforts-on-most-favored-nation-drug-pricing">Manatt's analysis of the letters</a> shows.</p><p>A day earlier, HHS relaunched HealthData.gov with more than three times as many public datasets. One story is about what medicines cost. The other is about the data anyone can now use to study it.</p><h2>Four demands and a deadline</h2><p>The letters asked each company to:</p><ol><li>Extend most-favored-nation pricing to Medicaid.</li><li>Commit to those prices on newly launched drugs for Medicare, Medicaid and commercial payers.</li><li>Negotiate harder with other countries and return the extra revenue to lower U.S. prices.</li><li>Sell directly to patients or businesses at most-favored-nation prices.</li></ol><p>The recipients were AbbVie, Amgen, AstraZeneca, Boehringer Ingelheim, Bristol Myers Squibb, Eli Lilly, EMD Serono, Genentech, Gilead, GSK, Johnson &amp; Johnson, Merck, Novartis, Novo Nordisk, Pfizer, Regeneron and Sanofi, <a href="https://www.biopharminternational.com/view/trump-letters-17-major-pharma-companies-outline-steps-most-favored-nation-drug-pricing">BioPharm International reported</a>. The letters warned the administration would use &ldquo;every tool in our arsenal&rdquo; if companies did not act.</p><h2>How the industry and markets reacted</h2><p>The S&amp;P 500 Pharmaceuticals Index fell 2.7% that day, <a href="https://www.supplychainbrain.com/articles/42264-trump-demands-us-drug-price-cuts-sending-pharma-shares-slumping">Bloomberg reported</a>. PhRMA spokesman Alex Schriver said, &ldquo;Importing foreign price controls would undermine American leadership.&rdquo;</p><h2>What happened next</h2><p>The White House has since announced pricing agreements with drugmakers, including nine more in August 2026, and launched TrumpRx.gov on February 5, 2026, according to a <a href="https://www.whitehouse.gov/fact-sheets/2026/08/fact-sheet-president-donald-j-trump-announces-deal-with-nine-additional-pharmaceutical-manufacturers-to-lower-drug-prices-for-americans/">White House fact sheet</a>.</p><h2>HealthData.gov: from about 3,000 datasets to more than 10,000</h2><p>On July 30, 2025, <a href="https://www.hhs.gov/press-room/living-open-data-plan-healthdatagov-launch.html">HHS announced</a> that HealthData.gov had grown from about 3,000 datasets in January 2025 to more than 10,000. It published version 1.0 of an HHS Open Data Plan, a Metadata Standard and a Data Inventory, and added search tools, APIs and dashboards. HHS Chief Data Officer Dr. Kristen Honey called open data the &ldquo;foundation for radical transparency, innovation, accountability, and public trust.&rdquo;</p><h2>Why it matters for students and residents</h2><ul><li><strong>Medicaid patients feel drug prices first.</strong> Cost shapes which prescriptions get filled. Ask about coverage before you choose between equivalent drugs.</li><li><strong>Free data for your research.</strong> HealthData.gov is a starting point for quality improvement and research projects. Our <a href="https://med-rise.com/research-course">research course</a> walks through the basics.</li></ul><p>Prices are being negotiated in letters and deals. The data to judge the results is public. More in <a href="https://med-rise.com/medical-news">MedRise Medical News</a>.</p><p><strong>Sources:</strong> <a href="https://www.manatt.com/insights/insight/white-house-announces-new-efforts-on-most-favored-nation-drug-pricing">Manatt</a>; <a href="https://www.biopharminternational.com/view/trump-letters-17-major-pharma-companies-outline-steps-most-favored-nation-drug-pricing">BioPharm International</a>; <a href="https://www.supplychainbrain.com/articles/42264-trump-demands-us-drug-price-cuts-sending-pharma-shares-slumping">Bloomberg via SupplyChainBrain</a>; <a href="https://www.whitehouse.gov/fact-sheets/2026/08/fact-sheet-president-donald-j-trump-announces-deal-with-nine-additional-pharmaceutical-manufacturers-to-lower-drug-prices-for-americans/">White House, August 2026</a>; <a href="https://www.hhs.gov/press-room/living-open-data-plan-healthdatagov-launch.html">HHS, July 30, 2025</a>.</p><p><em>MedRise Medical News summarizes public announcements and research for education only. It is not medical, legal or immigration advice.</em></p>]]></content:encoded><media:content url="https://med-rise.com/images/medical-news/og/trump-turns-up-the-heat-on-big-pharmawhile-hhs-unlocks-a-tro.jpg" medium="image" type="image/jpeg"/></item><item><title>CMS Health Tech Ecosystem: More Than 60 Companies Pledge to Build Interoperable Apps</title><link>https://med-rise.com/medical-news/trumps-digital-health-revolution-60-tech-titans-sign-on-to-a-cms-backed-health-tech-ecosystem</link><guid isPermaLink="true">https://med-rise.com/medical-news/trumps-digital-health-revolution-60-tech-titans-sign-on-to-a-cms-backed-health-tech-ecosystem</guid><pubDate>Wed, 30 Jul 2025 21:21:47 -0500</pubDate><dc:creator>MedRise News Desk (with AI assistance)</dc:creator><category>News</category><category>Medical News</category><description>More than 60 companies pledged to join CMS&#x27;s Health Tech Ecosystem in July 2025. What they committed to, fact-checked against CMS sources.</description><content:encoded><![CDATA[<p>More than 60 companies, including Amazon, Anthropic, Apple, Google and OpenAI, pledged on July 30, 2025 to help build a patient-centered digital health system, <a href="https://www.cms.gov/newsroom/press-releases/white-house-tech-leaders-commit-create-patient-centric-healthcare-ecosystem">CMS announced</a> after a White House event.</p><p>The target is familiar to anyone who has admitted a patient: the paper intake form and the records that do not follow patients between systems. The companies promised results by the first quarter of 2026.</p><h2>What the companies signed up for</h2><p>According to CMS:</p><ul><li><strong>21 networks</strong> pledged to meet the CMS Interoperability Framework criteria and become CMS Aligned Networks.</li><li><strong>11 health systems or providers</strong> committed to participate and support patient use.</li><li><strong>7 EHR vendors</strong> committed to help exchange data and &ldquo;kill the clipboard.&rdquo;</li><li><strong>30 companies</strong> pledged apps for diabetes and obesity management, conversational AI assistants for symptoms, navigation and scheduling, and digital check-in to replace paper forms.</li><li>CMS plans a Medicare.gov library of vetted digital health tools.</li></ul><p>The initiative grew out of a May 2025 request for information in which CMS asked the public how to modernize the country's digital health system, <a href="https://www.reedsmith.com/our-insights/blogs/health-industry-washington-watch/102lu2z/cms-announces-health-tech-ecosystem-initiative">Reed Smith noted</a>. CMS also said it could share Medicare claims data through aligned networks as early as the first quarter of 2026.</p><h2>Voluntary, not a mandate</h2><p>CMS describes the framework's criteria as voluntary. Patients would reach their records through aligned networks using a digital identity, rather than separate accounts and passwords for each portal. CMS Administrator Dr. Mehmet Oz said, &ldquo;We have the tools and information available now to empower patients to improve their outcomes.&rdquo;</p><p>Not everyone was reassured. <a href="https://fedscoop.com/trump-administration-tech-leaders-launch-effort-aimed-at-improving-health-records/">FedScoop reported</a> that some analysts warned health information could be put at risk as more apps gain access to records.</p><h2>What has happened since</h2><p>CMS has since launched the first wave of Health Tech Ecosystem tools, <a href="https://www.hipaajournal.com/?p=54956">The HIPAA Journal reported</a>. Which tools reach your hospital depends on its EHR vendor and network.</p><h2>Why it matters for students and residents</h2><ul><li><strong>Histories may arrive pre-filled.</strong> A medication list pulled from a patient's app still needs reconciliation. Verify it rather than copying it forward.</li><li><strong>AI may see the patient first.</strong> Symptom checkers and scheduling assistants will shape what patients expect from the visit.</li><li><strong>Privacy is part of the job.</strong> Know your institution's rules on patient-shared data. See our <a href="https://med-rise.com/medicine/residents/">resources for residents</a> and other <a href="https://med-rise.com/medical-news">Medical News</a>.</li></ul><p>The clipboard is not dead yet. But the companies that build most of your daily software have now promised, on the record, to try.</p><p><strong>Sources:</strong> <a href="https://www.cms.gov/newsroom/press-releases/white-house-tech-leaders-commit-create-patient-centric-healthcare-ecosystem">CMS, July 30, 2025</a>; <a href="https://fedscoop.com/trump-administration-tech-leaders-launch-effort-aimed-at-improving-health-records/">FedScoop</a>; <a href="https://www.hipaajournal.com/?p=54956">The HIPAA Journal</a>.</p><p><em>MedRise Medical News summarizes public announcements and research for education only. It is not medical, legal or immigration advice.</em></p>]]></content:encoded><media:content url="https://med-rise.com/images/medical-news/og/trumps-digital-health-revolution-60-tech-titans-sign-on-to-a.jpg" medium="image" type="image/jpeg"/></item><item><title>Google Releases MedGemma, Open AI Models That Draft Chest X-Ray Reports</title><link>https://med-rise.com/medical-news/googles-medgemma-the-free-to-use-ai-that-can-read-x-rayswhat-patients-should-know</link><guid isPermaLink="true">https://med-rise.com/medical-news/googles-medgemma-the-free-to-use-ai-that-can-read-x-rayswhat-patients-should-know</guid><pubDate>Wed, 30 Jul 2025 21:11:09 -0500</pubDate><dc:creator>MedRise News Desk (with AI assistance)</dc:creator><category>News</category><category>Medical News</category><description>Google&#x27;s open MedGemma models read medical images and text. A radiologist judged 81% of its chest X-ray reports clinically usable. What to know.</description><content:encoded><![CDATA[<p>Google released new open AI models on July 9, 2025 that read medical images and records, and a board-certified radiologist judged 81% of their chest X-ray reports good enough to lead to similar patient management, according to <a href="https://research.google/blog/medgemma-our-most-capable-open-models-for-health-ai-development/">Google Research</a>.</p><p>The models are free to download and adapt. That matters because hospitals and researchers can run them on their own systems instead of sending patient data to an outside service.</p><h2>What Google released</h2><ul><li><strong>MedGemma 27B Multimodal</strong>, which adds image and long-term health record interpretation to the earlier 4B multimodal and 27B text-only models.</li><li><strong>MedSigLIP</strong>, a 400-million-parameter image encoder that links medical images and text for classification and search.</li><li>All are part of Google's Health AI Developer Foundations, a set of open models meant as starting points for developers.</li></ul><h2>How well does it work?</h2><p>In an unblinded review, a US board-certified radiologist judged 81% of chest X-ray reports from MedGemma 4B accurate enough to lead to similar patient management as the original radiologist reports. MedGemma 4B scored 64.4% on the MedQA exam benchmark, among the best small open models, Google said. DeepHealth in Massachusetts has been exploring MedSigLIP for chest X-ray triage and nodule detection.</p><p>Google also said the larger MedGemma 27B models are competitive with much bigger models on several benchmarks, including retrieving and interpreting information from electronic health records. The announcement, by Google Research's Daniel Golden and Rory Pilgrim, points readers to a <a href="https://arxiv.org/abs/2507.05201">technical report</a> with the full evaluation.</p><h2>The catch</h2><p>81% also means about one in five reports would not have led to similar management. The review was unblinded and done by one radiologist. Google offers these models as developer starting points, so any hospital tool built on them needs its own validation before it touches patient care.</p><h2>What it means for students and residents</h2><ul><li><strong>AI drafts, you sign.</strong> If a draft report is wrong one time in five, the person who reads it carefully is the safety net.</li><li><strong>Ask how a tool was tested.</strong> Who judged it, on which patients, and was the review blinded? Our guide to <a href="https://med-rise.com/medicine/ai-medicine/">AI in medicine</a> lists the questions to ask.</li><li><strong>Open models lower the barrier to research.</strong> A student project can now start from a medical model instead of a general one. More in <a href="https://med-rise.com/medical-news">MedRise Medical News</a>.</li></ul><p>The models are free. Checking their work is still the clinician's job.</p><p><em>MedRise Medical News summarizes public announcements and research for education only. It is not medical, legal or immigration advice.</em></p>]]></content:encoded><media:content url="https://med-rise.com/images/medical-news/og/googles-medgemma-the-free-to-use-ai-that-can-read-x-rayswhat.jpg" medium="image" type="image/jpeg"/></item><item><title>Step 2 CK&#x27;s Passing Score Is Now 218: Prep Resources and the 2025 Rule Changes IMGs Need to Know</title><link>https://med-rise.com/articles/best-usmle-prep-resources-2025-ai-tools-step2-ck-highyield-img-residency-tips</link><guid isPermaLink="true">https://med-rise.com/articles/best-usmle-prep-resources-2025-ai-tools-step2-ck-highyield-img-residency-tips</guid><pubDate>Wed, 30 Jul 2025 20:57:37 -0500</pubDate><dc:creator>MedRise News Desk (with AI assistance)</dc:creator><category>Guide</category><category>Articles</category><description>USMLE raised the Step 2 CK passing score from 214 to 218 on July 1, 2025, and Canadian graduates became IMGs. What changed and how to plan your prep.</description><content:encoded><![CDATA[<p>Two rule changes that took effect on July 1, 2025, still shape how students plan for Step 2 CK and the Match. The USMLE raised the Step 2 CK passing standard from 214 to 218, and graduates of Canadian medical schools began to be treated as international medical graduates (IMGs) for U.S. residency.</p>
<h2>The Step 2 CK passing standard rose to 218</h2>
<p>The USMLE Management Committee announced on June 16, 2025, that examinees testing on or after July 1, 2025, need a 218 to pass, up from 214 (<a href="https://www.usmle.org/change-step-2-ck-passing-standard-begins-july-1-2025">USMLE announcement</a>). The committee reviews each exam's passing standard about once every four years. The current minimums are pass/fail for Step 1 (since January 26, 2022), 218 for Step 2 CK and 200 for Step 3 (<a href="https://www.usmle.org/scores-transcripts/examination-results-and-scoring">USMLE scoring</a>).</p>
<p>Because Step 1 is reported only as pass or fail, Step 2 CK is the main numeric score programs see. The minimum is a floor, not a target: competitive specialties expect scores well above it, so set your goal from your target specialty's match data, not the passing line.</p>
<h2>Canadian graduates are now IMGs</h2>
<p>The Liaison Committee on Medical Education (LCME) stopped accrediting Canadian schools on July 1, 2025, leaving the Committee on Accreditation of Canadian Medical Schools (CACMS) as the sole accreditor. People who graduate from a Canadian school on or after that date are IMGs for U.S. graduate medical education. To enter an ACGME-accredited residency they need ECFMG Certification (or a full, unrestricted license), and they need ECFMG Certification to be eligible for Step 3 (<a href="https://www.usmle.org/effective-july-1-2025-canadian-medical-graduates-will-be-designated-imgs">USMLE</a>; <a href="https://ecfmg.org/certification/eligibility-canadian-schools.html">ECFMG</a>).</p>
<p>For the Match, the NRMP says these graduates must be verified as eligible by ECFMG. Canadian graduates from before July 1, 2025, are not IMGs and are verified by their school (<a href="https://www.nrmp.org/help/item/i-am-a-student-graduate-from-a-medical-school-located-in-canada-how-do-i-get-verified-to-participate-in-the-main-residency-match/">NRMP</a>).</p>
<h2>Core prep resources</h2>
<p>These are the resources most students build around. Only the NBME self-assessments come from the exam's co-sponsor.</p>
<ul><li><strong>A main question bank</strong> such as UWorld or AMBOSS, done in timed, random blocks.</li><li><strong>NBME self-assessments</strong>, the official practice forms, to track your trend.</li><li><strong>A review book</strong> such as First Aid to fill content gaps.</li><li><strong>Spaced repetition</strong> with Anki, ideally tied to questions you missed.</li></ul>
<p>A workable routine: question blocks every day, a review of every explanation, a log of missed concepts, and an NBME form at regular intervals. Let that trend tell you when you are ready, rather than fixing a number of weeks in advance.</p>
<h2>Using AI tutors safely</h2>
<p>AI chat tools can generate practice cases and explain answers, but they can also be confidently wrong. Use them to quiz yourself and to rephrase explanations, and check any fact you plan to rely on against your question bank or a standard reference.</p>
<h2>For IMGs planning a residency application</h2>
<ul><li>Start ECFMG Certification early; you must hold it, or be on track for it, to enter residency.</li><li>Build U.S. clinical experience and collect U.S. letters of recommendation.</li><li>Research each program's recent IMG and visa sponsorship history before you apply.</li></ul>
<p>Related: <a href="https://med-rise.com/articles/2026-nrmp-match-results-what-they-mean-for-imgs">2026 Match results and what they mean for IMGs</a>.</p>
<p><em>Educational information only. Check current rules with USMLE, ECFMG and the NRMP before you act.</em></p>]]></content:encoded><media:content url="https://med-rise.com/images/articles/og/best-usmle-prep-resources-2025-ai-tools-step2-ck-highyield-i-photo.jpg" medium="image" type="image/jpeg"/></item><item><title>Ivermectin Mass Drug Administration Cuts Malaria Infections 26% in Kenya: BOHEMIA Trial</title><link>https://med-rise.com/medical-news/ivermectin-mda-cuts-malaria-26-in-kenyabohemia-trial</link><guid isPermaLink="true">https://med-rise.com/medical-news/ivermectin-mda-cuts-malaria-26-in-kenyabohemia-trial</guid><pubDate>Wed, 30 Jul 2025 12:22:21 -0500</pubDate><dc:creator>MedRise News Desk (with AI assistance)</dc:creator><category>News</category><category>Medical News</category><description>The NEJM BOHEMIA trial found monthly community-wide ivermectin cut malaria infection in Kenyan children by 26%. What the drug does and doesn&#x27;t do.</description><content:encoded><![CDATA[<p>Treating entire communities with ivermectin once a month for three months cut malaria infections among children by 26%, according to the BOHEMIA trial published in the <a href="https://doi.org/10.1056/NEJMoa2411262">New England Journal of Medicine</a> on July 24, 2025.</p><p>The drug was not treating malaria. Ivermectin kills mosquitoes that bite people who have taken it, so the idea is to cut transmission across a whole village, including in places where mosquitoes resist the insecticides on bed nets.</p><h2>What the trial did</h2><ul><li><strong>Where:</strong> Kwale County on the coast of Kenya, where malaria is highly endemic and bed net use is high.</li><li><strong>Who:</strong> 84 clusters with 28,932 eligible participants, randomized 1:1.</li><li><strong>What:</strong> ivermectin 400 µg/kg, or albendazole 400 mg as an active control, once a month for 3 months at the start of the short rains.</li><li><strong>Measured:</strong> malaria infection in children 5 to 15 years old, tested monthly for 6 months.</li></ul><p>The trial had two primary outcomes, malaria infection in children and adverse events in all eligible participants, analyzed by intention to treat. It was funded by Unitaid and led by Carlos Chaccour of ISGlobal in Barcelona with the Kenya Medical Research Institute.</p><h2>The result: 2.20 versus 2.66 infections per child-year</h2><p>Infection incidence was 2.20 per child-year at risk with ivermectin and 2.66 with albendazole, an adjusted incidence rate ratio of 0.74 (95% CI 0.58 to 0.95). Serious adverse events did not differ significantly between groups, and the authors identified no safety concerns.</p><h2>Why a new tool is needed</h2><p>The <a href="https://www.who.int/teams/Global-Malaria-Programme/Reports/World-Malaria-Report-2024">World malaria report 2024</a> estimated 263 million cases and 597,000 deaths in 2023, about 11 million more cases than in 2022. The trial's authors cite insecticide resistance and changes in mosquito behavior as threats to current control methods.</p><h2>What it means for students and residents</h2><ul><li><strong>Know the mechanism.</strong> This is vector control: protecting a community by killing mosquitoes, not curing an infected patient. Malaria treatment remains artemisinin-based therapy.</li><li><strong>Read beyond the headline.</strong> The effect was measured in one region, over one season, against an active control. Questions about other settings, resistance and cost remain open.</li><li><strong>Expect patient questions.</strong> Ivermectin's history makes it a lightning rod. Be ready to explain exactly what this trial did and did not show. More in <a href="https://med-rise.com/medical-news">MedRise Medical News</a>; sharpen your appraisal skills with <a href="https://med-rise.com/viva/">MedRise Viva</a>.</li></ul><p>An old deworming drug may get a new job, but only as one tool among several.</p><p><em>MedRise Medical News summarizes public announcements and research for education only. It is not medical, legal or immigration advice.</em></p>]]></content:encoded><media:content url="https://med-rise.com/images/medical-news/og/ivermectin-mda-cuts-malaria-26-in-kenyabohemia-trial.jpg" medium="image" type="image/jpeg"/></item><item><title>Paying for Medical School Under the New $200,000 Loan Cap: What a 529 Plan Can and Can&#x27;t Do</title><link>https://med-rise.com/articles/beat-the-200-k-loan-cap-the-ultimate-529-med-school-reserve-playbook-2025-guide</link><guid isPermaLink="true">https://med-rise.com/articles/beat-the-200-k-loan-cap-the-ultimate-529-med-school-reserve-playbook-2025-guide</guid><pubDate>Sun, 20 Jul 2025 19:07:05 -0500</pubDate><dc:creator>MedRise News Desk (with AI assistance)</dc:creator><category>Guide</category><category>Articles</category><description>New medical students can borrow up to $50,000 a year and $200,000 total in federal loans. How a 529 plan helps, and the Roth rules guides get wrong.</description><content:encoded><![CDATA[<p>Federal borrowing for medical school changed on July 1, 2026. Under the law signed July 4, 2025, new professional students, including medical students, can borrow up to $50,000 a year and $200,000 in total in Direct Unsubsidized loans, and Grad PLUS loans are no longer available to new borrowers. Students who already had loans for their program before that date may qualify for a temporary legacy provision (<a href="https://www.nasfaa.org/uploads/documents/Federal_Student_Aid_Change_OB3.pdf">NASFAA summary</a>; <a href="https://www.acenet.edu/Documents/TPs-OBBB-Loan-Limits-2026.pdf">American Council on Education</a>).</p>
<p>For scale, the median first-year cost of attendance at private medical schools was about $103,000 in 2023–24, and the median four-year cost for the class of 2025 was about $391,000 at private schools and $286,000 at public schools (<a href="https://students-residents.aamc.org/media/12846/download">AAMC</a>). Many students will face a gap the federal cap won't cover. A 529 education savings plan is one tool for part of it.</p>
<h2>What a 529 plan covers</h2>
<ul><li><strong>School costs:</strong> tuition, required fees, books, supplies, required equipment and computers, and room and board for students enrolled at least half time. Earnings grow tax-free, and withdrawals for these costs are free of federal tax.</li><li><strong>Credentialing costs (new in 2025):</strong> the same law added "qualified postsecondary credentialing expenses," including fees for tests needed to earn a recognized license or certification, for withdrawals after July 4, 2025 (<a href="https://www.savingforcollege.com/article/trump-budget-bill-529-plan-credentials-continuing-education">Saving for College</a>). Whether a particular exam, such as a USMLE Step, qualifies depends on how it fits that definition. Confirm with your plan administrator or a tax professional before paying exam fees from a 529, and keep receipts.</li><li><strong>Student loans:</strong> up to $10,000 per beneficiary over a lifetime, plus up to $10,000 for each of the beneficiary's siblings (<a href="https://www.savingforcollege.com/article/can-you-use-a-529-plan-to-pay-off-student-loans">Saving for College</a>).</li></ul>
<p>State tax rules don't always follow federal changes, so check how your state treats newer expense types before you withdraw.</p>
<h2>The Roth IRA rollover has strict limits</h2>
<p>Since 2024, leftover 529 money can be moved into a Roth IRA, but only when every condition is met (<a href="https://investor.vanguard.com/investor-resources-education/education-college-savings/529-roth-rollover">Vanguard</a>; <a href="https://www.journalofaccountancy.com/news/2023/jul/the-new-529-rollover-roth-ira.html">Journal of Accountancy</a>):</p>
<ul><li>The 529 account must have been open for at least 15 years.</li><li>Contributions made in the last five years, and their earnings, can't be rolled over.</li><li>The Roth IRA must belong to the 529 beneficiary, who needs earned income at least equal to the amount rolled over.</li><li>Each year's rollover counts toward the annual IRA contribution limit, and the lifetime maximum is $35,000 per beneficiary.</li></ul>
<p>So a 529 you open during medical school can't be rolled into a Roth for about 15 years. An account a parent opened for you as a child may already qualify.</p>
<h2>If money is left over</h2>
<p>You can change the beneficiary to another family member without tax or penalty, use up to $10,000 on student loans, or roll some into a Roth if the account qualifies. Withdrawals not used for qualified expenses are taxed on their earnings and usually face an extra 10% tax.</p>
<h2>Getting started</h2>
<ul><li>See whether your state gives a tax deduction or credit for contributing to its own plan before you choose an out-of-state plan.</li><li>Compare fees; low-cost index options matter more the longer the money is invested.</li><li>If you will need the money within a few years, choose a conservative investment option.</li><li>Relatives can contribute directly. Large gifts can involve gift-tax rules, so ask a tax professional.</li></ul>
<p>Related: <a href="https://med-rise.com/articles/-why-the-federal-medical-school-loan-cap-protects-not-excludes-first-generation-amp-low-income-students">Opinion: why the federal loan cap protects first-generation students</a>.</p>
<p><em>Educational information only; not tax, legal or financial advice. MedRise is not a financial adviser. Talk to a qualified professional before acting.</em></p>]]></content:encoded><media:content url="https://med-rise.com/images/articles/og/beat-the-200-k-loan-cap-the-ultimate-529-med-school-reserve-photo.jpg" medium="image" type="image/jpeg"/></item><item><title>Why the Federal Medical School Loan Cap Protects, Not Excludes, First-Generation and Low-Income Students</title><link>https://med-rise.com/articles/-why-the-federal-medical-school-loan-cap-protects-not-excludes-first-generation-amp-low-income-students</link><guid isPermaLink="true">https://med-rise.com/articles/-why-the-federal-medical-school-loan-cap-protects-not-excludes-first-generation-amp-low-income-students</guid><pubDate>Sun, 20 Jul 2025 17:09:17 -0500</pubDate><dc:creator>MedRise News Desk (with AI assistance)</dc:creator><category>Opinion</category><category>Articles</category><description>Since July 1, 2026, new medical and other professional students can borrow at most $50,000 a year and $200,000 in total in federal Direct Unsubsidized…</description><content:encoded><![CDATA[<p>Since July 1, 2026, new medical and other professional students can borrow at most <strong>$50,000 a year and $200,000 in total</strong> in federal Direct Unsubsidized loans (students in other graduate programs: $20,500 and $100,000), and Grad PLUS loans have ended for new borrowers (<a href="https://www.nasfaa.org/uploads/documents/Federal_Student_Aid_Change_OB3.pdf">NASFAA</a>)—a bold reform aimed at curbing the unchecked rise of tuition and <strong>preventing mortgage-sized medical school debt</strong>, especially for first-generation and low-income students.</p><p>At <strong>MedRise</strong>, we work at the intersection of medical education and healthcare workforce innovation. We believe this <strong>student loan reform is a necessary correction</strong>, not a form of exclusion.</p><h2>The Real Crisis: Unlimited Loans, Unlimited Tuition, Unsustainable Debt</h2><p>Under the Grad PLUS loan system, medical schools were free to charge any amount, knowing the government would fund it. The result?</p><ul><li><p>Median first-year tuition and fees at private medical schools reached about <strong>$72,700</strong> in 2023–24, and the median four-year cost of attendance for the class of 2025 was about <strong>$391,000</strong> at private schools (<a href="https://students-residents.aamc.org/media/12846/download">AAMC</a>).</p></li><li><p>Among 2024 graduates who borrowed, median education debt was <strong>$200,000</strong>, and the average at private schools was about <strong>$228,000</strong> (AAMC).</p></li><li><p>First-generation and low-income students bore the heaviest emotional and financial burdens.</p></li></ul><p>This was never sustainable. The federal loan cap is <strong>not about restricting access</strong>—it’s about <strong>protecting access to funds and limiting student debt</strong>.</p><h2>The Loan Cap Is a Step Toward Equity and Financial Health</h2><p>Here’s how this cap benefits future doctors—especially those from underserved backgrounds:</p><ul><li><p><strong>Encourages schools to lower tuition</strong> instead of shifting costs to vulnerable students.</p></li><li><p><strong>Reduces long-term interest payments</strong> and loan forgiveness reliance.</p></li><li><p><strong>Restores dignity and choice</strong> to primary care and public service careers.</p></li></ul><p><em>First-generation students won’t have to mortgage their future to become physicians.</em></p> <h2>Busting the Myth: This Will Hurt Low-Income and First-Gen Students</h2><p>Quite the opposite.</p><p>Capping federal loans means institutions must <strong>compete on value</strong>, not just amenities or prestige. Students still have access to:</p><ul><li><p><strong>HRSA scholarship and loan repayment programs, such as the National Health Service Corps</strong> (Pell Grants are for undergraduates only; see <a href="https://studentaid.gov/understand-aid/types/grants/pell">Federal Student Aid</a>)</p></li><li><p><strong>VA scholarships and loan repayment created or expanded by the 2018 VA MISSION Act</strong></p></li><li><p><strong>Loan repayment programs for underserved service</strong></p></li><li><p><strong>Private &amp; nonprofit scholarships</strong></p></li><li><p><strong>Tuition-for-service hospital partnerships</strong></p></li></ul><p>With smaller funding gaps and less bloat, these students can <strong>finish training with smaller balances and more financial security</strong>.</p><h2>Where MedRise Fits</h2><p>MedRise publishes practical guides on paying for medical school, including <a href="https://med-rise.com/articles/beat-the-200-k-loan-cap-the-ultimate-529-med-school-reserve-playbook-2025-guide">what a 529 plan can and can't do under the new cap</a>.</p><h2>Final Word: A Smarter Path to Medical Education Equity</h2><p>This isn’t austerity—it’s sustainability.</p><p>This isn’t exclusion—it’s evolution.</p><p>The <strong>federal student loan cap for medical school is a smart, long-overdue reform</strong> that prioritizes the financial well-being of first-generation and low-income students.</p>]]></content:encoded><media:content url="https://med-rise.com/images/articles/og/why-the-federal-medical-school-loan-cap-protects-not-exclud.jpg" medium="image" type="image/jpeg"/></item><item><title>How to Reset Mental Fatigue During an NBME Exam: 6 In-Seat Techniques</title><link>https://med-rise.com/articles/how-to-reset-mental-fatigue-during-the-nbme-6-proven-focus-hacks-you-can-do-without-leaving-your-seat</link><guid isPermaLink="true">https://med-rise.com/articles/how-to-reset-mental-fatigue-during-the-nbme-6-proven-focus-hacks-you-can-do-without-leaving-your-seat</guid><pubDate>Sun, 20 Jul 2025 16:19:43 -0500</pubDate><dc:creator>MedRise News Desk (with AI assistance)</dc:creator><category>Guide</category><category>Articles</category><description>You can&#x27;t leave your seat mid-block. Six quick resets that stay within testing rules, what each one does, and how strong the evidence behind it is.</description><content:encoded><![CDATA[<p>Long NBME and USMLE blocks wear down attention, and once a block starts you can't step away. USMLE rules say you may not leave the testing room during a block except in an emergency, and you may leave your station only when the break screen is showing (<a href="https://www.usmle.org/what-to-know/exam-day-information/break-time">USMLE break time</a>; <a href="https://www.usmle.org/step-exams/exam-day-information">USMLE exam-day rules</a>). School-run shelf exams follow their own proctoring rules, so check those too.</p>
<p>The techniques below take seconds, need no materials and stay within those rules. Practice them during timed question blocks so they're automatic on test day.</p>
<h2>1. Shift your focus near to far</h2>
<p>Look away from the screen to the farthest point you can see for a few seconds, then back. Repeat three to five times. It gives your eyes a break from close focus. It won't raise your score by itself, but it is a quick cue to reset when you catch yourself rereading the same line.</p>
<h2>2. Slow your breathing</h2>
<p>Breathe in through your nose for about four seconds, pause briefly, then breathe out slowly for six to eight seconds. Do two or three cycles. A systematic review of slow-breathing studies found it increases heart rate variability and is linked to more relaxation and alertness and less anxiety (<a href="https://doi.org/10.3389/fnhum.2018.00353">Zaccaro et al., 2018</a>). Keep it slow and gentle; fast, deep breathing can lower carbon dioxide and leave you lightheaded.</p>
<h2>3. Use a quiet tactile anchor</h2>
<p>Touch your thumb to each fingertip in turn while counting silently, then reverse. It is a grounding technique that pulls attention back to the present. There is little research on it during exams, but it is quick and invisible to anyone else.</p>
<h2>4. Answer an easier question next</h2>
<p>If you're stuck and spiraling, mark the question, move on, answer one you can handle quickly, then come back. A fast win breaks the loop of rereading a hard stem. Watch the block clock so you return to every marked question.</p>
<h2>5. Use a one-word cue</h2>
<p>Pick a word such as "focus" or "next" and say it silently the moment you notice your mind wandering. A meta-analysis of 32 sports studies found self-talk interventions improved task performance with a moderate effect, and worked best when people practiced them beforehand (<a href="https://doi.org/10.1177/1745691611413136">Hatzigeorgiadis et al., 2011</a>). Those studies were in sport, not exams, so treat this as a reasonable tool rather than a sure thing.</p>
<h2>6. The one-minute reset</h2>
<p>When focus is badly slipping: sit up, rest your hands in your lap, look past the screen for ten seconds, take three slow breaths, then go on to the next question.</p>
<h2>Pace in small chunks</h2>
<p>Split each block into checkpoints, for example every 10 questions, and compare your time with the block clock. Use each checkpoint for a quick reset.</p>
<h2>On scheduled breaks</h2>
<ul><li>Drink water and eat a small snack with some protein.</li><li>If you use caffeine, stick to the amount you're used to; test day isn't the time to try more.</li><li>Stand up, move and look at something far away.</li></ul>
<p>Related: <a href="https://med-rise.com/articles/best-usmle-prep-resources-2025-ai-tools-step2-ck-highyield-img-residency-tips">Step 2 CK's passing score and core prep resources</a>.</p>
<p><em>Educational information only; not medical advice. If anxiety or fatigue is affecting your exams, talk to your school's student support office or a clinician.</em></p>]]></content:encoded><media:content url="https://med-rise.com/images/articles/og/how-to-reset-mental-fatigue-during-the-nbme-6-proven-focus-h-photo.jpg" medium="image" type="image/jpeg"/></item><item><title>2025 NRMP Match Results: 54% of Matched Non-U.S. IMGs Went Into Internal Medicine</title><link>https://med-rise.com/articles/2025-nrmp-match-results-what-they-mean-for-imgs-and-residency-applicants</link><guid isPermaLink="true">https://med-rise.com/articles/2025-nrmp-match-results-what-they-mean-for-imgs-and-residency-applicants</guid><pubDate>Sun, 06 Apr 2025 08:07:20 -0500</pubDate><dc:creator>MedRise News Desk (with AI assistance)</dc:creator><category>Analysis</category><category>Articles</category><description>2025 NRMP Match results for IMGs: match rates, where 6,653 non-U.S. IMGs matched by specialty, the neurology and pathology openings, and SOAP data.</description><content:encoded><![CDATA[<p><strong>Looking for the latest data?</strong> See <a href="https://med-rise.com/articles/2026-nrmp-match-results-what-they-mean-for-imgs">2026 NRMP Match results: what they mean for IMGs</a>. This article covers the 2025 Match.</p>
<p>More than half of the 6,653 non-U.S. citizen IMGs who matched in 2025 went into one specialty. Categorical internal medicine took 3,573 of them, according to the NRMP's <a href="https://www.nrmp.org/wp-content/uploads/2025/03/Advance_Data_Tables_2025.pdf">Advance Data Tables 2025</a>.</p>
<p>That concentration is the most useful fact in the 2025 results for anyone building a list now. It shows where programs actually rank IMGs, which is a better guide than lists of "IMG-friendly" specialties passed around online.</p>
<p>It also came in a tougher year. Non-U.S. IMG applicants rose 14.4% to a record 11,465, but their match rate slipped to 58.0%, the NRMP's <a href="https://nrmp.org/wp-content/uploads/2025/03/2025_Match_by_the_Numbers.pdf">Match by the Numbers 2025</a> shows.</p>
<h2>2025 match rates: more IMG applicants, a slightly lower rate</h2>
<div class="post-table"><table>
<caption>PGY-1 match results, 2025 Main Residency Match, before SOAP. Source: NRMP Match by the Numbers 2025.</caption>
<thead><tr><th>Applicant group</th><th>Applicants ranking programs</th><th>Matched</th><th>Match rate</th><th>Change from 2024</th></tr></thead>
<tbody>
<tr><td>U.S. MD seniors</td><td>20,368</td><td>19,044</td><td>93.5%</td><td>No change</td></tr>
<tr><td>U.S. DO seniors</td><td>8,392</td><td>7,773</td><td>92.6%</td><td>+0.3 points</td></tr>
<tr><td>U.S. citizen IMGs</td><td>4,587</td><td>3,108</td><td>67.8%</td><td>+0.8 points</td></tr>
<tr><td>Non-U.S. citizen IMGs</td><td>11,465</td><td>6,653</td><td>58.0%</td><td>−0.5 points</td></tr>
</tbody>
</table></div>
<p>The Match itself set records: 43,237 positions offered, 40,764 filled and 52,498 registered applicants. Non-U.S. IMGs filled 16.6% of PGY-1 positions, up 1.4 points, while U.S. citizen IMGs filled 7.8%.</p>
<p>The squeeze shows in the margins. Non-U.S. IMG applicants grew by 1,444, but matches grew by 789, so roughly 55 extra matches for every 100 extra applicants (MedRise calculation).</p>
<h2>Where IMGs actually matched in 2025</h2>
<div class="post-table"><table>
<caption>PGY-1 positions filled by IMGs, 2025 Main Residency Match. Source: NRMP Advance Data Tables 2025, Table 2. Shares calculated by MedRise.</caption>
<thead><tr><th>Specialty (PGY-1)</th><th>Positions filled</th><th>Non-U.S. IMGs</th><th>Non-U.S. IMG share</th><th>U.S. citizen IMGs</th></tr></thead>
<tbody>
<tr><td>Internal Medicine, categorical</td><td>10,584</td><td>3,573</td><td>33.8%</td><td>1,145</td></tr>
<tr><td>Family Medicine</td><td>4,552</td><td>801</td><td>17.6%</td><td>626</td></tr>
<tr><td>Pediatrics, categorical</td><td>2,988</td><td>590</td><td>19.7%</td><td>251</td></tr>
<tr><td>Surgery, preliminary</td><td>673</td><td>240</td><td>35.7%</td><td>88</td></tr>
<tr><td>Neurology</td><td>925</td><td>223</td><td>24.1%</td><td>46</td></tr>
<tr><td>Psychiatry</td><td>2,380</td><td>190</td><td>8.0%</td><td>153</td></tr>
<tr><td>Pathology</td><td>619</td><td>168</td><td>27.1%</td><td>57</td></tr>
<tr><td>Medicine, preliminary</td><td>1,455</td><td>139</td><td>9.6%</td><td>52</td></tr>
<tr><td>Emergency Medicine</td><td>3,003</td><td>131</td><td>4.4%</td><td>315</td></tr>
<tr><td>Surgery, categorical</td><td>1,774</td><td>114</td><td>6.4%</td><td>100</td></tr>
<tr><td>Transitional year</td><td>1,617</td><td>106</td><td>6.6%</td><td>89</td></tr>
<tr><td>Anesthesiology</td><td>1,804</td><td>84</td><td>4.7%</td><td>47</td></tr>
<tr><td>Obstetrics and Gynecology</td><td>1,586</td><td>44</td><td>2.8%</td><td>50</td></tr>
<tr><td>Orthopaedic Surgery</td><td>929</td><td>14</td><td>1.5%</td><td>8</td></tr>
</tbody>
</table></div>
<p>Three patterns stand out:</p>
<ol>
<li><strong>Internal medicine, family medicine and pediatrics took three in four.</strong> Those three specialties accounted for 4,964 of the 6,653 non-U.S. IMG matches, or 74.6%.</li>
<li><strong>Neurology and pathology are the quieter doors.</strong> Non-U.S. IMGs filled 24.1% of neurology and 27.1% of pathology PGY-1 positions, a larger share than in family medicine (17.6%) or pediatrics (19.7%). Both are much smaller fields, so the absolute numbers are modest.</li>
<li><strong>U.S. citizen IMGs follow a different map.</strong> They filled 315 emergency medicine positions, more than twice the 131 filled by non-U.S. IMGs. The data do not say why; visa sponsorship is one factor applicants should check program by program.</li>
</ol>
<p>Preliminary surgery stands out too: non-U.S. IMGs took 35.7% of its filled seats. It is a one-year position, so it works as a bridge, not a destination.</p>
<h2>SOAP 2025: IMGs were two-thirds of the line</h2>
<p>When the algorithm finished, 2,521 positions went into SOAP. The NRMP's <a href="https://www.nrmp.org/wp-content/uploads/2025/05/Main_Match_Results_and_Data_20250529_FINAL.pdf">Results and Data report</a> counted 13,670 SOAP-eligible applicants, and 68.2% of them were IMGs.</p>
<p>Family medicine placed the most SOAP positions (805), and 965 were PGY-1-only, led by preliminary surgery (549) and the transitional year (260). Programs sent 3,757 offers; 2,318 were accepted. See which specialties had open seats in <a href="https://med-rise.com/articles/what-specialties-had-unfilled-positions-in-the-2025-residency-match">unfilled positions in the 2025 Match</a>.</p>
<h2>What to do with this for the 2027 Match</h2>
<ul>
<li><strong>Build your list where IMGs are ranked.</strong> If you are a non-U.S. IMG, the 2025 data say most matches came from internal medicine, family medicine and pediatrics, with neurology and pathology as smaller options. Check the 2026 numbers in our <a href="https://med-rise.com/articles/2026-nrmp-match-results-what-they-mean-for-imgs">2026 results analysis</a> before you finalize.</li>
<li><strong>Use score data, not rumor.</strong> The NRMP's <a href="https://www.nrmp.org/match-data/2026/07/charting-outcomes-characteristics-of-non-u-s-citizen-international-medical-students-graduates-who-matched-to-their-preferred-specialty-2026-main-residency-match/">Charting Outcomes for non-U.S. IMGs</a> (July 28, 2026) looks at Step 2 CK scores, the number of specialties ranked, and research, work and volunteer experiences of applicants who matched to their preferred specialty.</li>
<li><strong>Filter for visas first.</strong> If you need sponsorship, confirm on each program's own website which visa it sponsors before you spend an application. For immigration questions, ask an immigration attorney or the official agency.</li>
<li><strong>Know the 2027 deadlines.</strong> Standard NRMP registration closes January 29, 2027, and rank order lists must be certified by March 3, 2027, at 9 p.m. ET, per the <a href="https://www.nrmp.org/wp-content/uploads/2026/03/2027-Main-Residency-Match-Calendar-FINAL.pdf">2027 Match calendar</a>. IMGs must meet ECFMG verification requirements by March 3.</li>
<li><strong>Prepare for SOAP before you need it.</strong> Our <a href="https://med-rise.com/articles/soap-2027-match-week">SOAP 2027 guide</a> has the hour-by-hour schedule.</li>
<li><strong>Strengthen U.S. clinical experience.</strong> MedRise lists <a href="https://med-rise.com/medicine/observerships/">U.S. clinical observerships for IMGs in South Texas</a>.</li>
</ul>
<p>The 2025 Match did not close doors for IMGs. It showed exactly which ones were open, and how crowded they had become.</p>
<h2>FAQ</h2>
<h3>What was the IMG match rate in 2025?</h3>
<p>Before SOAP, 67.8% of U.S. citizen IMGs and 58.0% of non-U.S. citizen IMGs who ranked programs matched to PGY-1 positions.</p>
<h3>Which specialty matched the most IMGs in 2025?</h3>
<p>Categorical internal medicine, with 3,573 non-U.S. IMGs and 1,145 U.S. citizen IMGs in PGY-1 positions.</p>
<h3>Which smaller specialties took a high share of non-U.S. IMGs?</h3>
<p>Pathology (27.1% of filled PGY-1 positions) and neurology (24.1%) had higher non-U.S. IMG shares than family medicine or pediatrics.</p>
<h3>Did more IMGs apply in 2025?</h3>
<p>Non-U.S. IMG applicants rose 14.4% to 11,465, a record, while U.S. citizen IMG applicants fell 3.5% to 4,587.</p>
<h2>Sources</h2>
<ul>
<li><a href="https://nrmp.org/wp-content/uploads/2025/03/2025_Match_by_the_Numbers.pdf">NRMP, Match by the Numbers: 2025 Main Residency Match</a> (March 2025)</li>
<li><a href="https://www.nrmp.org/wp-content/uploads/2025/03/Advance_Data_Tables_2025.pdf">NRMP, Advance Data Tables: 2025 Main Residency Match</a> (March 2025)</li>
<li><a href="https://www.nrmp.org/wp-content/uploads/2025/05/Main_Match_Results_and_Data_20250529_FINAL.pdf">NRMP, Results and Data: 2025 Main Residency Match</a> (May 2025)</li>
<li><a href="https://www.nrmp.org/match-data/2026/07/charting-outcomes-characteristics-of-non-u-s-citizen-international-medical-students-graduates-who-matched-to-their-preferred-specialty-2026-main-residency-match/">NRMP, Charting Outcomes: non-U.S. citizen IMGs, 2026 Main Residency Match</a> (July 28, 2026)</li>
<li><a href="https://www.nrmp.org/wp-content/uploads/2026/03/2027-Main-Residency-Match-Calendar-FINAL.pdf">NRMP, 2027 Main Residency Match Calendar</a></li>
</ul>
<p><em>MedRise Articles share educational information only. They are not medical, legal or immigration advice. Confirm requirements with the official organization or program.</em></p>]]></content:encoded><media:content url="https://med-rise.com/images/articles/og/2025-nrmp-match-results-what-they-mean-for-imgs-and-residenc-photo.jpg" medium="image" type="image/jpeg"/></item><item><title>Didn&#x27;t Match Into Psychiatry as an IMG? Next Steps and How to Reapply</title><link>https://med-rise.com/articles/img-psychiatry-match-2025-what-to-do-if-you-didnt-match-how-to-reapply-successfully</link><guid isPermaLink="true">https://med-rise.com/articles/img-psychiatry-match-2025-what-to-do-if-you-didnt-match-how-to-reapply-successfully</guid><pubDate>Mon, 17 Mar 2025 17:57:49 -0500</pubDate><dc:creator>MedRise News Desk (with AI assistance)</dc:creator><category>Guide</category><category>Articles</category><description>If you didn&#x27;t match into psychiatry, SOAP and the post-SOAP list are your first options. How they work and how to build a stronger application for next cycle.</description><content:encoded><![CDATA[<p><strong>Looking for the latest data?</strong> See <a href="https://med-rise.com/articles/img-psychiatry-match-2026">IMG Psychiatry Match 2026: Non-U.S. IMGs Filled 222 Spots, Up 67% Since 2022</a>. This article covers an earlier cycle.</p><p>Psychiatry draws more applicants than it once did, and many international medical graduates (IMGs) who apply don't match on their first try. Plenty reapply and succeed, and the path starts during Match Week itself.</p>
<h2>During Match Week: SOAP</h2>
<p>If you're eligible for the Supplemental Offer and Acceptance Program (SOAP), you'll see the NRMP's List of Unfilled Programs in the R3 system on Monday of Match Week, when match status is released. You can send up to 45 applications during SOAP, and programs make offers in rounds through R3; an offer you accept is a binding commitment (<a href="https://students-residents.aamc.org/applying-residency/article/soap/">AAMC</a>; <a href="https://www.nrmp.org/residency/soap/">NRMP</a>).</p>
<p>One rule trips people up: neither you nor anyone acting for you may contact a SOAP program until the program contacts you after receiving your application (<a href="https://www.nrmp.org/about/news/2026/03/march-2026-illuminator-newsletter/">NRMP</a>).</p>
<p>Psychiatry often has few unfilled positions, so consider preliminary or transitional-year positions and other specialties you would genuinely be willing to train in.</p>
<h2>After SOAP ends</h2>
<p>SOAP ends on Thursday of Match Week. The NRMP then posts a final List of Unfilled Programs in R3 for unmatched applicants, adding programs that didn't take part in SOAP, and you may contact those programs directly (<a href="https://www.nrmp.org/match-calendars/main-residency-applicants/">NRMP calendar</a>). The list is not public; copying or posting it violates the Match Participation Agreement (<a href="https://www.nrmp.org/topic/policies/?post_type=help">NRMP</a>).</p>
<h2>If you take a preliminary year</h2>
<p>A preliminary internal medicine or transitional year keeps you in clinical training and gives you U.S. letters and experience. Openings to join psychiatry at the PGY-2 level come up only occasionally, so plan to reapply to categorical programs.</p>
<h2>Strengthening your application for the next cycle</h2>
<ul><li><strong>Scores:</strong> Step 2 CK carries more weight now that Step 1 is pass/fail. Some applicants take Step 3 before reapplying to add another score, but a weak result can hurt, so take it only when you are ready.</li><li><strong>U.S. clinical experience in psychiatry:</strong> hands-on rotations or externships where possible, <a href="https://med-rise.com/medicine/observerships/">observerships</a> otherwise, plus volunteer work in mental health or addiction settings.</li><li><strong>Letters:</strong> new letters from U.S. psychiatrists who supervised you.</li><li><strong>Personal statement:</strong> explain what you did during the gap and why psychiatry.</li><li><strong>Research and involvement:</strong> case reports or posters, and membership in groups such as the American Psychiatric Association.</li><li><strong>Program research:</strong> check each program's recent IMG and visa sponsorship history before you apply.</li></ul>
<h2>Related work while you reapply</h2>
<p>Research assistant or coordinator roles in psychiatry departments, telehealth support roles and a master's in public health or clinical research can keep you close to the field and strengthen your application.</p>
<h2>How MedRise can help</h2>
<p>MedRise offers one-on-one reapplication support, including application and personal statement review, interview practice and a plan for the next cycle. Email <a href="mailto:admin@med-rise.com">admin@med-rise.com</a> to schedule a free consultation.</p>
<p>Related: <a href="https://med-rise.com/articles/soap-list-2025-find-unfilled-residency-positions-apply-now">How the SOAP List of Unfilled Programs works</a>.</p>
<p><em>Educational information only. Check current dates and rules with the NRMP and AAMC.</em></p><p class="note obs-callout"><strong>Looking for a U.S. observership?</strong> MedRise arranges <a href="https://med-rise.com/medicine/observerships/">U.S. clinical observerships for IMGs</a> with physicians at teaching hospitals in South Texas, in internal medicine, family medicine and subspecialties. Applying is free.</p>]]></content:encoded><media:content url="https://med-rise.com/images/articles/og/img-psychiatry-match-2025-what-to-do-if-you-didnt-match-how.jpg" medium="image" type="image/jpeg"/></item><item><title>IMGs &amp; Ophthalmology: What to Do If You Didn’t Match in 2025</title><link>https://med-rise.com/articles/imgs-ophthalmology-what-to-do-if-you-didnt-match-in-2025</link><guid isPermaLink="true">https://med-rise.com/articles/imgs-ophthalmology-what-to-do-if-you-didnt-match-in-2025</guid><pubDate>Mon, 17 Mar 2025 17:52:35 -0500</pubDate><dc:creator>MedRise News Desk</dc:creator><category>Guide</category><category>Articles</category><description>Didn&#x27;t match ophthalmology through SF Match? An IMG&#x27;s next steps: unfilled spots, SOAP prelim years, research, observerships and a stronger reapplication.</description><content:encoded><![CDATA[<p>Didn’t match into ophthalmology as an IMG? Learn the next steps, alternative pathways, and how to strengthen your application for the next Match cycle.</p><p>The Ophthalmology residency match is one of the most competitive specialties, making it especially challenging for International Medical Graduates (IMGs). If you didn’t match in 2025, you are not alone! This guide will walk you through your next steps, alternative options, and strategies to improve your application for the next cycle.</p><h2>Why Is Ophthalmology Difficult for IMGs to Match Into?</h2><p>Ophthalmology is an extremely competitive specialty because:</p><p>✅ Limited Residency Positions: Only a few hundred ophthalmology positions are offered each year.</p><p>✅ High USMLE Scores Expected: Step 1 is now pass/fail, so programs lean on Step 2 CK, and matched applicants usually have high scores.</p><p>✅ Research Expectations: Programs prioritize applicants with ophthalmology-specific research.</p><p>✅ Few IMG-Friendly Programs: Most programs prefer U.S. medical graduates (USMGs).</p><p>If you didn’t match, don’t be discouraged! Let’s explore your options.</p><h2>Next Steps After Not Matching in Ophthalmology</h2><h3>Step 1 – Check for Unfilled Ophthalmology Programs (SF Match &amp; SOAP)</h3><p>Unlike most residency programs, ophthalmology does not participate in NRMP. Instead, it uses SF Match.</p><p>🔎 Check the SF Match List of Unfilled Programs</p><p>• Go to <a href="https://www.sfmatch.org/">SF Match</a> and check for any open positions.</p><p>• Some programs may still accept applications after the official Match.</p><p>🚨 NRMP SOAP for Prelim/Transitional Year</p><p>• If you didn’t secure a PGY-1 year, you may be eligible for SOAP to apply for a preliminary or transitional position.</p><p>• Consider matching into Internal Medicine or Surgery prelim years, which may help with reapplying.</p><h3>Step 2 – Consider an Alternative Specialty</h3><p>If you’re open to other fields, here are some IMG-friendly specialties related to ophthalmology:</p><p>🔹 Neurology → Neuro-Ophthalmology</p><p>🔹 Pathology → Ocular Pathology</p><p>🔹 Radiology → Ocular Imaging</p><p>Applying to an alternative specialty now could allow you to pursue an ophthalmology fellowship later.</p><h3>Step 3 – Strengthen Your Application for the Next Match Cycle</h3><p>If you decide to reapply next year, here’s how to make your application stronger:</p><p>📚 Boost Your USMLE Scores</p><p>• A USMLE Step you have passed can't be retaken to raise the score. If your Step 2 CK is low for ophthalmology, put your effort into research, letters and U.S. clinical experience; passing Step 3 can also help some IMG applications.</p><p>📝 Gain More Ophthalmology Research Experience</p><p>• Work on case reports, publications, or clinical trials related to ophthalmology.</p><p>• Connect with ophthalmology researchers through ARVO, AAO, or PubMed.</p><p>👨‍⚕️ Do an <a href="https://med-rise.com/medicine/observerships/">Observership</a> or Clinical Experience</p><p>• Look for U.S.-based ophthalmology observerships or externships.</p><p>• Some IMG-friendly programs allow hands-on research assistant positions.</p><p>📄 Improve Your Personal Statement &amp; Letters of Recommendation</p><p>• Obtain strong letters from U.S. ophthalmologists.</p><p>• Highlight passion for ophthalmology, clinical skills, and research experience.</p><p>📍 Network with Ophthalmology Programs</p><p>• Attend AAO (American Academy of Ophthalmology) conferences.</p><p>• Reach out to program directors and ophthalmologists for mentorship.</p><h2>Alternative Career Paths in Ophthalmology</h2><p>If reapplying isn’t an option, consider alternative career paths in ophthalmology:</p><p>👁 Fellowships Without Residency</p><p>• Some countries offer direct entry ophthalmology fellowships.</p><p>📊 Ophthalmic Industry Roles</p><p>• Work in ophthalmic research, medical writing, or clinical trials.</p><p>📡 Telemedicine &amp; AI in Ophthalmology</p><p>• Remote teleophthalmology jobs are expanding globally.</p><h2>Key Takeaways – Moving Forward After Not Matching in Ophthalmology</h2><p>✅ Check SF Match for unfilled spots</p><p>✅ Consider applying to SOAP for a PGY-1 position</p><p>✅ Gain more U.S. clinical experience &amp; research</p><p>✅ Improve USMLE scores &amp; application materials</p><p>✅ Explore alternative pathways in ophthalmology</p><p>💡 Pro Tip: Some applicants match on a later attempt after strengthening their application. Persistence and targeted improvements are key.</p><h2>FAQ – Common Questions from IMGs Who Didn’t Match in Ophthalmology</h2><h3>Can I apply for SOAP if I didn’t match into ophthalmology?</h3><p>Yes! If you need a PGY-1 year, you can apply for prelim or transitional year positions in SOAP.</p><h3>What are the most IMG-friendly ophthalmology programs?</h3><p>There is no official list. Check each program's website and SF Match listing for IMG eligibility and visa sponsorship, and look at whether its current residents trained abroad.</p><h3>Should I do a research year before reapplying?</h3><p>If your USMLE scores are low or you lack research experience, a research year in ophthalmology can improve your chances.</p><h2>Final Thoughts – Keep Moving Forward!</h2><p>Not matching into ophthalmology is not the end of your journey. Whether you reapply next year, consider an alternative specialty, or pursue a related career path, there are many ways to stay in ophthalmology.</p><p>📌 Need personalized guidance? <a href="https://med-rise.com/contact/?topic=student#form">Contact MedRise</a> for residency consultation.</p><p>🔗 Related Resources:</p><p>👉 <a href="https://www.sfmatch.org/">SF Match Unfilled Positions</a></p><p>👉 <a href="https://www.aao.org/">AAO Career Center</a></p><p>👉 <a href="https://students-residents.aamc.org/applying-residencies-eras/applying-residencies-eras">ERAS Application Guide</a></p><p class="note obs-callout"><strong>Looking for a U.S. observership?</strong> MedRise arranges <a href="https://med-rise.com/medicine/observerships/">U.S. clinical observerships for IMGs</a> with physicians at teaching hospitals in South Texas, in internal medicine, family medicine and subspecialties. Applying is free.</p>]]></content:encoded><media:content url="https://med-rise.com/images/articles/og/imgs-ophthalmology-what-to-do-if-you-didnt-match-in-2025.jpg" medium="image" type="image/jpeg"/></item><item><title>The SOAP List of Unfilled Programs: Who Can See It, When, and How to Apply</title><link>https://med-rise.com/articles/soap-list-2025-find-unfilled-residency-positions-apply-now</link><guid isPermaLink="true">https://med-rise.com/articles/soap-list-2025-find-unfilled-residency-positions-apply-now</guid><pubDate>Mon, 17 Mar 2025 17:45:56 -0500</pubDate><dc:creator>MedRise News Desk (with AI assistance)</dc:creator><category>Guide</category><category>Articles</category><description>The NRMP&#x27;s List of Unfilled Programs opens in R3 on Monday of Match Week, only for eligible applicants. How SOAP works and what changes when it ends.</description><content:encoded><![CDATA[<p><strong>Looking for the latest data?</strong> See <a href="https://med-rise.com/articles/soap-2027-match-week">SOAP 2027 Match Week Runs March 15-18, With All Four Offer Rounds on One Thursday</a>. This article covers an earlier cycle.</p><p>The Supplemental Offer and Acceptance Program (SOAP) is how unmatched and partially matched applicants fill open residency positions during Match Week. It starts with the NRMP's List of Unfilled Programs, and access to that list is tightly controlled.</p>
<h2>Who can see the list</h2>
<p>Only applicants the NRMP deems SOAP-eligible can see it, and each sees only the programs they are eligible for based on their match status (<a href="https://www.nrmp.org/wp-content/uploads/2026/02/Navigating-MW-SOAP-for-Applicants.pdf">NRMP</a>). To be eligible you must be registered for the Main Residency Match, be unmatched or partially matched, and be eligible to start training on July 1; for IMGs that depends on ECFMG status by the NRMP's deadlines. If you didn't register for the Match, you can't see the list.</p>
<h2>When it appears</h2>
<p>The list opens in the NRMP's R3 system on Monday of Match Week, when applicants learn whether they matched. Applications open the same day; in 2026 the window ran from Monday, March 16, at 11 a.m. ET to Thursday, March 19, at 9 p.m. ET (<a href="https://students-residents.aamc.org/applying-residency/article/soap/">AAMC</a>).</p>
<h2>How to apply</h2>
<ul><li>Review the list in R3 and note the programs that fit.</li><li>Apply through the application service the program uses, usually ERAS. You get 45 applications for all of SOAP, including programs you reapply to.</li><li>Programs review applications, contact the applicants they want to interview and submit preference lists in R3. You don't rank programs.</li><li>Offers arrive in rounds through R3. You can receive more than one offer in a round, and an offer you accept is a binding commitment (<a href="https://www.nrmp.org/residency/soap/">NRMP</a>).</li></ul>
<h2>The contact rule</h2>
<p>Neither you nor anyone acting for you, including advisers and consultants, may contact a SOAP program until the program contacts you after receiving your application (<a href="https://www.nrmp.org/about/news/2026/03/march-2026-illuminator-newsletter/">NRMP</a>). The NRMP investigates reported violations.</p>
<h2>After SOAP ends</h2>
<p>SOAP ends on Thursday of Match Week. The NRMP then posts a final List of Unfilled Programs in R3 that adds programs that didn't participate in SOAP, and unmatched applicants may contact those programs directly (<a href="https://www.nrmp.org/match-calendars/main-residency-applicants/">NRMP</a>). In the 2024 cycle, the list stayed available until May 1 (<a href="https://www.nrmp.org/wp-content/uploads/2023/06/2024-Match-Week-and-SOAP-Schedule.pdf">NRMP 2024 schedule</a>).</p>
<p>The list is never published on the NRMP's public website. Copying, sharing or posting it is a violation of the Match Participation Agreement (<a href="https://www.nrmp.org/topic/policies/?post_type=help">NRMP</a>), so be wary of anyone offering "the full SOAP list."</p>
<h2>If you don't get a position</h2>
<p>Keep checking the post-SOAP list, contact programs directly, and start planning the next cycle with research, clinical experience or a preliminary year.</p>
<p>Related: <a href="https://med-rise.com/articles/img-psychiatry-match-2025-what-to-do-if-you-didnt-match-how-to-reapply-successfully">Didn't match into psychiatry? Next steps</a>.</p>
<p><em>Educational information only. Dates change every year; check the NRMP Match Week schedule and AAMC SOAP guidance for the current cycle.</em></p>]]></content:encoded><media:content url="https://med-rise.com/images/articles/og/soap-list-2025-find-unfilled-residency-positions-apply-now.jpg" medium="image" type="image/jpeg"/></item><item><title>Navigating Academic Dismissal from a Caribbean Medical School: Understanding Your Options for Appeal</title><link>https://med-rise.com/articles/navigating-academic-dismissal-from-a-caribbean-medical-school-understanding-your-options-for-appeal</link><guid isPermaLink="true">https://med-rise.com/articles/navigating-academic-dismissal-from-a-caribbean-medical-school-understanding-your-options-for-appeal</guid><pubDate>Thu, 07 Nov 2024 17:11:22 -0600</pubDate><dc:creator>MedRise News Desk (with AI assistance)</dc:creator><category>Guide</category><category>Articles</category><description>Medical school can be a challenging journey, and for some students, it may come with unexpected setbacks. Academic dismissal is one of the most difficult…</description><content:encoded><![CDATA[<p>Medical school can be a challenging journey, and for some students, it may come with unexpected setbacks. Academic dismissal is one of the most difficult challenges a student can face. However, being dismissed doesn’t necessarily mean the end of your medical career. Caribbean medical schools, known for their rigorous programs and unique challenges, have specific guidelines and pathways for students who wish to appeal an academic dismissal. In this post, we'll walk you through the appeal process, what options might be available, and how to approach the situation proactively.</p><h2>Why Do Academic Dismissals Happen?</h2><p>Academic dismissals in medical school typically occur due to a combination of academic, personal, or health-related issues that impact performance. Common reasons for dismissal can include:</p><ul><li><p>Failing grades or an inability to meet GPA requirements</p></li><li><p>Inadequate performance on key exams, such as the USMLE Step 1 or 2</p></li><li><p>Attendance or professionalism concerns</p></li><li><p>Health challenges, including physical or mental health issues, that impact academic performance</p></li></ul><p>Caribbean medical schools, while offering tremendous opportunities, also have distinct challenges that can impact student performance, including resource limitations, fast-paced schedules, and high expectations.</p><h2>Step 1: Understand Your School’s Policies on Academic Dismissal</h2><p>Each Caribbean medical school has its own set of policies and procedures for academic dismissals and appeals. The first step is to review the student handbook or academic policies to fully understand:</p><ul><li><p>The reasons for your dismissal</p></li><li><p>The timelines and guidelines for filing an appeal</p></li><li><p>Any specific requirements or documentation needed to submit an appeal</p></li></ul><p>Often, schools provide a limited window to initiate an appeal, so it’s essential to act quickly. Familiarizing yourself with these guidelines helps you make informed decisions and navigate the process more effectively.</p><h2>Step 2: Assess the Grounds for Your Appeal</h2><p>When appealing a dismissal, it’s critical to present a strong case by addressing why the dismissal should be reconsidered. Some grounds for an appeal may include:</p><ul><li><p><strong>Health or Personal Circumstances</strong>: Documented medical conditions or life events (e.g., illness, family issues) that impacted academic performance. Schools may be open to reconsidering dismissals if a health issue, especially one that has since been resolved, significantly affected your ability to succeed.</p></li><li><p><strong>Violation of Student Rights</strong>: If you believe you experienced unfair treatment or discrimination, especially regarding race, religion, or disability, this can form a legitimate basis for appeal. Collecting evidence and documenting incidents are crucial in this case.</p></li><li><p><strong>Lack of Adequate Support or Accommodations</strong>: If your school failed to provide necessary accommodations for a documented disability, this may strengthen your appeal. Check your student handbook for the school’s written accommodation policy and whether it was followed. Many Caribbean schools are accredited by international agencies such as ACCM or CAAM-HP rather than U.S. bodies, and whether U.S. disability law applies to a school outside the United States is a question for a lawyer.</p></li><li><p><strong>Academic Irregularities</strong>: If there were irregularities in the assessment or grading processes, or if your educational experience did not meet the expected standards, these may also be grounds for an appeal.</p></li></ul><h2>Step 3: Prepare a Comprehensive Appeal Letter</h2><p>Your appeal letter is your chance to present your case clearly and persuasively. It should be professional, concise, and to the point. Here’s a breakdown of what to include:</p><ol><li><p><strong>Introduction</strong>: Briefly introduce yourself and state the purpose of the letter (i.e., to appeal the dismissal decision).</p></li><li><p><strong>Statement of Circumstances</strong>: Provide an honest and specific explanation of the circumstances that led to your academic challenges. Be transparent about any obstacles you faced and how they impacted your performance.</p></li><li><p><strong>Supporting Documentation</strong>: Include documentation to support your claims, such as medical records, emails, or other records that validate your situation. This evidence helps build a credible case.</p></li><li><p><strong>Plan for Improvement</strong>: Outline a clear, actionable plan to address the challenges you faced and explain how you intend to improve your academic performance. This may include seeking additional tutoring, adopting new study methods, addressing health issues, or working with an academic advisor.</p></li><li><p><strong>Request for Reconsideration</strong>: Politely request reconsideration of your dismissal based on the circumstances and evidence presented.</p></li></ol><h2>Step 4: Explore Alternative Solutions if the Appeal is Denied</h2><p>If your appeal is denied, there are still options available:</p><ul><li><p><strong>Transfer to Another Medical School</strong>: Most medical schools ask transfer applicants for a letter of good standing from their current school, which makes transferring after a dismissal difficult. Ask each school’s admissions office directly before you apply.</p></li><li><p><strong>Ask About Readmission</strong>: Some schools let dismissed students apply for readmission after a set period. A leave of absence is usually requested while you are still enrolled, so if you are struggling but not yet dismissed, ask about one early.</p></li><li><p><strong>Switch to a Related Health Field</strong>: For students open to alternative career paths, there are numerous health-related fields where medical training can be valuable, such as public health, clinical research, healthcare administration, and education.</p></li></ul><h2>Step 5: Seek Guidance and Support</h2><p>Navigating an academic dismissal can be overwhelming, but you don’t have to go through it alone. Consulting with mentors, advisors, or professionals who specialize in medical education can provide valuable insights and help strengthen your case.</p><p>At MedRise, we understand the unique challenges Caribbean medical students face and are here to support you in exploring your options. Whether it’s understanding your appeal rights, preparing documentation, or finding alternative pathways, we’re here to guide you through every step. Don’t let a setback define your future—take the next step toward making your medical career dreams a reality.</p><h2>Conclusion: Your Journey Isn’t Over</h2><p>Academic dismissal is a significant hurdle, but it doesn’t mean the end of your journey in medicine. With a well-prepared appeal, support from advisors, and a clear plan for improvement, you can overcome this challenge. Remember, resilience and persistence are key traits of a successful physician. Continue to advocate for yourself, seek guidance, and keep moving forward toward your goals.</p> <p><em>Educational information only; not legal advice. For deadlines or disputes, read your school’s written policies and consider talking to an education lawyer.</em></p>]]></content:encoded><media:content url="https://med-rise.com/images/articles/og/navigating-academic-dismissal-from-a-caribbean-medical-schoo.jpg" medium="image" type="image/jpeg"/></item><item><title>IMG-Friendly Internal Medicine Programs in New York (2027 Match)</title><link>https://med-rise.com/articles/top-img-friendly-internal-medicine-programs-in-ny</link><guid isPermaLink="true">https://med-rise.com/articles/top-img-friendly-internal-medicine-programs-in-ny</guid><pubDate>Thu, 07 Nov 2024 17:08:28 -0600</pubDate><dc:creator>MedRise News Desk (with AI assistance)</dc:creator><category>Guide</category><category>Articles</category><description>Seven New York internal medicine programs checked against their own pages for the 2027 Match: who sponsors J-1 or H-1B, exam rules, and how to check the rest.</description><content:encoded><![CDATA[<p><strong>Updated November 14, 2026, for the 2027 Match.</strong> We checked each program below against its own website or its AMA FREIDA listing. Visa and exam rules change every cycle, so open the linked page and confirm before you apply or spend a signal.</p>

<h2>Quick answer</h2>
<p>New York's most IMG-heavy internal medicine programs are mostly city and community teaching hospitals in the Bronx, Brooklyn and Upper Manhattan. Of the seven programs we checked, Jacobi, BronxCare, St. Barnabas and Maimonides state that they sponsor both J-1 and H-1B visas, and Brookdale says J-1 sponsorship may be available. Harlem Hospital says almost all of its residents are international graduates.</p>

<h2>Seven New York programs we checked</h2>
<div class="post-table"><table>
<thead><tr><th>Program (area)</th><th>What the program itself states</th><th>Source checked</th></tr></thead>
<tbody>
<tr><td><strong>Jacobi Medical Center/Albert Einstein College of Medicine</strong> (Bronx)</td><td>Sponsors J-1 and H-1B. 34 categorical PGY-1 positions. All USMLE Steps must be passed on the first attempt.</td><td><a href="https://jacobimed.org/application-information/" rel="noopener">Program site</a></td></tr>
<tr><td><strong>BronxCare Health System</strong> (Bronx)</td><td>J-1 through ECFMG; will consider H-1B. 34 first-year positions. IMGs must have passed Step 1 and Step 2 CK to be considered.</td><td><a href="https://freida.ama-assn.org/program/1403511263" rel="noopener">FREIDA</a> (updated Oct 31, 2026)</td></tr>
<tr><td><strong>St. Barnabas Hospital (SBH Health System)</strong> (Bronx)</td><td>Lists H-1B and J-1 visa sponsorship among resident benefits.</td><td><a href="https://www.sbhny.org/?p=3197" rel="noopener">Program site</a></td></tr>
<tr><td><strong>Harlem Hospital Center</strong> (Manhattan)</td><td>Says almost all of its residents are international graduates. Step 1 and Step 2 must be passed on the first attempt. Applications through ERAS and the NRMP only. Visa policy: confirm with the program.</td><td><a href="https://www.vagelos.columbia.edu/education/residencies-fellowships-and-training/harlem-hospital-center/residency-programs/internal-medicine-residency-program/frequently-asked-questions" rel="noopener">Program FAQ</a></td></tr>
<tr><td><strong>Maimonides Medical Center</strong> (Brooklyn)</td><td>Sponsors J-1 and H-1B, but says H-1B sponsorship is not assured because of the recent H-1B executive order and litigation. A valid ECFMG certificate is required.</td><td><a href="https://maimo.org/medical-education/faqs/" rel="noopener">Medical education FAQ</a></td></tr>
<tr><td><strong>Brookdale Hospital Medical Center (One Brooklyn Health)</strong> (Brooklyn)</td><td>IMGs must be ECFMG certified. Step 1 and Step 2 are required, with no minimum score cutoff. J-1 sponsorship "may be available."</td><td><a href="https://onebrooklynhealth.org/healthcare-professionals/internal-medicine-residency-brookdale" rel="noopener">Program site</a></td></tr>
<tr><td><strong>NYC Health + Hospitals/Woodhull</strong> (Brooklyn)</td><td>IMGs must hold ECFMG certification at the time of application. ERAS and NRMP only. Visa policy: confirm with the program.</td><td><a href="https://www.nychealthandhospitals.org/woodhull/internal-medicine-residency-program/" rel="noopener">Program site</a></td></tr>
</tbody>
</table></div>
<p><strong>Watch the program name.</strong> Jacobi's site warns that the Jacobi Medical Center/North Central Bronx Hospital program is a separate residency from the Jacobi/Einstein program. Check the NRMP code before you apply or rank.</p>

<h2>Other New York programs to look up</h2>
<p>These programs often appear on IMG lists. We have not yet checked their 2027 policies, so look each one up before relying on it: Lincoln Medical Center (Bronx), One Brooklyn Health/Interfaith (Brooklyn), NYC Health + Hospitals/South Brooklyn Health (Brooklyn), SUNY Downstate (Brooklyn), NYC Health + Hospitals/Metropolitan (Manhattan), Jamaica Hospital and Flushing Hospital (Queens), Nassau University Medical Center (Long Island) and SUNY Upstate (Syracuse).</p>
<p>Large academic programs such as NYU Langone, Columbia, Weill Cornell and Mount Sinai also appear on some lists. Check their FREIDA graduate mix before you spend a signal there.</p>

<h2>How to check any program in about five minutes</h2>
<ol>
<li><strong>FREIDA first.</strong> On the program's <a href="https://freida.ama-assn.org/" rel="noopener">FREIDA</a> page, read the visa status (J-1, H-1B, F-1), the "Types of Graduates" three-year averages and the "Data last updated" date.</li>
<li><strong>Then the program's own page.</strong> Look for the visa policy, first-attempt rules, a graduation-year cutoff, when ECFMG certification is due (at application or before the start date) and any U.S. clinical experience requirement.</li>
<li><strong>Match the name and NRMP code.</strong> One hospital can run more than one internal medicine program.</li>
<li><strong>Be careful with third-party "IMG %" sites.</strong> They often disagree. On one such site, the same Brooklyn program showed 0% IMGs on its program page and 92% on the site's own IMG-friendly list.</li>
<li><strong>Email the coordinator only with a question the website does not answer,</strong> such as whether they take H-1B transfers or need Step 3 before ranking.</li>
</ol>

<h2>J-1 or H-1B: the short version</h2>
<ul>
<li><strong>J-1:</strong> sponsored by ECFMG, not the hospital. Step 3 is not required. Most J-1 physicians must spend two years in their home country after training unless they get a waiver (INA 212(e)), for example through Conrad 30.</li>
<li><strong>H-1B:</strong> sponsored by the hospital. You must pass USMLE Steps 1, 2 and 3 before the petition is filed, and there is no home-country requirement. Fewer programs offer it, and some want Step 3 passed before they rank you.</li>
</ul>
<p>This is general information, not legal or immigration advice. For your own case, ask the program's GME office or an immigration attorney.</p>

<h2>Where internal medicine stands for 2027</h2>
<p>In the 2026 Match, non-U.S. IMGs matched at 56.4%, and 54.4% of those who needed a visa matched. Categorical internal medicine still had 537 PGY-1 positions unfilled after the Match, before SOAP. See <a href="https://med-rise.com/articles/2026-nrmp-match-results-what-they-mean-for-imgs">2026 NRMP Match results for IMGs</a> and <a href="https://med-rise.com/articles/unfilled-residency-positions-by-specialty-2026-match">unfilled positions by specialty</a>.</p>
<p>For the 2027 Match, rank order lists are due March 3, 2027 at 9 p.m. ET, and Match Day is March 19, 2027.</p>

<h2>Sources</h2>
<ul>
<li><a href="https://jacobimed.org/application-information/" rel="noopener">Jacobi Medical Center IM residency: application information</a></li>
<li><a href="https://freida.ama-assn.org/program/1403511263" rel="noopener">AMA FREIDA: BronxCare Health System internal medicine</a></li>
<li><a href="https://www.sbhny.org/?p=3197" rel="noopener">SBH Health System internal medicine residency</a></li>
<li><a href="https://www.vagelos.columbia.edu/education/residencies-fellowships-and-training/harlem-hospital-center/residency-programs/internal-medicine-residency-program/how-apply" rel="noopener">Harlem Hospital Center IM residency: how to apply</a></li>
<li><a href="https://maimo.org/medical-education/faqs/" rel="noopener">Maimonides Medical Center: medical education FAQ</a></li>
<li><a href="https://onebrooklynhealth.org/healthcare-professionals/internal-medicine-residency-brookdale" rel="noopener">One Brooklyn Health: Brookdale IM residency</a></li>
<li><a href="https://www.nychealthandhospitals.org/woodhull/internal-medicine-residency-program/" rel="noopener">NYC Health + Hospitals/Woodhull IM residency</a></li>
<li><a href="https://www.aafp.org/students/medical-school/img-resources/visa-requirements-for-international-medical-graduates" rel="noopener">AAFP: visa requirements for IMGs</a></li>
<li><a href="https://psychiatry.org/psychiatrists/international/international-medical-graduates-resources/visa-and-immigration-basics-for-imgs" rel="noopener">APA: visa and immigration basics for IMGs</a></li>
<li><a href="https://www.nrmp.org/" rel="noopener">NRMP</a></li>
</ul>]]></content:encoded><media:content url="https://med-rise.com/images/articles/og/top-img-friendly-internal-medicine-programs-in-ny.jpg" medium="image" type="image/jpeg"/></item><item><title>What Residency Programs Can&#x27;t Ask You: NRMP Rules vs. Anti-Discrimination Law</title><link>https://med-rise.com/articles/questions-that-cannot-be-asked-per-nrmp</link><guid isPermaLink="true">https://med-rise.com/articles/questions-that-cannot-be-asked-per-nrmp</guid><pubDate>Thu, 07 Nov 2024 16:20:40 -0600</pubDate><dc:creator>MedRise News Desk (with AI assistance)</dc:creator><category>Guide</category><category>Articles</category><description>NRMP rules bar programs from asking where else you applied or how you&#x27;ll rank them. Personal questions fall under employment law. How to respond.</description><content:encoded><![CDATA[<p>Two separate sets of rules limit what residency interviewers can ask. The NRMP's Match Participation Agreement covers questions about your applications and rankings. Personal questions, such as your age or family plans, are governed by federal and state anti-discrimination law, because residents are employees.</p>
<h2>What NRMP rules prohibit</h2>
<p>Programs may not ask you to reveal where else you have applied or interviewed, which specialties or locations you are considering, which programs you signaled, or how you plan to rank them (<a href="https://www.nrmp.org/wp-content/uploads/2025/10/NRMP-Conference-Program-Policy-Handout.pdf">NRMP program policy handout</a>; <a href="https://www.nrmp.org/topic/match-participants/?post_type=help">NRMP help</a>). You may volunteer that information, but you don't have to. Programs can still ask why you are interested in their program, specialty or region, and they can tell you they are interested in you.</p>
<p>Neither side may demand a commitment: a program can't ask you to promise to rank it first, and you shouldn't press a program on where it will rank you. The NRMP says questions about application, interview and ranking intentions tell a program nothing about how well you fit its culture and mission (<a href="https://nrmp.org/wp-content/uploads/2025/01/Nov-24-Policy-Corner.pdf">NRMP Policy Corner</a>).</p>
<h2>What anti-discrimination law restricts</h2>
<p>Laws enforced by the Equal Employment Opportunity Commission make it illegal for employers to discriminate against applicants because of race, color, religion, sex (including pregnancy, sexual orientation and gender identity), national origin, age (40 or older), disability or genetic information (<a href="https://www.eeoc.gov/node/24185">EEOC</a>). Questions on these topics invite a discrimination claim, so well-run programs avoid them. Examples:</p>
<ul><li>How old are you, or what year did you finish high school?</li><li>Are you married, pregnant or planning to have children?</li><li>What is your religion, or will you need religious holidays off?</li><li>Where were you born, or what is your native language?</li><li>Do you have a disability or a medical condition? Disability-related questions are generally off-limits before a job offer.</li></ul>
<p>Some related questions are allowed. A program can ask whether you are authorized to work in the United States or will need visa sponsorship, and it can describe the call schedule and ask whether you can meet it. Many states add protections, such as for marital status, so the rules vary by location.</p>
<h2>How to respond</h2>
<ul><li><strong>Redirect:</strong> answer the concern behind the question. To "Do you have kids?" you might say, "I'm fully prepared for the demands of residency."</li><li><strong>Decline politely:</strong> "I'd like to keep the focus on my training and qualifications."</li><li><strong>For NRMP questions:</strong> "I'm keeping my rank list private, but I'm very interested in this program because..."</li></ul>
<h2>How to report a problem</h2>
<p>Report possible Match Participation Agreement violations to the NRMP at <a href="mailto:policy@nrmp.org">policy@nrmp.org</a>. For possible discrimination, talk to your school's dean's office; you can also contact the EEOC or your state's civil rights agency.</p>
<p>Related: <a href="https://med-rise.com/articles/nrmp-questions-answered">NRMP Match rules explained</a>.</p>
<p><em>Educational information only; not legal advice.</em></p>]]></content:encoded><media:content url="https://med-rise.com/images/articles/og/questions-that-cannot-be-asked-per-nrmp-photo.jpg" medium="image" type="image/jpeg"/></item><item><title>NRMP Match Rules Explained: The Binding Commitment, the Withdrawal Deadline and Common Violations</title><link>https://med-rise.com/articles/nrmp-questions-answered</link><guid isPermaLink="true">https://med-rise.com/articles/nrmp-questions-answered</guid><pubDate>Thu, 07 Nov 2024 16:16:05 -0600</pubDate><dc:creator>MedRise News Desk (with AI assistance)</dc:creator><category>Guide</category><category>Articles</category><description>The NRMP Match is a binding contract. What the Match Participation Agreement requires of applicants, the violations that cause trouble, and what happens next.</description><content:encoded><![CDATA[<p>The National Resident Matching Program (NRMP), a nonprofit founded in 1952, runs the Main Residency Match, which places applicants in U.S. residency programs using both sides' rank order lists. Every participant agrees to the Match Participation Agreement (MPA), and it is a binding contract.</p>
<h2>NRMP vs. ERAS</h2>
<p>ERAS, run by the Association of American Medical Colleges, is how you send applications, letters and transcripts to programs. The NRMP handles Match registration, rank order lists, the matching algorithm and SOAP.</p>
<h2>The rules that matter most</h2>
<h3>1. A match is binding</h3>
<p>If you match, or accept an offer during SOAP, you are committed to train at that program. Only the NRMP can grant a waiver of that commitment; programs and applicants can't release each other (<a href="https://www.nrmp.org/topic/match-participants/?post_type=help">NRMP help</a>; <a href="https://nrmp.org/policy/professional-behavior">NRMP professional behavior</a>). Rank only programs you would actually attend.</p>
<h3>2. Withdraw on time if you take another position</h3>
<p>If you accept a position outside the Match, such as a military residency position, withdraw from the Match before the Rank Order List Certification Deadline; failing to withdraw by that deadline is a violation (<a href="https://www.nrmp.org/topic/match-participants/?post_type=help">NRMP</a>). The deadline falls in early March; for the 2025 Match it was Wednesday, March 5, at 9 p.m. ET (<a href="https://nrmp.org/wp-content/uploads/2025/02/Navigating-MW-SOAP-for-Programs.pdf">NRMP</a>). Check the <a href="https://www.nrmp.org/match-calendars/main-residency-applicants/">NRMP calendar</a> for the current year.</p>
<h3>3. No pressure about rankings</h3>
<p>Programs may not ask where else you applied or interviewed or how you will rank them, and neither side may require a ranking commitment from the other. You can volunteer information if you choose (<a href="https://www.nrmp.org/wp-content/uploads/2025/10/NRMP-Conference-Program-Policy-Handout.pdf">NRMP</a>).</p>
<h3>4. Don't contact SOAP programs first</h3>
<p>During SOAP, applicants and anyone acting for them may not contact a program until the program initiates contact after receiving the application (<a href="https://www.nrmp.org/about/news/2026/03/march-2026-illuminator-newsletter/">NRMP</a>). SOAP is part of the Main Residency Match, not a separate match you have to choose between.</p>
<h3>5. Keep the List of Unfilled Programs private</h3>
<p>Copying, sharing or posting the List of Unfilled Programs for anyone not registered for the Match is a violation (<a href="https://www.nrmp.org/topic/policies/?post_type=help">NRMP</a>).</p>
<h3>6. Be truthful</h3>
<p>Give accurate, complete information to the NRMP, to programs and to your school. Misrepresenting credentials, publications or eligibility can lead to sanctions.</p>
<h2>What happens after a reported violation</h2>
<p>The NRMP investigates, gathering information from the applicant, the program and anyone else with knowledge of the situation (<a href="https://www.nrmp.org/topic/match-participants/?post_type=help">NRMP</a>). Confirmed violations can bring sanctions, including bars from future Matches and a notation that programs can see in your Match history.</p>
<h2>Applying in Canada too</h2>
<p>You can take part in both the NRMP Match and Canada's CaRMS match. Under an agreement between the two, an applicant who matches in the country whose match runs first is removed from the other (<a href="https://www.nrmp.org/topic/the-match-process/navigating-r3/?post_type=help">NRMP</a>).</p>
<p>Related: <a href="https://med-rise.com/articles/questions-that-cannot-be-asked-per-nrmp">What residency programs can't ask you</a>.</p>
<p><em>Educational information only. Read the current Match Participation Agreement and confirm deadlines with the NRMP.</em></p>]]></content:encoded><media:content url="https://med-rise.com/images/articles/og/nrmp-questions-answered.jpg" medium="image" type="image/jpeg"/></item><item><title>Medical School Stock Trading</title><link>https://med-rise.com/articles/medical-school-stock-trading</link><guid isPermaLink="true">https://med-rise.com/articles/medical-school-stock-trading</guid><pubDate>Thu, 07 Nov 2024 15:02:34 -0600</pubDate><dc:creator>MedRise News Desk</dc:creator><category>Opinion</category><category>Articles</category><description>Published November 7, 2024. Prices and ratios are from that date and have not been updated. This is the author&#x27;s analysis, not investment advice. Medical…</description><content:encoded><![CDATA[<p><em>Published November 7, 2024. Prices and ratios are from that date and have not been updated. This is the author's analysis, not investment advice.</em></p> <p>Medical schools have been a part of the public stock market. One in particular is Adtalem Global Education Inc. (ATGE) which is the holding company for Chamberlain University, Walden University, American University of the Caribbean School of Medicine, Ross University School of Medicine, and Ross University School of Veterinary Medicine. The stock was trading at $75.30 on September 22, 2024, and today on November 7 it was trading at $90.66 (Adtalem Global Education, 2024; NYSE). </p><p>While there are several stock valuation methods, I decided to utilize absolute valuation to determine how this company is doing. Their P/E Ratio is 20.75 and the EPS is $3.44 which means it is priced higher than its earnings (these values reflect trailing 12 months). The company has a price-to-sales ratio of 1.79 which means it is valued at about 1.8 times its sales. Their gross margin is 55.47% (Adtalem Global Education, 2024). To understand relative I found out that it is trading above its industry peers at 20.13x ratio vs 19.77x (Yahoo Finance, 2024). </p><p><strong>References</strong></p><p>Adtalem Global Education. (2024, August 8). <em>Adtalem Global Education fiscal fourth quarter and full-year 2024 results</em>[Press release]. <a href="https://s24.q4cdn.com/745190157/files/doc_financials/2024/q4/Press-Release-Adtalem-Global-Education-Fiscal-Fourth-Quarter-and-Full-Year-2024-Results-FINAL.pdf">https://s24.q4cdn.com/745190157/files/doc_financials/2024/q4/Press-Release-Adtalem-Global-Education-Fiscal-Fourth-Quarter-and-Full-Year-2024-Results-FINAL.pdf</a></p><p>New York Stock Exchange (NYSE) (2024). <em>Adtalem Global Education Inc. (ATGE) stock information</em>. Retrieved November 7, 2024, from https://www.nyse.com/quote/XNYS:ATGE</p><p>Yahoo Finance. (2024, September 20). Why Adtalem Global Education Inc. stock is trending. <em>Yahoo Finance</em>. <a href="https://finance.yahoo.com/news/why-adtalem-global-education-inc-131408334.html">https://finance.yahoo.com/news/why-adtalem-global-education-inc-131408334.html</a></p>]]></content:encoded><media:content url="https://med-rise.com/images/articles/og/medical-school-stock-trading.jpg" medium="image" type="image/jpeg"/></item><item><title>How Interest Grows on Medical School Loans, and How to Make Compounding Work for You</title><link>https://med-rise.com/articles/future-value-and-compounding-for-the-medical-student</link><guid isPermaLink="true">https://med-rise.com/articles/future-value-and-compounding-for-the-medical-student</guid><pubDate>Thu, 07 Nov 2024 12:29:24 -0600</pubDate><dc:creator>MedRise News Desk (with AI assistance)</dc:creator><category>Guide</category><category>Articles</category><description>Federal student loans charge simple daily interest, not compound interest. How interest builds during school, when it is added to your balance, and how to compound.</description><content:encoded><![CDATA[<p>Compound interest earns interest on past interest. Put $100 in an account that pays 5% a year and you have $105 after one year and $110.25 after two, not $110, because the second year's 5% is figured on $105. Over decades, that difference is what makes early saving so powerful. Student loans work differently, and the difference matters for medical students.</p>
<h2>Federal loans charge simple daily interest</h2>
<p>Federal Direct Loans are "daily interest" loans: interest accrues every day on the principal, and unsubsidized loans start accruing as soon as the money is sent to your school, whether or not you are making payments (<a href="https://mohela.studentaid.gov/DL/resourceCenter/StudentLoanInterest.aspx">MOHELA, a federal loan servicer</a>). Because the interest is simple, unpaid interest does not itself earn interest unless it is capitalized, meaning added to your principal.</p>
<p>Since July 1, 2023, the Department of Education has eliminated capitalization in every case not required by law (<a href="https://www.eseanetwork.org/news-and-resources/blogs/used/education-department-releases-final-regulations-to-expand-and-improve-targeted-debt-relief-programs">U.S. Department of Education</a>). One common remaining trigger is the end of a deferment on an unsubsidized or PLUS loan (<a href="https://www.tateesq.com/learn/student-loan-interest-capitalization">Tate Law</a>).</p>
<h2>A hypothetical example</h2>
<p>For 2026–27, new graduate and professional Direct Unsubsidized Loans carry a fixed 8.07% rate (<a href="https://fsapartners.ed.gov/fsa-print/publication/1007224">Federal Student Aid</a>). Suppose a student owes $200,000 at 8.07%:</p>
<ul><li>Simple interest adds about $16,140 a year, or about $44 a day.</li><li>Over four years with no payments, that is about $64,560 of unpaid interest on top of the principal.</li><li>If that unpaid interest were capitalized, future interest would be figured on about $264,560, so each year would add about $21,350 instead of $16,140.</li></ul>
<p>Paying even part of the interest during school or residency keeps the balance from growing, and knowing which events trigger capitalization helps you avoid adding interest to principal unnecessarily. Each loan is fixed at the rate set for the year it was first disbursed, so your actual rates may differ.</p>
<h2>Put compounding on your side</h2>
<p>If you have earned income, such as from tutoring, scribing or summer work, a Roth IRA lets investments grow and be withdrawn tax-free in retirement, and you can take out your contributions (not earnings) at any time. Small, early contributions matter: $1,000 that grows 7% a year becomes about $7,600 in 30 years. Returns are never assured, and markets can fall, but time in the market is the one advantage students have over attending physicians.</p>
<h2>Bottom line</h2>
<ul><li>Federal loans grow linearly unless interest is capitalized; know your capitalization triggers.</li><li>Pay interest when you can, and track each loan's rate.</li><li>Start compounding for yourself early, even with small amounts.</li></ul>
<p>Related: <a href="https://med-rise.com/articles/beat-the-200-k-loan-cap-the-ultimate-529-med-school-reserve-playbook-2025-guide">What a 529 plan can and can't do under the new loan cap</a>.</p>
<p><em>Educational information only; not financial, tax or legal advice. MedRise is not a financial adviser.</em></p>]]></content:encoded><media:content url="https://med-rise.com/images/articles/og/future-value-and-compounding-for-the-medical-student.jpg" medium="image" type="image/jpeg"/></item><item><title>How Elections Impact the Healthcare Sector: What to Know</title><link>https://med-rise.com/articles/how-elections-impact-the-healthcare-sector-what-to-know</link><guid isPermaLink="true">https://med-rise.com/articles/how-elections-impact-the-healthcare-sector-what-to-know</guid><pubDate>Thu, 07 Nov 2024 12:22:06 -0600</pubDate><dc:creator>MedRise News Desk</dc:creator><category>Analysis</category><category>Articles</category><description>Published November 7, 2024, before that year&#x27;s U.S. elections. It reflects what was known then and has not been updated. Every election including this one…</description><content:encoded><![CDATA[<p><em>Published November 7, 2024, before that year's U.S. elections. It reflects what was known then and has not been updated.</em></p> <p>Every election including this one of 2024 with Donald Trump or with Kamala Harris, brings about significant changes across industries, and healthcare is no exception. Policies, funding, and regulations often shift with new administrations, directly influencing medical professionals, facilities, and patients. As healthcare providers and professionals prepare for the potential impacts of election outcomes, understanding the ways policies can shape healthcare can be invaluable.</p><p>In this blog post, we’ll explore the key areas of healthcare likely to be affected by elections, including healthcare funding, regulatory changes, and implications for medical education.</p><h2>1. Healthcare Funding and Access</h2><p>Election outcomes often impact government funding for healthcare programs, which can affect hospital budgets, insurance coverage, and access to care. Changes to Medicare, Medicaid, and funding for public health programs can have a ripple effect, influencing how healthcare providers allocate resources and treat patients. Medical students and residents can stay informed about these trends to better understand potential changes in their practice environments and the financial landscape of healthcare services.</p><h2>2. Regulation and Compliance</h2><p>Healthcare is one of the most heavily regulated sectors, and new administrations may bring in changes that affect how hospitals, clinics, and private practices operate. Compliance with updated health information privacy laws, insurance coverage requirements, and pharmaceutical regulations are just a few examples of areas that can change after an election. For healthcare providers, staying updated on regulatory shifts ensures they remain compliant and prepared for new operational requirements.</p><h2>3. Public Health and Preventive Care Initiatives</h2><p>Public health policies, including vaccination programs, preventive care initiatives, and mental health services, often take center stage in election platforms. Election outcomes may influence funding and support for these initiatives, impacting how healthcare professionals approach patient care. Medical students interested in public health should pay attention to changes in these areas, as they can shape career opportunities and practice focus.</p><h2>4. Implications for Medical Education and Training</h2><p>For medical students and residents, election outcomes can also impact the structure and funding of medical education. Changes in policies related to student loans, residency funding, and healthcare education grants can affect how medical professionals finance their training and access educational resources. By staying aware of these potential shifts, students can make informed decisions about their education and career path.</p><h2>5. Technology and Innovation in Healthcare</h2><p>Finally, new policies may promote advancements in healthcare technology and digital health. Some administrations may support funding for telemedicine, electronic health records, and AI-driven medical innovations, which can transform patient care and open up new career pathways for healthcare professionals. Staying informed about technology policy trends can help doctors, students, and healthcare organizations anticipate and adopt new tools effectively.</p><h2>Staying Informed and Adapting to Change</h2><p>Election cycles bring uncertainty, but staying informed on policy changes and understanding their potential impacts on healthcare can help professionals adapt and continue providing quality care. For those in the medical field, paying attention to healthcare-related election outcomes can help you plan ahead, from adapting to new regulations to seizing opportunities in emerging areas of healthcare. By doing so, medical students, healthcare providers, and patients alike can navigate the evolving landscape of healthcare with greater awareness and preparedness.</p><p>At MedRise, we’re committed to keeping healthcare professionals and students informed about the latest trends and policy changes that shape the healthcare industry. Follow our blog for more updates on topics that matter to your career and future in medicine.</p>]]></content:encoded><media:content url="https://med-rise.com/images/articles/og/how-elections-impact-the-healthcare-sector-what-to-know.jpg" medium="image" type="image/jpeg"/></item><item><title>Building Wealth as a Medical Student With Just $500: A Three-Step Starter Plan</title><link>https://med-rise.com/articles/building-wealth-as-a-medical-student-with-just-500-the-rockefeller-method</link><guid isPermaLink="true">https://med-rise.com/articles/building-wealth-as-a-medical-student-with-just-500-the-rockefeller-method</guid><pubDate>Thu, 07 Nov 2024 12:09:06 -0600</pubDate><dc:creator>MedRise News Desk (with AI assistance)</dc:creator><category>Opinion</category><category>Articles</category><description>For medical students, finances are often tight, and the demands of school make it challenging to focus on building wealth. But what if you could take a…</description><content:encoded><![CDATA[<h2></h2><p>For medical students, finances are often tight, and the demands of school make it challenging to focus on building wealth. But what if you could take a few small, strategic steps now to set the foundation for long-term financial success? A simple three-part framework, sometimes marketed as the "Rockefeller Method," can guide you even on a limited budget. Here’s how medical students can apply it with just $500.</p><h2>The three parts</h2><p>The framework has three parts: <strong>protect and diversify what you have</strong>, <strong>control your cash flow</strong>, and <strong>plan for the long term</strong>. Even with a modest starting amount, they help you build habits that pay off over time.</p><h2>Step 1: Asset Protection and Diversification</h2><p>The first step in wealth building is protecting what you have and setting up streams for growth. Even with $500, you can make meaningful moves here.</p><ol><li><p><strong>Start an Emergency Fund ($100)</strong>: Put aside $100 to start an emergency fund. While this amount may seem small, it's a safety net for unexpected expenses. Adding to it gradually creates a habit of saving and keeps you from relying on debt when minor emergencies arise. Consider keeping it in an FDIC- or NCUA-insured high-yield savings account instead of a regular savings account. The FDIC’s national average savings rate was 0.38% in August 2026, and many online high-yield accounts pay several times that, so compare current rates before you open one (<a href="https://www.fdic.gov/national-rates-and-rate-caps">FDIC national rates</a>).</p></li><li><p><strong>Micro-Investing for Growth ($150)</strong>: Consider putting $150 into a micro-investment account that allows fractional stock or index fund investments. Platforms like Acorns, Stash, or Robinhood let you start small, investing in the stock market or diversified funds with minimal upfront costs. This helps you begin growing wealth while developing an understanding of investments.</p></li><li><p><strong>Invest in Financial Knowledge ($50)</strong>: Use $50 to build your financial literacy. Buy a few finance books or sign up for a course on investing or budgeting basics. Building a foundation of financial knowledge early on is invaluable, especially for future high earners like doctors. Understanding how money grows and how to protect it will serve you well for life.</p></li></ol><h2>Step 2: Cash Flow and Income Control</h2><p>Managing your income and expenses well, even on a limited budget, is essential for financial stability. Here’s how to keep things on track:</p><ol><li><p><strong>Budget Consistently</strong>: Use a budgeting app such as Rocket Money or YNAB (You Need a Budget), or a simple spreadsheet, to track every dollar. Sticking to a budget makes it easier to see where your money is going, which is especially important when you’re balancing school expenses and personal spending.</p></li><li><p><strong>Automate Savings and Investing</strong>: Set up automated weekly or monthly contributions to your emergency fund and investment account. Even $5 a week adds up over time and becomes a powerful wealth-building habit. Automatic transfers keep you on track even when life gets busy, helping your money grow consistently.</p></li><li><p><strong>Explore Low-Cost Side Hustles ($100)</strong>: Consider using $100 to start a small side gig, like tutoring, freelancing, or content creation. Look for options that require minimal startup costs but offer flexibility around your study schedule. This extra income can go directly into your savings or investments, accelerating your wealth-building journey.</p></li></ol><h2>Step 3: Legacy and Generational Wealth Planning</h2><p>Legacy planning may sound premature when you’re just starting out, but taking small steps now can set you up for a lifetime of smart financial management.</p><ol><li><p><strong>Learn About Generational Wealth</strong>: With so many free resources available, take some time to understand the basics of wealth transfer, tax-advantaged accounts, and trusts. Starting to think about the long-term impact of your financial decisions will help you build a stronger foundation.</p></li><li><p><strong>Start a Simple Roth IRA ($100)</strong>: If you have any earned income from a job or side gig, consider contributing $100 to a Roth IRA. This retirement account grows tax-free, and starting one early lets your money compound over decades. Roth IRAs also offer the flexibility to withdraw your contributions without penalty if you need funds for emergencies.</p></li><li><p><strong>Consider Philanthropy</strong>: Purposeful money decisions include giving back. As you grow your finances, set aside a small portion of any gains or extra income for causes you care about. This helps reinforce a healthy mindset around money, reminding you to use it in ways that create a positive impact.</p></li></ol><h2>Final Thoughts</h2><p>Even with just $500, medical students can start building wealth by following these three steps. By establishing an emergency fund, dipping a toe into investing, automating savings, and learning about long-term financial strategies, you’re not only securing your financial future but also building habits that will serve you throughout your medical career and beyond.</p><p>Building wealth takes time, but this framework can keep you on track. These initial steps may be small, but with consistency, they have the potential to grow into a foundation of financial security and independence. Start small, stay disciplined, and let these habits guide you toward a prosperous future.</p><p><em>Educational information only; not financial advice. MedRise is not a financial adviser, and we do not earn referral fees from the companies named in this article.</em></p>]]></content:encoded><media:content url="https://med-rise.com/images/articles/og/building-wealth-as-a-medical-student-with-just-500-the-rocke.jpg" medium="image" type="image/jpeg"/></item><item><title>Caribbean Medical School Accreditation Explained: ECFMG, WFME and NCFMEA</title><link>https://med-rise.com/articles/understanding-caribbean-medical-school-accreditation-and-its-implications-for-medrise-users</link><guid isPermaLink="true">https://med-rise.com/articles/understanding-caribbean-medical-school-accreditation-and-its-implications-for-medrise-users</guid><pubDate>Thu, 07 Nov 2024 10:53:16 -0600</pubDate><dc:creator>MedRise News Desk (with AI assistance)</dc:creator><category>Guide</category><category>Articles</category><description>Your school&#x27;s accreditor affects ECFMG Certification, USMLE eligibility and federal loans. What ECFMG, WFME and NCFMEA each do, and what to check.</description><content:encoded><![CDATA[<p>U.S. MD programs are accredited by the Liaison Committee on Medical Education (LCME). Caribbean schools are accredited by national or regional agencies instead, and three outside bodies decide what that accreditation is worth for a U.S. career: ECFMG, the World Federation for Medical Education (WFME) and the U.S. Department of Education's National Committee on Foreign Medical Education and Accreditation (NCFMEA).</p>
<h2>ECFMG: the gateway to the USMLE and residency</h2>
<p>International medical graduates need ECFMG Certification to enter ACGME-accredited residency programs. Eligibility starts with the school: it must be listed in the World Directory of Medical Schools with an ECFMG Sponsor Note stating that its students and graduates can apply for ECFMG Certification and examination (<a href="https://imed.ecfmg.org/resources/CertificationFactSheet.pdf">ECFMG fact sheet</a>).</p>
<p>In 2024, ECFMG put its Recognized Accreditation Policy into effect. A school meets the policy if its accreditor is recognized by WFME or NCFMEA, the two organizations ECFMG has approved; more than 50 agencies worldwide hold one of those recognitions (<a href="https://ecfmg.org/focus/issue86.html">ECFMG</a>; <a href="https://www.ecfmg.org/accreditation/resources.html">ECFMG accreditation resources</a>). ECFMG said the policy would not, at first, be a requirement for ECFMG Certification, and that it will keep evolving (<a href="https://caam-hp.org/?p=2216">CAAM-HP summary of the ECFMG policy</a>). Many school websites still describe the older plan, under which WFME recognition would have become mandatory in 2024, so check ECFMG's own pages for the current rule.</p>
<h2>NCFMEA: about federal loans, not schools</h2>
<p>NCFMEA does not accredit schools. It reviews the standards a foreign country uses to accredit its medical schools and decides whether they are comparable to U.S. standards (<a href="https://surveys.ope.ed.gov/erecognition/wwwroot/documents/NCFMEA_Guidelines.pdf">NCFMEA guidelines</a>). A comparability determination is one of the requirements for a foreign school's students to borrow U.S. federal student loans. On its own, it doesn't make you eligible for the USMLE or the Match.</p>
<h2>What to check about your school</h2>
<ul><li>Its World Directory listing and ECFMG Sponsor Note.</li><li>Its accreditor, and whether WFME or NCFMEA recognizes that accreditor.</li><li>Whether it takes part in U.S. federal student aid, if you plan to borrow.</li><li>Its recent USMLE pass rates and residency placement results, from sources you can verify.</li><li>Any state rules on clinical rotations or licensing for graduates of international schools, if you have a target state.</li></ul>
<h2>Where MedRise fits</h2>
<p>MedRise helps students make sense of these rules and plan around exam and residency requirements. We are not a law firm and can't give legal advice.</p>
<p>Related: <a href="https://med-rise.com/articles/navigating-academic-dismissal-from-a-caribbean-medical-school-understanding-your-options-for-appeal">Academic dismissal from a Caribbean school: your options</a>.</p>
<p><em>Educational information only. Confirm current requirements with ECFMG, the U.S. Department of Education and your school.</em></p>]]></content:encoded><media:content url="https://med-rise.com/images/articles/og/understanding-caribbean-medical-school-accreditation-and-its-photo.jpg" medium="image" type="image/jpeg"/></item><item><title>Residency Process</title><link>https://med-rise.com/articles/residency-process-guide</link><guid isPermaLink="true">https://med-rise.com/articles/residency-process-guide</guid><pubDate>Thu, 07 Nov 2024 10:13:00 -0600</pubDate><dc:creator>MedRise News Desk</dc:creator><category>Guide</category><category>Articles</category><description>Learn about the residency process, timeline, order of events, and have your questions answered.</description><content:encoded><![CDATA[<p>There are a lot of uncertainties when applying for residency. There’s questions like “do I wait for my step score before submitting my residency application or submit to ERAS without a Step 2 score?” Or for that matter even a Step 1 score that might be missing from your application.</p><p>People often wonder will their application be considered late if they don't submit on the day that the application opens. Understanding the overall structure is key to answer those questions. As someone who has worked in a residency program before let's start with the overview of the residency process.</p><p><strong>Preparation Phase</strong></p><ul><li><p><strong>Self-Assessment and Specialty Selection:</strong> MedRise offers tools and resources to help you evaluate your interests and strengths, aiding in the selection of a specialty that aligns with your career goals.</p></li><li><p><strong>Understanding Program Requirements:</strong> Access comprehensive databases and guidance materials to familiarize yourself with various residency programs' criteria and expectations.</p></li><li><p><strong>Document Preparation</strong></p><ul><li><p><strong>Curriculum Vitae (CV) Enhancement:</strong> Utilize MedRise's templates and expert advice to craft a CV that effectively showcases your academic and clinical experiences.</p></li><li><p><strong>Personal Statement Development:</strong> Receive personalized feedback and examples to write a compelling personal statement tailored to your chosen specialty.</p></li><li><p><strong>Letters of Recommendation (LoRs):</strong> Learn strategies for selecting appropriate recommenders and tips on how to request strong, supportive letters.</p></li></ul><p><strong>ERAS Application Submission</strong></p><ul><li><p><strong>Application Guidance:</strong> MedRise provides step-by-step instructions on completing the Electronic Residency Application Service (ERAS) application accurately and efficiently.</p></li><li><p><strong>Program Selection Strategy:</strong> Access data-driven insights to help you choose programs that match your profile and preferences.</p></li></ul><p><strong>Interview Preparation</strong></p><ul><li><p><strong>Mock Interviews:</strong> Participate in simulated interviews to practice common questions and receive constructive feedback.</p></li><li><p><strong>Interview Tips:</strong> Gain access to resources that offer advice on professional conduct, attire, and effective communication during interviews.</p></li></ul><p><strong>Rank Order List (ROL) Submission</strong></p><ul><li><p><strong>Strategic Ranking Advice:</strong> MedRise offers guidance on how to rank programs based on your preferences and the likelihood of matching, ensuring an informed and strategic approach.</p></li></ul><p><strong>Post-Match Support</strong></p><ul><li><p><strong>Onboarding Assistance:</strong> Access checklists and resources to help you navigate the onboarding process smoothly after matching.</p></li><li><p><strong>Unmatched Applicants:</strong> For those who do not match, MedRise provides information on the Supplemental Offer and Acceptance Program (SOAP) and alternative pathways to secure a residency position.</p></li></ul></li></ul><p>By leveraging MedRise's comprehensive resources and expert guidance at these critical stages, you can enhance your residency application, increase your chances of matching successfully, and embark on your medical career with confidence.</p> <figure> <img src="https://med-rise.com/images/articles/blog-post-title-one-nnd8b-2.webp" alt="" loading="lazy" decoding="async">  </figure>]]></content:encoded><media:content url="https://med-rise.com/images/articles/og/blog-post-title-one-nnd8b.jpg" medium="image" type="image/jpeg"/></item></channel></rss>
